incivo works by blocking the activity of the virus that causes hepatitis c infection . it is used to treat adult patients with chronic hepatis ck infection in patients who are at least 1865 years of age and who are not previously treated with peginterferon alfa - 2b , ribavirin and telaprevir . these belong to a group of medicines called ns3 - 4a protease inhibitors . if you are not sure about any of these , talk to your doctor , pharmacist or nurse before you are given ibivo . how does i work when you are being treated with a type of the viral ( hla - b * 5701 ) from the age of 1865 , who are already taking two other forms of the same type of virus . the two active substances in 
do not take incivo : - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). - when taking peginterferon alfa and ribavirin , please carefully read the package leaflets from their respective manufacturers and their contradications ( e . g . pregnancy precautions ) carefully read all the information contained in the patient alert card given to you by your doctor . warnings and precautions talk to your doctor or pharmacist before taking the combined active substances , especially if they are used in combination with inciva . in addition , some patients may experience severe side effects when they first start using the medicine alfuzosin . this may increase the risk of symptoms of an enlarged prostate . patients who are also taking alpha - 1 - arrenoreceptor antagonists (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will prescribe the appropriate dose regimen for you based on your condition and body weight . the recommended dose regimen is 3 to 6 mg twice a day . this means taking 2 to 8 tablets every day for 6 days . for patients with both hepatitis c virus infection and human immunodeficiency virus infection , efavirenz is not recommended . if your doctor determines that you should take incivo at the same dose as for any other medicine , it is important that you follow the instructions in the package leaflets that are provided with these medicines . do not combine peginterferon alfa and ribavirin in one dose . it is especially important to keep track of the doses of these medicines as directed by your doctor and nurse 
like all medicines , this medicine can cause side effects , although not everybody gets them . rash may begin as an itchy skin rash . your doctor will tell you what to do if the rash gets worse or gets worse during the treatment . other symptoms that may occur following the re - administration of incivo include : - a severe skin reaction - tell your doctor immediately if you develop a skin r . report it immediately to your doctor if your rash does not go away or becomes severe or persists with other symptoms . signs of a rash such as fever , tiredness , swelling of the face and swelling of lymph glands , a wide - spread rash with peeling skin , fever and flu - like symptoms , and painful skin skin . these may be more common in children and adolescents . very common side effects ( may affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . this medicine does not require any special temperature storage conditions . incivo tablets should be stored in the original bottle and keep the bottle tightly closed in order to protect from moisture . the bottle contains one or more desiccants to keep the tablets dry . keep the desiccants in the bottle and do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet in the tablet core contains 375 mg telaprevir ( as mesilate ).  the other ingredients are : tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anonymous , sodium lauryl sulphate , croscarmellose sodium , and sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol ( 6000 ), talc , titanium dioxide ( e171 ), and iron oxide yellow ( see section 2 ). what if you get any of the information in this pack , please tell your doctor or pharmacist . what you need to know before you take any tablets , including what 
the active substance of zinbryta is daclizumab beta , which is a monoclonal antibody . what is zinbyta used for and why it has been prescribed for you ? your doctor has prescribed zinbeta because you have multiple sclerosis and you have had therapy for two ms treatment before , or when other treatments have not helped . inflammation reduces the protective sheath around the nerves ( central nervous system ), which controls the function of the brain and spinal cord . this loss of myelin ( also called demyelinating ) can lead to relapsing mesocogia , with repeated attacks ( relapses ). it is not known how this medicine works and how it works when your nerves no longer work properly . these attacks may be a sign that the disease is getting worse .
you should not be given zinbryta : if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine listed in section 6 . if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . read section 6 " possible side effects ". liver problems : do not take zinbecco - any other autoimmune disorders . do not use any other medicines , herbal supplements or any medicines or supplements . this is because some people taking these medicines may have liver side effects . your doctor may need to change your dose , monitor you more closely while you are being treated with these medicines . you should also tell your physician if : you have ever had depression or have in the past you have or think you have had , or you have
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to inject the recommended dose of zinbryta is 150 mg once a week . your doctor will decide whether to increase your dose based on results of a blood test carried out to check how well your liver is working . the recommended starting dose for adults and children of three years of age and older is one 40 mg dose . if your doctor decides that you will need this blood test , your doctor may decide that you should inject yourself zin bryta under the skin ( subcutaneously ). this can be your thigh , stomach , or back . or your upper arm . instructions for injecting zinbrita are given at the end of section 7 . you will be instructed how to give the injections at the same time each week 
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . your doctor will discuss the side effects with you and will explain the potential risks and benefits of your treatment . serious side effects tell your doctor or pharmacist immediately : liver problems ( very common , may affect more than 1 in 10 people ) unexplained nausea ( feeling sick ) or vomiting ( being sick ), stomach pain increased tiredness loss of appetite ( anorexia ) your skin or the whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon : may affect up to 1 in 100 people severe inflammation of the liver that may lead to death . contact your doctor immediately if your liver is not working properly . you may also experience muscle
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the zinbryta pre - filled syringe after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the product in the original package in order to protect from light . once removed from the refrigerator , use a new yeringe / pen . if you are not sure of this , please read the information under ' storage conditions ' at the end of this leaflet . remember to record the date when you first remove your pen from your refrigerator and the date after which it should be disposed of . you may also need to record when you have first removed a storage period of less than 30 days ( but not above 30 ). you must record the exact date on the
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 mg of daclizab beta in 1 ml solution for injection ( injection ) or one 150 micrograms solution for diagnostic use ( in 0 . 5 millilitres / litre of water for injection ). the other ingredients ( excipients ) are sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see end of section 2 under ' important information about some of the ingredients of zinbeta with sodium '), sodium content of the pack zin bryta is a colourless to slightly yellow solution . it is supplied as a sYringe / pen ( pre  filled pen ) with an attached needle .
wilzin belongs to a group of medicines known as metabolism products . it is used in adults to treat wilsson ' s disease , which is caused by a rare inherited defect in copper excretion in the liver , the eyes and the brain . this causes liver damage and neurological disorders in which the intestine is damaged , causing its further accumulation in the body . the active substance in wILzin is remdesivir . you will find this medicine in a medical clinic and it is prescribed for you because : - you have a problem with your liver . - your doctor has prescribed this treatment specifically for you in order to minimise the risk of confusion .
do not take wilzin - if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilszin ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . if any of these apply to you , or you are not sure , tell your doctor or pharmacist before taking wILzin . you may be given a lower dose of 1 g / m2 of your own blood during initial therapy . patients who suffer from signs and symptoms of  Wilson ' s disease may be treated with another anti - copper agent , penicillamine . your doctor will decide if and when you should be switched to 2 g for a second time . before you are given witzin for the initial treatment , your doctor may ask you to take other anti
what wilzin contains the different dose regimens are available in different strengths and strengths . the strengths are 25 mg and 50 mg each day . 1 dose will be given by your doctor . if you are switching from a higher dose to a lower dose , you may be given a 50 mg dose two weeks later . 2 doses can be given at the same time , based on how well you tolerate the medicine . each dose is taken in millilitres ( ml ) of water , with or without food . 25 mg tablets are available for patients who weigh less than 1 kg and who are unable to swallow tablets . it is also available as 50 mg tablets in multipacks comprising 2 packs , each containing a total of 25 mg . children aged 1 to 6 months must take the same dose as their parents , and their caregiver will decide which dose is most appropriate
like all medicines , wilzin can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common : affects 1 to 10 users in 100 ; uncommon : effect on 1 to10 users in 1 , 000 ; rare : efect on 10 users impotence : not known ( frequency cannot be estimated from the available data ) very common , but very common at the start of treatment : changes in : stomach irritation during treatment ; changes in blood tests that may show an increase in some liver and pancreatic enzymes and a decrease in blood red and white cells . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effect not listed in this leaflet . reporting of side effects you can help provide more information on
keep out of the reach and sight of children . do not store above 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains - the active substance is zinc . each hard capsule contains 25 mg zinc ( equivalent to 83 . 92 mg of zinc acetate dihydrate ). each capsule contains 50 mg or 100 mg zinc (" corresponding to 167 . 8 % [ qtc ]) ( g c dc ). the other ingredients are : capsule content : magnesium stearate . capsule shell : gelatin , titanium dioxide ( e171 ), brilliant blue fcf . printing ink : shellac , carnauba wax , white sb . 25 mg hard capsules . bottle imprinted with " gcf " on one side and " 50 mg " on the other side . the printingink is made of black iron oxide and white , with a blue imprinting ink filled with
bictegravir is an antiretroviral medicine known as an integrase strand transfer inhibitor . it contains the active substances emtricitabine and neomycin . each of these active substances is a rare but potentially life - threatening type of medicine called a nucleoside reverse transcriptasse inhibitor ( nrti ) tenofovir alafenamide belongs to a class of anti- retroviral medicines known as a nuclear - modified tRNA - 1 ( nutrtis ) biktarvy is used for the treatment of human immunodeficiency virus ( hiv ) infection in adults , adolescents , and children of 1 year of age . this type of hiv has been known to infect other people . by interfering with your immune system , bi
do not take biktarvy - if you are allergic to bictegravir , emtricitabine or tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking the following medicines : rifampicin , used to treat some bacterial infections such as tuberculosis - saint john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor or pharmacist before taking the medicine if : you have liver problems or you have ever had liver disease , including hepatitis . your doctor may want to monitor you more closely , especially if your condition has worsened during treatment . you have chronic
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . do not take antacids to prevent stomach ulcers , heartburn or acid reflux caused by aluminium or magnesium hydroxide mineral supplements and vitamins , magnesium and iron ( see section 2 under ' what you need to know before you take biktarvy '). your doctor may decide to reduce your dose , temporarily or permanently , depending on your condition and on your individual condition . if your doctor thinks that the effect of these medicines is too strong or too weak , talk to your doctor , pharmacist or nurse . patients on dialysis : take the tablet ( s ) at the same time each day and follow the instructions for use . you must not take more tablets than your prescribed dose . when you do take more than the recommended dose : if
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the side effects above , tell your doctor immediately : - inflammation or infection . in some patients with advanced hiv infection ( aids ) and a history of opportunistic infections ( infections that occur in people with a weak immune system ), signs and symptoms of inflammation from previous infections may occur soon after hiv treatment is started . it is thought that these symptoms are due to an improvement in the body ' s immune response , enabling the body to fight infections that may have been present with no obvious symptoms . this can be due to autoimmune disorders ( when the immune system attacks healthy body tissue ). this is particularly common in people taking biktarvy and tends to occur in very rare cases . however , in some cases , the body may not be 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and the carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the seal tightly closed in order to protect from light . please do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what biktarvy contains - the active substances are bictegravir , emtricitabine and tenofovir alafenamide . - each biktarivy tablet contains bictégravir sodium equivalent to 50 milligrams bictedregravir and 200 milligrammes entricit abine et / tenoviralafèneamide fumarate equivalent to 25 milliliters tenophovir altafénavir . the other ingredients are tablet core microcrystalline cellulose ( e460 ), croscarmellose sodium , magnesium stearate . film - coating polyvinyl alcohol , titanium dioxide , macrogol and talc , iron oxide red , and iron oxide black . not all pack sizes may be marketed .
novonorm is an oral antidiabetic medicine that contains the active substance repaglinide . it helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancréas does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . there are many factors that a person needs to know before he or she becomes ill : - it is important that you continue to follow the advice on diet , exercise and weight reduction that you will need to keep following the advice about diet and exercise that you have been given by your doctor , pharmacist or nurse . novonorgm can be given alone , or together with metformin , which is also used to treat diabetes .
do not take novonorm : - if you are allergic to repaglinide or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment : you have type 1 diabetes . this is when the acid level in your blood is raised ( diabetic ketoacidosis ). you have a severe liver disease . you take gemfibrozil ( a medicine used to lower increased fat levels in the blood ) 47 you have liver problems . your doctor may need to change the dose of novonom if the patient with moderate liver disease is taking it , but there is no information on the safety and efficacy of the product . there is insufficient experience with the use in patients with a severely liver disease you have kidney problems as there is limited experience with this medicine in these patients .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before a main meal ( for example , a 4 hour meal or a 30 minute snack ). the maximum recommended daily dose is 16 mg . do not increase your dose unless your doctor tells you to . if your blood sugar is too low , you may get a hypo , or your doctor may tell you to stop taking novonorm . your diabetes is not a problem ; therefore , your doctor should monitor the effectiveness of your treatment , so that it is easy for you to do normal daily activities , and to reduce the risk of it coming into contact with someone who is helping you to achieve your goals 
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of novonorm in adults ( very common , may affect more than 1 in 10 people ) is a hypo in section 2 . however , in a small number of cases , it can become severe and life - threatening and require immediate medical attention . in general , the hypo is essentially benign and disappears after a short time , usually without being permanently unconscious and leading to coma . allergy allergy is very rare ( may affect up to 1 in every 10 , 000 people ). symptoms such as swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating can be signs of anaphylactic reaction . if you have any questions about how this medicine works or why this medicine has been prescribed for you , ask
what novonorm contains the active substance is repaglinide . the other ingredients are microcrystalline cellulose ( e460 ), calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol 85 %, magnesium stearate , meglumine and poloxamer , iron oxide yellow ( only in the 1 mg tablet and in the 2 mg tablet ). the colouring is light brown , with " rvt " on one side and " nvr " on the other side . iron oxide red ( not all pack sizes may be available in your country ). what novovom looks like and contents of the pack novonomm tablets are round and convex and 0 . 5 mg . they have " 1 " and " 2 " printed on
pumarix is a vaccine for use in adults aged 18 years and over . it is intended to be given before or during the next pandemic flu ( influenza ) in order to protect against global warming and endemic global warming ( e . g ., north - or central hemisphere ) and may be caused by various types of influenza . the most common type of pandémic flu is not ordinary flu but can be spread by any age group . when a person is given the vaccine , the body ' s natural defence system ( immune system ) produces its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , it is important to tell your doctor if you or your child has any questions about what the vaccine may contain .
pumarix should not be given : if you have previously had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the substances that may be present in trace amounts as follows : egg and chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . however , in a pandemic situation , it may be appropriate for you to have the vaccine given as soon as possible and you may require medical treatment . in case you have an allergic response , you should not receive pu marix , as there is insufficient experience with this vaccine in children below 33 years of age . warnings and precautions talk to your doctor , pharmacist or nurse before you are given Pumarix 
pumarix is intended for use in adults aged 18 years and over . if you are not sure , talk to your doctor , pharmacist or nurse before you are given Pumarix . your doctor may administer a similar h5n1 as03 to children and adolescents ( from 18 years of age onwards ) when they are unsure about their dose . the recommended dose and duration of use are as follows : - a dose ( 0 . 5 ml ), - at the same dose frequency as for adults ; - in infants who are 3 - 9 years old or weighing less than 3 months to less than 10 - 17 years depending on the dose and dose , - your doctor will decide the appropriate dose for your child . puMarix is given as an injection into a muscle ( usually in the upper arm ). for further information on the use of this
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions which may cause you to have dangerously low blood pressure . if this is not treated it may lead to shock . you may need emergency treatment . the following side effects have been reported : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles , joint pain common : may affect up to 1 in every 10 people redness and swelling around the place of the injection fever sweating shivering diarrhoea feeling sick common . may affect less than1 in every 100 people injection site reactions : swollen hands , ankles or feet shaking . not known ( frequency cannot be estimated from the available data ) runny nose sneezing bruising , redness around the area of skin where the
keep this vaccine out of the sight and reach of children . before the vaccine is mixed : do not use the suspension and the emulsion after the expiry date which is stated on the carton . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . do not freeze . the vaccine should be used immediately after preparation . if not used immediately , the vaccine may be stored at room temperature ( up to 24 hours ) or below 30 .
what pumarix contains active substance : split influenza virus , inactivated , containing antigen * equivalent to : a / vietnam / 5 / 2005 ( h5n1 ) like strain used ( pr8 - ibcdc- rg2 ) * expressed in 0 . 5 ml * propagated in eggs ** expressed in microgram haemagglutinin this vaccine complies with the who recommendation and eu decision for the pandemic . the vaccine contains an ' adjuvant ' as03 that is used for the vaccinated infants , children and infants who cannot be fed their own sex without the help of their doctor ' s advice as this may affect the way the vaccine works . other ingredients : the other ingredients are : sodium chloride , disodium hydrogen
somakit toc is a radiopharmaceutical product that contains an active substance called edotreotide . the powder contains a nuclear medicine equivalent to gallium ( 68ga ) chloride , which is produced by recombinant dna technology . people who have been trained by the nuclear medicine doctor know that they have a high level of gallium (" 68Ga ] chloride "). people who are unable to take the medicine will be given information about this procedure . it is taken from a vein in one of their body areas , using a medical imaging procedure called positron emission tomography ( pet ). this medical procedure helps to obtain clearer images of the abnormal cells and tumours . as a result , the doctor can better understand how to treat your disease . if you have any questions about the use of so
do not use somakit toc - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). for signs of allergic reaction , see section 4 " contents of the pack and other information ". warnings and precautions talk to your doctor or pharmacist before you are given this medicine if any of these apply to you : - you have kidney or liver problems . you have renal or hepatic disease . children and adolescents do not give this medicine to children under 18 years of age because it is not known how long you will be protected from dehydration . - the examination will be carried out by a doctor under supervision of a healthcare professional . after 28 days , other medical conditions that affect the body such as cushing syndrome ( inflammation of the thyroid disease , or tumour ( of pituitary gland , lung
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakit toc will only be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . the quantity to be used 29 depends on the nuclear medicine doctor supervising the procedure . for the quantity of som akit tb , the recommended dose is 100 to 200 mbq ( megabecquerel , a unit used to express radioactivity ). the quantity required depends on your body surface area . administration and conduct of the procedure you will usually only be given one injection , but you will need to follow the instructions of your nuclear medicine physician . detailed instructions for administration and administration are given at the end of the leaflet . after radiolabelling 
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) to somakit toc . symptoms may include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may be severe . they may include stinging at the injection site , exposure to ionising radiation associated with the least risk of cancer and hereditary abnormalities ( see section 2 ). if you get any side effects tell your doctor or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . do not use somakit toc after the expiry date which is stated on the label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . after radiolabelling , in - use stability has been demonstrated for 4 hours at temperatures up to 25 and from a microbiological point of view , the product should not be used if it shows any visible sign of deterioration . if radioactive products are to be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines you no longer use .
what somakit toc contains - the active substance is edotreotide . one vial of powder contains 40 micrograms / 0 . 10 - phenanthroline ; gentisic acid , mannitol , formic acid ; sodium hydroxide and water for injections . the solvent contains sodium and , after radiolabelling , the solution contains hydrochloric acid ( e507 ) per vial . instructions for radiopharmaceutical preparation : the vial contains a glass vial with black flip - off cap . it is supplied as a white powder for solution for injection . each vial is packed in a cardboard box , with a clear plastic cap , to deliver a single dose of 40 iu ( 10 . 125 ml ). the
afinitor is an anticancer medicine containing the active substance everolimus . neverolimus works by blocking a receptor in the tumour , which is involved in the growth and spread of cancer cells . dansevoisin is used to treat adults with hormone receptor - positive advanced breast cancer in postmenopausal women who do not have enough hormones ( non - steroidal aromatase inhibitors ), to help control the disease under control . it is used in combination with a medicine called exemestane ( a so - called s - alumatitor ) and as a side effect of hormones , hormone therapy , for the treatment of advanced tumours and neuroendocrine tumours ( tumours in the stomach and bowels ) that have spread beyond the original tumour and / or to other organs .
you should not be given afinitor - as your doctor has told you . you should check with your doctor if you are not sure . before starting cancer treatment , tell your doctor about all the risks and benefits that you might have if any of the following applies to you : - are allergic to everolimus , to sirolimus or temsirolivimus or to any other ingredients of this medicine ( listed in section 6 ). if this applies to yew - these are all very common , and you must not be used to be treated with vuettazone . - you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or nurse before you are given vuetor if : you have any problems with your liver or any disease which may affect your liver . your doctor may prescribe a different dose
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg once a day . you should swallow your tablet whole with a glass of water . do not chew or break the tablet before swallowing . your doctor may decide to increase your dose of afinitor if your condition is not well controlled . patients with liver problems may need a lower dose of aspergillus ( 5 mg / 6 mg ) or a dose of 7 . 5 mg once daily ( starting in the morning and evening ). your doctor will decide the most appropriate starting dose depending on how you respond to certain side effects . if the tablet dose is too high or too weak , talk to your doctor as soon as possible to reassess the effects of the medicine . stopping treatment with Afinitor should be stopped unless your
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and seek medical help immediately if you experience any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps the following side effects have been reported with Afinitor : very common ( may affect more than 1 in 10 people ): increased temperature , chills ( signs of infection ) fever , coughing , difficulty breathing , wheezing these may be signs of inflammation of the lung ( pneumonitis ). cough , sore throat , runny nose , congestion of the sinuses , sinusitis , urinary tract infection , pneumonia , fungal infections , oral candidiasis ( infection
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , blister or blister after " exp ". store below 25 . store in the original package in order to protect from moisture . open the blister just before taking the tablet . the tablets should not be disposed of via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what afinitor contains - the active substance is everolimus . chacunitor 2 . 5 mg film - coated tablets : each tablet contains 2 , 5 mg of Everolimus ( as mesilate ). pouritor 5 mg movie - coating : one tablet contains 5 mg everoli Mus ( as miricon ). vueitor 10 mg video - capturing tablet - disposing of 10 mg of neverolimus are ingredients in the tablet core . the other ingredients are butylhydroxytoluene ( e321 ), magnesium stearate , lactose monohydrate ( see section 2 ), hypromellose , crospovidone , water for injections , all in the vial , partially hydrolysed ). what the heck are the contents of the pack agonyl alcohol - free white to slightly
what laventair ellipta is and how it works laventAIR ellippa contains two active substances , umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what lventair flatulence is and why this medicine has been prescribed for you is important to know how to use it and why it is used so that you can breathe more easily and effectively during your days at work . how laventaire ellipine is used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles around the airways tighten . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the 
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). this medicine should not be used in children and adolescents . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : - you have asthma ( it is not known if this medicine is safe or effective in people with asthma ). it should be used with caution in patients with asthma and patients with heart problems , high blood pressure , an eye problem called narrow - angle glaucoma , have an enlarged prostate , difficulty passing urine or a blockage in your bladder , or have a history of epilepsy or have thyroid gland problems ; diabetes ; or severe liver problems . immediate breathing difficulties include tightness of the chest and difficulty breathing
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use laventair ellipta regularly it is very important that your doctor , pharmacist or nurse shows you how to use it for as long as your condition is improving . if symptoms of a sudden attack of breathlessness or wheezing get worse or get worse you must use a quick - acting reliever inhaler ( such as salbutamol ). to use the inhalers instructions , see ' step - by - step instructions ' in this leaflet for full information .
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you have any of the following symptoms after taking laventair ellipta , stop using it and tell your doctor immediately . uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) or redness rare side effects these may affect less than 1 in 1 , 000 people : swelling , sometimes of the face or mouth ( angioedema ) becoming very wheezy , coughing or having difficulty in breathing suddenly feeling weak or light headed ( which may lead to collapse ). if any of these side effects causes you problems , talk to your doctor .
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microlitres ) and 22 microgramms ( 0 . 25 microlitre ) vilantanterol ( as trifenatate )- the other ingredients are lactose monohydrate ( see section 2 under ' laventaire ellippa contains lactoses ') and magnesium stearate ( e470b ). what laVENTair elipta looks like and contents of the pack laventAIR ellipinta is a white to off - white powder for inhalations , supplied in a single - use inhaler . the elli
tremfya contains the active substance guselkumab , a monoclonal antibody . this medicine attaches to a specific target in the body . the target of this medicine is il - 23 , which is a substance found on the surface of psoriasis . moderate to severe " plaque p soriaticsis " is an inflammatory condition that affects the skin and nails . it helps to improve the condition of your skin and the appearance of nails , and to reduce symptoms such as scaling . shedding , flaking , itching , pain and burning .
do not use tremfya - if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor . if your doctor thinks you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or nurse before using the medicine if : you have an active infection or you have been in close contact with someone who has active tuberculosis warnings , precautions or tests have not been carried out before you are given the medicine yourself . you have ever had or might now be at an increased risk of getting an infection . your doctor will check you for signs and symptoms of an infection before you start to use the medicine ( see section 4 ). you might be at risk of infections and allergic reactions . vaccination you should not be given 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of tremfya is 100 micrograms ( 1 pre - filled syringe ) given by injection under the skin ( subcutaneous injection ). it can be given from the age of 4 weeks up to 8 weeks after your injection . your doctor will decide how many days of treatment are needed . do not use more than your doctor tells you to . you should not attempt to inject yourself if your doctor thinks it is not effective or you feel you do not need it . for instructions on how to inject the medicine , see the box at the end of this leaflet . read the " instructions for use " for the injection carefully before you start using the product . it is very important that you read and follow the instructions of your doctor , pharmacist or nurse
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor , pharmacist or nurse straight away if you notice any of the side effects listed below : serious allergic reaction , which may include : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , with a red rash or raised bumps other side effects include the following listed below for your alert card . reporting of side effects you can help provide more information on the safety of this medicine . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects it is very important that you get this information . for more information , see the package leaflet of the medicine you are taking .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . this medicine should not be used if the solution is cloudy or contains flakes or large particles . after first opening of the refrigerator , allow the premixel to reach room temperature ( up to 25 ) and use within 30 days , even if it is not empty . your doctor or pharmacist is responsible for disposing of this medicine .
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg / 0 . 5 ml solution for injection ( injection ). - other ingredients ( excipients ) are histidine ( e331 ), hetidine monohydrochloride monohydrate , polysorbate 80 , sucrose , and water for injections . what histamine - derived solutions look like and contents of the pack solution is clear to opalescent , colourless to pale brownish - yellow , crystalline and aqueous to pale yellow solution . the solution is a clear colourless and clear to slightly yellow - to tan - white , clear to opaque , solution , free from visible particles , in a glass via
trepulmix contains a medicine called treprostinil . treprastiginil belongs to a group of medicines called prostacyclins , which are hormones that help to control blood pressure by relaxing blood vessels . prostacycles help to prevent blood from clotting . the active substance in TREpulmix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ) in adults who are still undergoing surgical treatment , and where exercise capacity ( the ability to carry out physical activity ) has not been demonstrated . it is not a cure for symptoms of the disease . in operation - related thrombophlembolic lung hypertension , when blood pressure is too high , or it interferes with the blood vessels of the heart and lungs .
do not take trepulmix : - if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if your doctor thinks you may have a disease called " pulmonary veno- occlusive disease ". this is a condition in which the blood vessels in the lungs become swollen , or there may be a higher pressure in the blood vessel between the heart and the pulmonary vessels . if the medicine has not been studied in patients with severe liver disease . tell your doctor or pharmacist if : you have ever had a heart problem before . you have had , in the last six months , severe changes in heart rate severe coronary heart disease , such as unstable angina a chest defect or 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is given as a continuous subcutaneous infusion under the skin ( intravenously ) through a small tube ( cannula ) in the abdomen or thigh . your doctor will decide how many treatments you need . before each infusion , you will be supplied with a portable pump containing your treprostinil . the pump must be connected to the infusion line and should be slowed down in case of accidental overdose . dose the usual dose is 1 to 2 . 5 mg per kg body weight , given every 5 to 10 minutes . how often you will have infusion you will usually have one infusion rate and your condition will be checked regularly . no special dose adjustments are necessary . patients with liver or kidney disease your
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , light - headedness or fainting at the start of low blood pressure skin rashes , muscle pain ( myalgia ) joint pain ( arthralgi ) swelling of feet , ankles , limbs swelling at the infusion site redness and swelling of the skin at the site of infusion bruising , swelling of hands , feet or ankles not known : frequency cannot be estimated from the available data fainting , which may occur with this medicine . trepulmix is given with medicines that reduce blood pressure . these are usually mild to moderate and usually go away within a few days . they can also occur with certain other conditions , but can be serious . do not try to treat
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicinal product does not require any special storage conditions . a trepulmix vial may be stored at room temperature ( up to 30 ) for up to one continuous subcutaneous infusion before use . in a single reserve ( syringe ) of undiluted TREpulmix , this 72 - hour period must be kept at all times , even if it is not used within the 72 hours it should be discarded . any unused medicine must be disposed of in accordance with local requirements . the following conditions are the responsibility of the user and would normally not be longer than the times stated above for reconstituted and discolouration , or other signs of deterioration , unless d
what trepulmix contains - the active substance is treprostinil . one gram ( 0 . 5 ml ) solution for injection contains 1 mg ( corresponding to 10 mg ) of TREprostiginil ( as sodium salt ). one vial of 10 mg contains 10 mg ( 5 mg ), corresponding with 10 mg of trepstINil ( since sodium salt is present in the form of sulphonylurea ). - one sachet of 2 , 5 mg ( 4 mg / 2 . 7 mg ). each vial contains 2 : 5 mg of delamanida . if you are not sure of the dose , talk to your doctor or pharmacist . the dose is the same as for the other ingredient : pegv1 inhibitor ( for the active ingredient ). the 10 mg
thorinane contains the active substance enoxaparin sodium . it is a low molecular weight heparin ( lmwh ) which is very similar to the natural protein contained in your blood . Thorinanne can be used in two different ways . 1 ) stopping existing blood clots from getting any bigger . this helps your body to break them down and stop them causing you harm . the other important part of your blood is through diet and exercise . by doing so , you will be able to eat and drink more blood than you should , and you will also be asked to drink more water . your doctor will also give you the lowest possible effective way of stopping blood clumps , especially if you are a patient with severe kidney problems .
do not use thorinane - if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include : rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you may be allergic to other low molecular weight heparins ( such as nadroparin , tinzaparin or dalteparin ). - you have ever had a reaction after you have been given hparin that caused a severe drop in the number of your clotting cells ( platelets ). this reaction can be a sign of 
like other similar medicines ( medicines to prevent blood clotting ), thorinane may cause bleeding which may potentially be life - threatening . in some cases the bleeding may not be obvious . at the first sign of any bleeding event that does not stop by itself or if you experience signs of excessive bleeding ( exceptional weakness , tiredness , paleness ), dizziness or headache with unexplained swelling , contact your doctor immediately . your doctor may decide to keep you under closer observation or change your medicine . take special care with Thorinansane : in case of a severe allergic reaction ( e . g . difficulty breathing , swelling of the lips , mouth , throat or eyes ), blockage of  a blood vessel which could lead to a bleeding clot , such as cramping pain , diarrhoea
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and pre - filled syringe labels after exp . store below 25 in the original package in order to protect from light . after dilution the solution should be used immediately , but within 8 hours it should not be used . this medicine is for single use only . discard any unused thorinane vial after first use . use immediately or store at room temperature ( not above 25 ). do not freeze . if refrigerated , allow the solution to come to room temperature prior to use , and in any case no longer than 8 hours from the time you first remove the vial from the refrigerator , or allow it to come into contact with the liquid . only use the torinnane pre  - loaded 
what thorinane contains - the active substance is enoxaparin sodium . each ml of solution contains 100 micrograms of énoxaparain sodium ( as mesilate ). each pre - filled syringe delivers 0 . 2 milligrams ( corresponding to a concentration of 2 , 000 microgram ) of еnoxa parin sodium when reconstituted with water for injections , i . e . vial . quantity of solution used is : a single - use , colourless type i neutral glass barrel with fixed needle and needle shield , closed with chlorobutyl rubber stopper and a blue polypropylene plunger rod . pack size of 2 ( 5 packs of 5 ) pre  filled pens . not all pack sizes may be marketed 
senstend contains lidocaine and prilocaine and belong to a group of medicines called local anaesthetics . it is used for the treatment of lifelong premature ejaculation in adult men . the head of the penis must be changed frequently to avoid ejection during adulthood .
do not use senstend : - if you are allergic to lidocaine or prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using , if : you have ever had allergy or sensitivity to other local anaesthetics , other than amide - type local anesthesias . you have a genetic disease or other condition that affects your red blood cells ( glucose ) such as phosphate deficiency , anaemia ( methaemoglobinaemia ). you have medicine sensitivities that increase the risk of sensitivity , you have severe liver problems . during treatment with this medicine , avoid accidental contact with ears , eyes , nose and mouth , especially in the eyes and in the dark corners of your eyes . contact
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . senstend is only suitable for use in adults . the recommended dose is 3 sprays ( 3 ml ) in the morning , followed by 1 spray ( 1 spray ) into the head of the penis . your doctor will decide how many sprays you need . a maximum of 3 doses can be used within 24 hours if kept in a locked cupboard . after 4 hours , the spray container should be removed from the pump mechanism and the valve should be opened . avoid contact with eyes , nose , mouth and ears if the pump is accidentally sprayed into the air , it should only be used for 1 second . press the plunger down and pull down the foreskin onto your head of your penis with the help of the valve . 1
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection decreased feeling in and around the penis feeling of burning in the inner lining of the peni increased feeling in the upper right hand side of the womb headache local irritation of the throat or irritation on the skin redness on the failure to ejaculate during sexual intercourse abnormal orgasm tingling in or around the inis pain or discomfort in or surrounding area ofthe penis itching , oedema feeling of heaviness in the lower arm or leg pain , especially when the sex drive or temptation to perform an action that could harm an unborn child . not known ( frequency cannot be estimated from the available data ) allergic reaction (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the metal container after exp . store below 25 and use within 12 months after first opening of the container . use the metallic container immediately or puncture , break or burn it if not used immediately . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . - two different strengths of solution are available : - each spray delivers 150 microlitres lidocanine / 50 micrograms pfizer , corresponding to 50 microliters / ml . this dose provides a steady amount of 7 . 5 microgram( iu ) of lidocabine & 2 . 4 microgram ( vwf ) pctfe / 20 microgram / dose . each spray container contains 5 or 12 sprays . the concentrate is a clear , colourless to light yellow cutaneous spray , solution in an aluminium spray container with metering valve . pack size : 1 spray container of 6 . 6 cm x 5 cm . not all pack sizes may be marketed 
opdivo is a medicine used in the treatment of advanced melanoma ( a type of skin cancer ) in adults . it is used when the incidence of advanced melanoma cannot be estimated from the available data or when complete resection in adults ( treatment with surgery ) is not feasible ( adjuvant therapy ). advanced non - small cell lung cancer ( lung cancer that is advanced in adults advanced renal cell carcinoma ) advanced kidney cancer in adults classical hodgkin lymphopenia ( all ) that has come back or has not responded to previous therapies ( e . g . an autologous stem - cell transplant ) or when a transplant is needed . advanced cancer of the head and neck in adults advance urothelial carcinoma ( lung and bladder and urinary tract cancer ). the active substance in this medicine is nivolumab 
do not use opdivo : - if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before you are given the medicine if : you have ever had problems with your heart such as a change in the rhythm or rate of the heartbeat , or an abnormal heart rhythm . your lungs can get damaged , causing breathing difficulties or cough . these may be signs of inflammation of the lungs ( pneumonitis or interstitial lung disease ). you have diarrhoea ( watery , loose or soft stools ), or any symptoms you might have . you have been told by your doctor that you have inflammation ofthe intestines ( colitis ), such as stomach pain , difficulty in breathing or swallowing . o
the recommended dose of opdivo in adult patients is 240 mg ( 2 x 480 mg ) given once a week . your doctor will decide whether to increase your dose to 4 mg / kg , depending on your response . if you have been prescribed a different dose , your doctor may decide to give you a lower dose . the recommended dosage of opsdivo when used in combination with ipilimumab is for the treatment of skin cancer . use in children and adolescents the recommended recommended starting dose in children is 1 mg nivolumab per kilogram of your body weight . this dose is calculated by your doctor according to the weight of the child ( 0 . 5 - kg ) divided into equal doses . additional doses in children ( 2 years of age and older ) if the child is less than 4 kg of age ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special storage conditions . opdivo may be stored below 25 for up to 48 hours at refrigerated temperature . once the infusion solution has been prepared it should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains - the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nyvolum . - each vial contains either 40 mg , 4 mg or 100 mg ( 10 mg or 240 mg ) per 24 hours , corresponding to a concentration of 24 mg / 0 . 5 mmol / millilitre ( vwf ).  the other ingredients are : sodium citrate dihydrate , sodium chloride ( see section 2 under ' important information about some of the ingredients of the concentrate '), mannitol ( e421 ), pentetic acid , polysorbate 80 , salts such as sodium hydroxide , hydrochloric acid and water for injections . not all pack sizes may be marketed .
the active substance of clopidogrel tad , claudine , belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by reducing the size of these structures , the body ' s own immune system is unable to remove them completely ( a process known as thrombosis ). by limiting their size , antiplatelets medicinal products reduce the chances of blood clats ( thrombi ) forming in hardened blood vessels ( arteries ). this process is known as atherothrombosesis . it is taken with caution to reduce the risk of atherathrombotic events ( such as stroke , heart attack , or death ). you have been
do not take clopidogrel tad 30 - if your doctor or nurse has told you you that you are allergic to clopizigrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if the medicine has been prescribed for you by your doctor , you should be told that you have severe liver disease before you start taking the medicine . warnings and precautions if any of these apply to you , or you are not sure , please tell your doctor before taking clocidogrell t ad . talk to your doctor about any risk of bleeding , including : - an untreated condition that puts you at risk of developing a risk of internal bleeding ( such as an stomach ulcer ), or a blood disorder
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day ( for example , one tablet of 150 mg or one of the many other ingredients in the medicine ), unless you are suffering from severe chest pain ( unstable angina or heart attack ). your doctor will determine the appropriate dose based on the weight of your child . usually , the dose is 300 mg . however , your doctor may prescribe you a lower dose of one 75 - mg tablet ( 4 tablets of 75 mg ) once a day as described above . you should take 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the whites of the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' what you need to know before you take clopidogrel tad '). - swelling in the mouth or skin disorders such as rashes and itching , blisters ofthe skin . this may be the first signs of an allergic reaction . the most common side effects ( affects 1 to 10 users in 10 , 000 ) are : headache , dizziness , headache
what clopidogrel tad contains - the active substance is clopizigrel ( as hydrochloride ). - each film - coated tablet contains 75 mg of cpd - crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil in the tablet core as well as polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide and yellow iron oxide , talc and macrogol 3000 in the movie - coating . you will find a link to the tablet vial if you have any questions about how this tablet works or why this medicine has been prescribed for you . do not take a double dose ( two doses on the same day ) to make up for a forgotten dose , please ask your doctor for advice . not all pack sizes may be marketed . what 
tacforius contains the active substance tacrolimus . it is an immunosuppressant . following your organ transplant ( e . g . liver , kidney ), your body ' s immune system will try to reject the transplanted organ . your doctor will prescribe tac forius to you in order to reduce the rejection of those organs , which you will not be able to accept . this will include those who have had their transplantation in the past . the medicine is used in adults , adolescents , children and adolescents . there are other medicines used to suppress your immune system , and this medicine can reduce the amount of new organs being taken out of the body by the kidney or heart . you will be given any previous treatment you were taking before your transplantation .
do not take tacforius : - if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking . - be sure that you tell the doctor if your dose is too low . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you must not be given if : your doctor thinks you may be allergic , ask your doctor for advice . your doctor will be able to give you any macrolide - antibiotic such as erythromycin , clarithromycin or josamycin . during the administration of tacrolivimus immediate release capsules ( e .g , taccni ) you will receive two doses during the prolonged - release period prior to administration , as tacrol
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed to you by a doctor with experience in the treatment of transplant patients . make sure that you receive the same tacforius medicine every time you collect your prescription , unless your transplant specialist has agreed to change to a different taccrolimus medicine . your doctor will tell you exactly the dose of this medicine to take . do not change the dose yourself . you should take this medicine at the right time and in the right way . to prevent the rejection of your transplanted organ will be calculated according to your body weight . initial daily doses just after transplantation will generally be in the range of 0 . 10 - 00 . 30 mg per kg body weight per day on the day 35 of transplantation . when treating rejection , these same dose
like all medicines , this medicine can cause side effects , although not everybody gets them . infections you must tell your doctor if you get any signs of infections while you are being given tacforius . severe effects may occur . allergic and anaphylactic reactions benign and malignant tumours have been reported in patients treated with tacfordius treatment . cases of pure red cell aplasia ( a very severe reduction in red blood cell counts ) have also been reported . agranulocytosis , a severely lowered number of white blood cells , haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ) and febrile neutropenia ( an increase in the number of black blood cells which fight infection ). these are signs of a reduction in the numbers of platelets . lymphocytes are important in the body to help your body
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . for all the prolonged - release hard capsules , use within 1 year of opening the aluminium wrapping . store in the original package in order to protect from moisture .
what tacforius contains - the active substance is tacrolimus . - each capsule of tac forius 0 . 5 mg contains 0 5 mg of tacrolivimus ( as monohydrate ). - one capsule each time you open a new opening opens new openings , allowing for greater openness . the opening may be observed as early as week 1 . each capsule contains approximately 1 mg ( 1 mg ) of tacrolulimus ( AS monohydrate
clopidogrel zentiva contains the active substance ' croscarmellose sodium '. it belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood otrosis of forming clots ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombosis . it is taken with caution to reduce the risk in adults who have had at least one other risk factor , such as stroke , heart attack , or death . you have been prescribed clopdоpa that your doctor has prescribed for you . your doctor
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to the active substance , or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor thinks this is too strong or not strong enough , tell your doctor or pharmacist as you may be at increased risk of severe liver disease . take special care with clodogrell  Zentiva the following are reasons why this medicine may not be suitable for you . see section " taking other medicines " and " take other precautions " for more information . you should tell your dentist that you are taking , have recently taken or might take any other medicines , including those medicines obtained without a prescription . be aware that some people who have a risk of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if there is still a certain type of severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg . your doctor will also give you one 300 mg tablet , once at least 4 weeks , up to a maximum of 75 mg , for as long as your treatment is successful . you should not take more than the 75 mg dose recommended by your doctor , but your doctor should give you the lowest possible effective dose . for further information , see
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the whites of the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' what you need to know before you take clopidogrel zentiva '). - swelling in the mouth or skin disorders such as rashes and itching , blisters ofthe skin . this may be the signs of an allergic reaction . the most frequently reported side effects are : headache , fatigue , dizziness , confusion , inability to fall asleep or stay asleep 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . if clopidogrel zentiva is packed in aluminium blisters , store below 30 . when stored in polyurethane syringe , it does not need to be re - primed . however , in order to protect from light , the product should not be put back in the refrigerator and should be disposed of in accordance with local requirements . once reconstituted in all aluminium boxes , this medicine should be used immediately . any unused product must be discarded after withdrawal of the dose and return to the pharmacy or the following recycling programme . these measures will help to protect the environment .
what clopidogrel zentiva contains - the active substance is called cbs . - each tablet contains 75 mg of clintirol ( as hydrogen sulphate ). ( see section 2 ' cd ') - some of the ingredients in the tablet core are lactose ' and ' colloidal ' contain hydrogenated castor oil ', mannitol ( e421 ), hydrogenated castle oil , microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose ( е463 ) and lactoses monohydrate ( milk sugar ), hypromellose ( 8cps ), triacetin ( 80f ), red iron oxide and titanium dioxide , and carnauba wax , indigo carmine wax .
yttriga is a radioactive medicine . it is used in combination with another medicine to deliver tiny radiation doses . if you have any questions about the treatment , ask your doctor . this medicine is only supplied as a single dose vial . each vial is stored in a refrigerator ( 2 - 8 ). storage at room temperature ( at or below + 25 ) means that the medicine is stable for a long time .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions pregnant , think you may be pregnant or are planning to become pregnant . talk to your doctor , pharmacist or nurse before you are given this medicine . do not mix yettrigga with a radioactive medicine , another medicinal product or with radiopharmaceuticals after the expiry date which is stated on the label and carton after " exp ". children and adolescents this medicine is for single use only . storage of radioactive material the risk for radioactive medicinal products should be considered in accordance with local requirements . children do not give this medicine to children under 2 years of age or to children below 16 years . this is because the product has not been tested in this age group . other medicines and 
your doctor will determine the optimal dosage for you and will explain the potential risks and benefits of the treatment . method of administration yttriga is to be administered under the supervision of a physician experienced in radiolabelling of medicinal products . the diagnosis and treatment of specific diseases will be carried out by your doctor and will be supervised by a specialist in appropriate premises . if you are given more than you should in the event of an overdose , you will receive appropriate treatment under appropriate circumstances .
like all medicines , yttriga can cause side effects , although not everybody gets them . if any of the side effects get serious , or if you notice any side effects not listed in this leaflet , please tell your doctor , pharmacist or nurse . reporting of side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises . storage is in accordance with local regulations relating to radioactive substances . the following information is intended for the specialist only . keep this medicine out of the sight and reach of children . do not use after the expiry date which is stated on the vial label and the carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . any unused medicine or waste material should be disposed of in compliance with local requirements .
what yttriga contains - the active substance is chloride . 1 ml sterile solution for injection contains 1 g of hydrochloric acid . the other ingredient is water for injections ( see section 3 under ' sodium content '). what the product looks like and contents of the pack the medicine is presented as a v - shaped bottom and a colourless type i glass vial , with 10 mm of a flat bottom , closed with a silicon stopper and an aluminium seal .
the active substance of ciambra is cisplatin , another anti - cancer medicine . it is used for treatment of malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , in patients who have not received prior chemotherapy . ciama is also given in combination with cISplatin for the initial treatment of patients with advanced stage of lung cancer . you may be given ciambaa if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy , but it may still be given as a treatment by a doctor or a nurse , especially when it is first given if there is still a possibility that you may still develop lung cancer after other initial chemotherapy has been used .
do not use ciambra : - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . please tell your doctor before you receive or during breast - feeding ; you must discontinue breast , feeding and follow - up during treatment with ciama . - you have recently received or are about to receive a vaccine against yellow fever . your doctor will discuss with you whether you can still be given the medicine , although the risk is lowered by the occurrence of this , you should not be given ciambamba . you have previously had problems with your kidneys . before each infusion you will be monitored carefully for changes in your blood and your kidney and liver function to check that you have enough
ciambra will be given to you in a hospital or clinic and the doctor will calculate your dose for you . the recommended dose is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area in square meter ( m2 ). your doctor will use this body surface area for work out your dose and will adjust the dose during treatment based on your blood cell counts and on your general condition . a healthcare professional , nurse or doctor will have mixed the CIAmbra powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution for injection before it is given ( s ) to make sure it is safe for you to drink it . you will always receive ciama by infusion into one of your veins ( intravenous use ). the infusion will last approximately 10 minutes 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately or contact the casualty department at your nearest hospital , if you get any of the following : 52 fever or infection ( common ): when ciambra is used in combination with a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . get medical help right away if your child gets chest pain ( uncommon ) or has a fast heart rate ( unusually intense pain , redness , swelling or sores in your mouth ) and allergic reaction . signs may include skin rash ( very commonly referred to as burning or prickling sensation , often with fever ). skin reactions may last
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special storage conditions . the infusion solution of pemetrexed can be stored for up to 24 hours at 2 - 8 , at 15 - 25 . if the reconstituted solution is not used immediately , the inffusion solution should be stored in the refrigerator at 2 to 8 and protected from light . however , chemical and physical in - use stability of the ciambra reassortant has not been demonstrated for longer than one day . once removed from refrigerated storage times and conditions prior to use are the responsibility of the user . for single use only . any unused solution must be disposed of in accordance with local requirement .
what ciambra contains - the active substance is pemetrexed . - each vial of ciembra 100 mg contains 100 milligrams ( millilitres ) of pemexed ( as pemezed disodium hemipentahydrate ). - every other syringe of cytoplasmic pharmacopoeia containing 500 mg contains 500 milligramms ( mg ) delamanid , corresponding to 25 mg / ml ( 0 . 5 mg ), corresponding with the ph adjustment indicated by the doctor . further dilution by a healthcare provider is required prior to administration . the other ingredients are mannitol  ( e421 ), hydrochloric acid ( for phe adjustment ) and / or sodium hydroxide
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) that are used to prevent certain infections from coming back in your blood . immunogam has been shown to increase levels of human hepatitis b immunisculitis , especially of the type of immunoglobuin g ( igg ). it can be detected from a blood plasma of screened individuals . what immunogam is used for immunogam can be used to treat the following diseases : - haemodialysed patients . vaccination with hpb is initiated by a qualified syringe . the product works by enabling the body to produce its own protection ( h5n1 ) in : healthy , stable and reliable means that it can supply sufficient quantities , such as : sufficient numbers of a certain type of virus carrier . - patients with an immune
immunogam should not be used : - if you have ever had an allergic reaction to human immunoglobulins or other blood products , or any of the other ingredients of immunogam ( listed in section 6 ). this could be due to an iga deficiency . warnings and precautions talk to your doctor , pharmacist or nurse before you are given immunogam . allergic reactions have been reported in patients receiving iga containing products . children and adolescents ( below 18 years of age ) receiving immunogam may experience adverse reactions such as chills , headache , fever , and vomiting . in the early stages of allergic reactions , you may experience nausea , arthralgia , joint pain , low blood pressure and moderate low back pain . your doctor will make sure that you have antibodies against hepatitis b immunoglobuulin regularly , since human he
immunogam is intended for vaccination against hepatitis b virus . it is intended that the first vaccine dose should be administered in accordance with official recommendations . the recommended dose is one vial ( 0 . 5 ml of total body weight ), together with one dose ( 100 micrograms ) of human hepatis - b immunoglobulin to be administered by a healthcare professional . dosage and administration prevention of the following doses are recommended for adults and children of all ages who have previously been infected with a possible increase in the risk of developing a new strain . dose against the active substance is 500 iu per day for 24 to 72 hours inhaled patients . administration of the first dose in haemodialysed patients is also recommended for the use of the 500 microgram dose in infants up to 2 months of age . seroconversion after
like all medicines , immunogam can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common : affects 1 to 10 users in 100 % uncommon : effect 1 to10 users in 1 , 000 % rare : effects 1 to 0 users in 10 000 ? undesirable effects observed during clinical trials with immunogam , the effects on the muscle were mainly observed during post - marketing use . uncommon ( effect affecting less than 1 per 10 . 000 ) very rare ( effect was observed between 1 and 10 users per 1000 ) not known ( frequency cannot be estimated from the available data ): 7 nausea , fatigue , induration , swelling and discolouration of the lips , mouth , tongue or throat . not known : frequency cannot
keep this medicine out of the sight and reach of children . do not use immunogam after the expiry date which is stated on the carton and on the label of the vial after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the container in the outer carton in order to protect from light . before using immunogam , check that the solution is clear or contains no particles , is cloudy or has deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains the active substance is human hepatitis b immunoglobulin . immunogam 1 mg / ml solution for injection contains 5 mg of human plasma protein of which at least 96 % is immunogam . the other ingredients are polysorbate 80 , water for injections , and skimmed silicon dioxide . see section " immunogam has a low - to - intermediate intermediate value ". WHAT immunogam looks like and contents of the pack immunogam is presented as a solutions for injection in a glass vial . it is a clear to slightly opalescent , colourless to pale yellow liquid . each pack contains 1 vial of solution .
remicade contains the active substance infliximab , which is of human , mouse or human origin - derived origin ( tnf - alpha )- a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called ' tumour necrosis factor ' ( tot nf ). remade is one of a family of medicines known as ' thnf blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew '' s disease ) paediatric use remyade may be used in adults and children 6 years of age and older for the treatment of crohn 's disease or ulcer
do not use remicade : - if you are allergic to infliximab or any of the other ingredients of remade ( listed in section 6 ). if your doctor thinks you may be allergic ( hypersensitive ) to proteins derived from mouse origin . tb is a serious infection that can occur in people with pneumonia or sepsis . it can happen in people who have heart failure , and so may need medical attention . warnings and precautions talk to your doctor before you start to use , or while you are being treated , at any time . you must tell your doctor if : you are not sure if any of these apply to you . your doctor may need to change your dose . take special care with reMICade see ' handling instructions ' at the end of this leaflet . before using re
rheumatoid arthritis the usual dose is 3 milligrams for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), p soriasis , ulcerative colitis and crohn 's disease the normal dose is 5 milligramms for each kg ( kg ) of bodyweight . your doctor will decide the dose you need . use in children and adolescents remicade is for infusion . the medicine will be given as an infusion ( drip ) ( over 2 hours ) into one of your veins , usually in your arm . after the third treatment , your doctor may decide to give the dose to you in one or more of your patients over one or two hours . when given as a single dose , it is unlikely to
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however some patients may experience serious side effects and may require treatment . side effects may also occur after your treatment with remicade has stopped . tell your doctor straight away if you notice any of the following : signs of an allergic reaction such as swelling of your face , lips , mouth or throat which may cause difficulty in swallowing or breathing , skin rash , hives , swelling of the hands , feet or ankles . some of these reactions may be serious or life - threatening . you should seek medical advice from your doctor , pharmacist or nurse . more information on the signs of such an reaction can be found at the end of section 2 " allergic side effects ". children and adolescents 12 years of age and older : pain in the muscles ,
remicade will generally be stored by the health professionals at the hospital or clinic . the storage details should you need them are as follows : keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . this medicine can also be stored in the original carton outside of refrigerated storage up to a maximum of 2 8 days at room temperature ( up to 25 ). do not freeze . after removing from the refrigerator , allow the medicine to come up to room temperature . use in children and adolescents the maximum recommended storage time from the time of infusion is 3 mg / m2 stored at 2 8 and 28 , but not beyond an additional 24 hours at 25 after removal from refrigeration . your doctor will determine the correct storage conditions prior to use . if you have any further questions on
what remicade contains the active substance is infliximab . each single - use vial contains 100 milligrams of intrigue ( as mesilate ). after preparation each ml of concentrate contains 10 mg of intrusion ( as isotope ). the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate ( e339 ) and dibasic salt ( see end of section 2 for further information ). what retinade looks like and contents of the pack remade is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder must be reconstituted and diluted before it is given to you , the solvent is a white to off - white cake or powder . some of the ingredients in the vial are : powder : re
rasagiline mylan is used for the treatment of parkinson ' s disease in adults . it can be used together with or without levodopa ( another medicine that is used in this medicine ) to treat parkinsons ' disease in adult patients . with parkinSON 's disease , there is a loss of cells that produce dopamine in the brain . dopami is essentially a chemical in the body that is involved in movement control . rasagile mylan encourages and stimulates the production of dopema within the brain to continue to grow .
do not take rasagiline mylan : - if you are allergic to rasagisiline or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions severe liver problems talk to your doctor or pharmacist before taking the following medicines : rasagaline mylan belongs to a group of medicines called monoamine oxidase ( mao ) inhibitors ( e . g . for treatment of depression or parkinson ' s disease ) or to medicinal and natural products , especially st john  s wort . pethidine ( a strong pain killer ). you must wait at least 14 days before starting rasagiatal mylan treatment . before starting treatment with mao inhibitors , you should also read the package leaflets for pethamine
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet of 1 mg taken by mouth once daily . rasagiline mylan should be taken every day at the same time of the day ( except on the first day ). you should swallow the tablet whole with a glass of water . do not chew , crush or split the tablet before swallowing as it may change the colour of the tablet . you should not take rasagide mylan with grapefruit or grapefruit juice unless your doctor tells you to do so . if your doctor thinks that you may have taken rasagaline recently , tell your doctor , pharmacist or nurse immediately . store in a refrigerator ( 2 - 8 ). do not freeze or shake . once removed from the glacial lake front of the glacier , rasag
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be more serious than those caused by placebo . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effect affects 1 to 10 users in 100 ) uncommon ( effect impacts 1 to 1 users in 1 , 000 ) very rare ( effect effects less than1 user in 10,000 ) not known ( frequency cannot be estimated from the available data ). very common abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy fever flu ( influenza ) general feeling of being unwell ( neck pain ) chest pain ( angina pectoris ) diarrhoea , stomach pain ( gastroenteritis ) rash , redness of the skin ( erythema multiforme 
what rasagiline mylan contains - the active substance is rasagisline . each tablet contains rasagariline tartrate equivalent to 1 mg rasagiata .  the other ingredients are microcrystalline cellulose ( e460 ), tartric acid , maize starch , pregelatinized maize meal , talc, stearic acid [ e570 ]) and edible edible film - coating . see information in section 2 . what rasagamine mylan looks like and contents of the pack rasagigiline tablets are white to off - white , 11 . 5 mm long and 6 mm wide , biconvex tablets , debossed with " gsi " on one side and " 1 " on the other side . the tablets are provided in blister packs containing 7 , 10 , 28 , 30 ,
do not use hulio if : you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). you have a severe infection , such as tuberculosis ( see " warnings and precautions "). it is important that you tell your doctor if you have symptoms of infections , e . g . fever , wounds , feeling tired , dental problems . you have moderate or severe heart failure . this is because it may have caused a serious heart condition ( called " allergic reaction "). if your doctor determines that you have allergic reactions with symptoms such as chest tightness , wheezing , dizziness and swelling or a rash , do not inject more hülio and contact your doctor immediately since , in rare cases , these reactions can be life
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . polyarticular juvenile idiopathic arthritis in children and adolescents ( from 2 to 17 years of age ): - for patients who weigh 10 kg or more , or who weigh 30 kg or less , hulio 20 mg is available as a single dose . for patients aged 2 to17 years , the usual dose is 30 mg / kg , but can be increased up to a maximum of 40 mg every other week . enthesitis - related arthritis in patients aged 6 to 17 year , and who weigh 15 kg to less than 30 kg : a daily dose of hULio is 20 mg . this can be used to treat children and young people aged between 6 and 17 years whose condition is not well controlled by technology .
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require urgent medical treatment . side effects may occur at least up to 4 months after the last hulio injection . seek medical attention urgently if you notice any of the following signs of allergic reaction or heart failure : severe rash , hives swollen face , hands or feet trouble breathing , swallowing ; pale complexion ; dizziness ; persistent fever ; bruising or bleeding ; signs and symptoms of infection such as fever , feeling sick , cough , flu - like symptoms , chills ; nausea and vomiting ; joint pain , back pain ; pain in joints . uncommon : may affect up to 1 in 100 people anaemia , which can be
what hulio contains the active substance is adalimumab . the other ingredients are monosodium glutumate , sorbitol ( e420 ), methionine , polysorbate 80 , hydrochloric acid , and water for injections ( see section 2 " important information about some of the ingredients of hULio " in section 4 ). what helio looks like and contents of the pack hellio 40 mg solution for injection in a sterile solution is provided as a single - use vial containing 40 mg / ml solution ( 0 . 8 % opalescent , colourless to pale yellow ) and has a rubber stopper . each vial contains a colourless or pale yellow solution and is supplied in either a carton containing 1
yellox contains bromfenac , a member of a class of medicines called non - steroidal anti - inflammation drugs ( nsaids ) which help reduce inflammation . Yellox is used for the treatment of eye inflammation following cataract surgery in adults .
do not use yellox : - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have asthma , skin allergy , or intense inflammation in your nose that is not controlled with other nsaids . your doctor may need to adjust your dose . you are also taking other non - topical steroids ( e . g ., acetylsalicylic acid , ibuprofen , ketoprofène , diclofеnac ) when taking this medicine together with topical steroids ( cortisone ) may increase your chance of unwanted side effects or increase your risk of bleeding problems . this is because of the extrapolation of haem
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop of yellox in each eye ( s ) once a day at about the same time each day . you can use the drops at any time of the day , with or without food . keep the bottle tightly closed in order to protect from light . do not remove the drops until the day after your cataract surgery . method of administration yellowx is for oral use . it is for use in adults only . wash your hands before you use the eye drops . remove the bottle cap . hold the bottle , pointing down , between your thumb and fingers . tilt your head back . pull down your lower eyelid with a finger . bring the bottle tip close to the eye . this will help to prevent it from sticking to your eye 
what yellox contains - the active substance is bromfenac . each ml of solution contains brom Fenac ( as sodium sesquihydrate ). each vial contains 33 mg of bromfedenac in the form of boric acid ( e330 ), borax , sodium sulphite anhydrous , benzalkonium chloride, tyloxapol , povidone ( k30 ), disodium edetate , and sodium hydroxide to adjust acidity levels . what the yarrow looks like and contents of the pack yyx is a clear yellow liquid ( solution ). it is supplied in a pack containing 5 glass vials with a screw cap .
dzuveo contains the active substance sufentanil . it belongs to a group of strong painkillers called opioids . sufenteanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). you have a serious lung or breathing problem . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you should not be given the medicine if : you have ever had any condition that affects your breathing ( e . g . asthma , wheezing , or shortness of breath ) you have been told that the effects on your breathing are too strong or too weak , and you are not able to take the medicine as your doctor has told you ( see section 4 ). your doctor may need to change your dose or stop treatment if any of these apply to you , including a head injury or brain tumour . changes in your heart and circulation , especially slow heart rate 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet per day by using the single - dose administration device . this medicine should be administered under the supervision of a doctor experienced in the use of this medicine . do not take dzuveo with strong painkillers such as sufentanil 30 mg . take the sublingual tablet immediately after use in the provided container with the disposable single  dose applicator provided in the pack . it is best to place the tablet in a glass or cup of water , using only one side of the tongue ( see instructions for use at the end of this leaflet ). the tablets dissolve in the liquid under the tongue and the tablet can be put back into the cup , so that there is no need for you to drink it . after 10 minutes , your doctor may
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you get any of the following side effects as these may be signs of severe breathing problems : slow and shallow breathing . if any of these side effects occur , contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ): nausea ( feeling sick ), vomiting ( being sick ) and feeling hot ( common side effect ). common may affect up to 1 in10 people : inability or difficulty sleeping . not known ( frequency cannot be estimated from the available data ). dzuveo may make you more likely to get infections or to develop infections . your doctor will tell you how to recognise them and what to do if they cause you problems . headache , being sick ( vomiting ), feeling hot , cough , diarrh
dzuveo will be stored by the health professionals at the hospital or clinic . the storage details are as follows : keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton , bottle or blister after exp . this medicine does not require any special temperature storage conditions . tell your pharmacist if you notice any visible sign of deterioration . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 milligrams ( mg ) of sufenteanil ( as citrate ). the other ingredients are mannitol ( e421 ), dicalcium phosphate , hypromellose ( 4cp ), croscarmellose sodium , indigo carmine ( k29 / 32 ), and stearic acid ( see end of section 2 ). what the applicator looks like and contents of the pack the tablet is white to off - white with round edges , marked with " 3 " on one side . it is supplied in a single - dose applicators ( labelled [ sublingual tablet ]. not all pack sizes may be available in your country . this medicinal product is available in three strengths : one suf
erleada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has not spread to other parts of the body or cannot be removed with surgical treatments . sensitive prostate cancer has come back in some patients who have not responded to surgical treatment and are not able to tolerate testosterone - resistant prostate cancer . erleda works by blocking the activity of androgens in the body , allowing the cancer to grow and thrive . while at the same time , it helps the body to absorb and destroy male sex hormones , such as testosterone , which in turn enables prostate cancer cells to multiply and divide .
do not take erleada if : you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). you are pregnant or think you may be pregnant ( see pregnancy , see contraception section ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . this medicine is for oral use . take special care with this medicine tell your doctor if you have : - a history of seizures - any medicines that can cause blood clots ( e . g . warfarin , acenocoumarol ) - or have any heart or blood vessel conditions , including heart rhythm problems ( arrhythmia ), which can increase the risk of falls . you should tell your healthcare provider if any of these apply to you . before you take the medicine , take extra care if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 240 mg once a day for the following day . you should take erleada about the same time each day , taking it with or without food . this medicine is for oral use . swallow the tablets whole , with some water or other non - alcoholic drink . do not crush , open or chew the tablets , to avoid unintended interfering with the preparation of the tablet . taking this medicine by mouth with food is not recommended . if necessary , your doctor may tell you to take it with other medicines , or with food , preferably at the same times each day with food ( for example , apple sauce , grapefruit or grapefruit juice ). you should swallow the whole tablet with a glass of water
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and tell your doctor straight away if you develop any of the following symptoms : - reddish , non - elevated , target - like , circular patches on the trunk , with central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may also be preceded by fever and flu- like symptoms ( toxic epidermal necrolysis ). serious side effects possible side effects may include fit , seizure or similar signs . uncommon ( may affect up to 1 in 100 people ): if your doctor considers that you may need to have a surgical procedure . your doctor may decide to delay your appointment . - you may experience a
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalutadite .  the other ingredients are : tablet core : colloidal anhydrous silica , croscarmellose sodium ( e468 ), hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose and silicified microscopic cellulose . the film coat consists of iron oxide black and iron oxide yellow , macrogol ( 6000 ), polyvinyl alcohol ( partially hydrolysed ) talc , and titanium dioxide , all in the tablet coating . what erin looks like and contents of the pack erin - era tablet is a colourless to slightly yellowish , round curved tablet debossed with " 60 " on one side
this medicine is a radiopharmaceutical product for diagnostic use only . axumin contains the active ingredient fluciclovine and is used to carry out a type of scan ( called a pet scan ) for patients who have not previously undergone treatment for prostate cancer . other tests may also show that the presence of prostate specific antigen ( psa ) has been confirmed to be present in the cancer , in case you need to have an aexumin pet scan in order to help your doctor determine whether the cancer has spread to other parts of the body . your doctor will take the scan if you have any questions about the results of the test . you may also like to have a test conducted to find out if the scan has been appropriate for you . the use of aXumin does involve exposure to small amounts of radioactivity . this procedure is to ensure that the
do not use axumin : - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you must not be given aexumin in order to treat kidney problems . - you should be on a low sodium diet as this may make you more likely to get infections . your doctor will tell you how much you should take . children and adolescents do not give this medicine to children or adolescents under 18 years old because the images are not clear and colourless . pregnancy and breast - feeding it is not known if a child is born prematurely . driving and using machines it is unlikely to affect your ability to drive and use machines . however , if the product is used after the expiry date stated on the label and
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . dose the nuclear medicine doctor supervising the procedure will decide on the quantity of aXumin to be used in your case . it will be the smallest quantity necessary to get the desired information . the quantity to be administered usually recommended for an adult ranges from 370 mbq ( megabecquerel , the unit used to express radioactivity ). administration and conduct of the procedure aixumin is given intravenously ( into a vein ) in hospital . after a flush of sodium chloride solution is usually sufficient to carry out the test that your doctor needs
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were reported : uncommon ( may affect up to 1 in 100 people ) - stop using the medicine . tell your doctor immediately if you notice any of the following serious side effects after using axumin ( see section 2 ): - pain , rash , altered taste in the mouth , or altered sense of smell . this radiopharmaceutical will deliver low amounts of ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects 25 - very common : side effects from clinical studies have been reported . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this product .
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . axumin must not be used after the expiry date which is stated on the label after exp .
what axumin contains - the active substance is fluciclovine . each tablet of aixumin 1600 mg contains 1600 mg of flucclovine ( 1600 mg / ml ) or 16000 micrograms ( 16 . 0 g / min ) in one tablet . the recommended doses for aexumin 3200 mg : the recommended dosage for patients who need a higher dose than 3200 is 32000 mg . ( additional information ) the other ingredients are : sodium citrate , concentrated hydrochloric acid , sodium hydroxide ( see section 2 under ' sodium content ') and water for injections ( see also section 2 for important information about the content of the tablets ). - each tablet contains a total of 1600 mg ( 16000 mg ) of solution for injection ( multidose ). packs of 1
the active substance of azopt , brinzolamide , belongs to a group of medicines called carbonic anhydrase inhibitors . they work by reducing pressure within the eye . their action is to reduce pressure in the eye which in some cases can be life - threatening or fatal . aziopt eye drops are used to control high pressure inthe eye , which can be a sign of an illness called glaucoma . increasing the pressure inside the eye can damage your sight .
do not take azopt if you have severe kidney problems . are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). allergic to medicines called " sulphonamides " ( medicines used to treat diabetes , infections or diuretics ( water tablets ). warnings and precautions talk to your doctor or pharmacist before taking the medicine if : you have the same allergy or you have too much acidity in your blood ( hyperchloraemic acidosis ) you have not taken the medicine before . you are breast - feeding . before you start to take the medicine you will be carefully checked by your doctor for any signs that suggest that you do not have any of these conditions . your doctor may want to monitor you more closely , and maybe decide to change your dose , if this happens to you . it is very important to tell your doctor
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is two drops in each eye , once a day in the morning and once in the evening . use azopt in both eyes if your doctor tells you to . 1 ) wash your eye . do not swallow or inject . it is best to rinse your eyes with water after each use . ( see instructions for use , at the end of this leaflet ). you can use the same dose every day , but it is not necessary to change the time of day you use it . how to use use 1 2 ) after using , wash your hands thoroughly . twist off the bottle cap . after removing the cap , snap collar is loose . hold the bottle , pointing down , between your thumb and finger . tilt your head
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision - eye irritation ; eye pain  eye discharge  itchy eye  dry eye - abnormal eye sensation  redness of the eye the most frequently reported side effects are : bad taste the most common is a slight increase in the amount of sugar in the blood . uncommon side effects which may affect more than 1 in 100 people - effect on the eye ( frequency cannot be estimated from the available data ): - allergic reaction ( e . g . swelling of the face , lips , tongue or throat ), difficulty in swallowing , hives , and increased tear production . reporting of side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle label and the carton after exp . this medicine does not require any special temperature storage conditions . azopt is for single use only . once opened a pack containing a single bottle should be used immediately . use in children and adolescents do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brinzolami .  the other ingredients are benzalkonium chloride ( see section 2 ), carbomer 974p ( edetate disodium ), mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid and / or sodium hydroxide to keep acidity levels ( ph levels ) normal . what the azeopt looks like and contents of the pack azamopt is a milky liquid ( a suspension ). it is supplied in a 5ml clear plastic ( droptainer ) bottle with a screw cap . the bottle contains a desiccant . not all pack sizes may be marketed .
the active substance of forxiga is dapagliflozin . it belongs to a group of medicines called " oral anti - diabetics ". these are medicines taken by mouth for diabetes . they work by lowering the amount of sugar ( glucose ) in your blood . for adults ( 18 years of age and older ) for the treatment of diabetes called " type 1 diabetes ", which occurs when your body does not make any insulin when it is treated . there is a certain type of diet and exercise " that you need to keep to : " good " or " bad "; " medium " ( overweight or obese ) ". " type 2 diabetes " ( where your body is not able to use any insulin properly ). the insulin that your body makes does not work as well as it should . you have diabetes : when your blood does not contain enough insulin or is unable to use the insulin it
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment : feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath ( especially a bitter or metallic taste in your mouth ), a different odour to your urine or sweat , rapid weight loss . the above symptoms could be a sign of " diabetic ketoacidosis " a problem you can get with diabetes because of increased levels of " ketone bodies " in your urine and blood , seen very rarely , in case you have this problem . your doctor may want to monitor you more closely , see a
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of forxiga for type 2 diabetes is one 10 mg tablet once a day . your doctor may prescribe you a lower dose of one 5 mg tablet if your doctor thinks you have a liver problem . do not take more tablets than your doctor tells you to take . for example , your doctor will prescribe the strength that is right for you , and that is based on your condition . the recommended starting dose is one tablet twice daily . you can take the tablet with or without food . however , try to take your tablet at the same time each day , as this will help you remember to take it . type 1 diabetes the usual dose is two tablets twice daily ( 10 tablets ) taken once daily , once in the morning and once
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are angioedema , seen very rarely ( may affect up to 1 in 10 , 000 people ). these are the signs of diabetic ketoacidosis . if you have type 1 diabetes ( see also section 2 warnings and precautions ), you may be at risk of developing a higher risk . in patients with type 2 diabetes , the risk is higher than in those who take forxiga , but who may be more likely to have it . only a few patients have experienced the following : increased levels of " ketone bodies " in your urine . this may cause difficulty swallowing and / or hives , or breathing problems . these effects are usually mild to moderate and usually go away within 2 to 3 days after starting treatment and rarely . diabetic
what forxiga contains - the active substance is dapagliflozin . - each FORxiga 5 mg film - coated tablet ( tablet ) contains dapagloviflouzin propanediol monohydrate equivalent to 5 mg dapaglingifloooozin ( as mesilate ).  the other ingredients are : tablet core : microcrystalline cellulose ( e460i ), lactose ( see section 2 under ' for more information on lactase '), crospovidone ( type a ), silicon dioxide and magnesium stearate . film coat : polyvinyl alcohol , titanium dioxide , macrogol 3350 , and yellow iron oxide , indigo carmine ( an off - white ) and sda 35a yellow tan ( s ) - orange ,
mepact contains the active substance mifamurtide which works by stopping the growth of certain bacteria , which are part of the immune system . the medicine is used to treat adults with osteosarcoma ( bone cancer ) which has come back 2 to 30 years after it has spread and cannot be removed by surgery to remove the tumour . it is also used in combination with chemotherapy to kill some of the cancer cells which have come back .
do not take mepact : - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). - when you are taking medicines containing ciclosporin , other calciumineurin inhibitors ( nsaids ), which are used to treat problems with your heart or blood vessels such as blood clots( thrombosis ), bleeding ( haemorrhage ) or inflammation of the veins ( vasculitis ). warnings and precautions talk to your doctor or pharmacist before taking Mepact and if : you have long - lasting or worsening symptoms and / or you experience no improvement after months or years of mepacting treatment . you have asthma or other breathing disorders . your doctor may want to monitor you more closely if your asthma is getting worse , if
treatment mepact will be given to you in a hospital or clinic under the supervision of a doctor experienced in the use of this medicine . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage your doctor will calculate the dose you need based on your body surface area in square meters ( m2 ) and will give you an initial prescription for 2 mg mifamurtide every 12 to 24 hours . your dose will be adjusted by your doctor according to your individual treatment treatments and your chemotherapy schedule . if necessary , your chemotherapy will be postponed until you are ready to receive your chemotherapy . it will take 36 weeks for you to fully understand the instructions for use . duration of treatment you will be monitored carefully for signs of an interruption in the processing of the powder . the freeze - dried powder is transformed into a liquid
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported very commonly in patients receiving mepacting as transient users of paracetamol . however , this does not necessarily mean that you will be at increased risk of fever . during treatment with mypact , you may experience stomach problems such as nausea , vomiting or loss of appetite as a result of chemotherapy . tell your doctor immediately if you experience continuing fever or chills after 8 weeks . warnings and precautions talk to your doctor , pharmacist or nurse before taking me Pact . you may develop an infection such as rash , or any problems breathing or wheezing . these may be signs of a serious allergic reaction . swallow the tablets whole , with a glass of water . do not chew , crush or split the tablets .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . this medicine does not require any special temperature storage conditions . keep the vial in outer carton in order to protect from light . reconstituted suspension with sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection will be stored at 2 to 8 for a period of 6 months . at the end of this period the product should not be used if it shows signs of deterioration such as particles in the suspension or if the suspension is not clear . any unused suspension must be thrown away in accordance with local requirements .
what mepact contains - the active substance is mifamurtide . each vial contains 4 mg / 0 . 4 mbq of mfamuratide ( 18f ). after reconstitution with suspension , each ml of suspension contains approximately 00 . 08 mg rdna ( g - ra ). - this medicine contains no other ingredients . - 1 - palmitoyl - 2- oleoy sn - grycero - 3 , phosphocholine ( pdn ) ( 1 , 2 ) and 2 - dioleayl- ssn- glycero 3 - serine monosodium salt ( e339 ) see section 2 for more information about some of the ingredients of me
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used in adults , adolescents and children of all ages who have redness on the face and / or rosacea to reduce the amount of redness that occurs in the facial skin and in children of any age , as a result of severe enlargement ( dilation ) of the small blood vessels of the skin . mirvasto acts by reducing the size of the blood vessels , thereby limiting the excess blood flow which results in redness .
do not take mirvaso : - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor , pharmacist , or nurse before taking Mirvaso ( see section 2 , possible side effects ). the medicine is injected under the skin and should only be given under the supervision of a doctor experienced in the use of certain medicines for depression or parkinson ' s disease . these include monoamine oxidase ( mao ) inhibitors ( e . g . selegiline and moclobemide ), tricyclic antidepressants ( imipramine ) and tetracyclic antagonistidepressants (" maprotiline , mianserin , mirtazapin ). if any of these apply to you , tell your
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is only suitable for use on the skin and only on the face . this medicine is for subcutaneous use . do not stick to any other part of your body or to other body surfaces , e . g . your eyes , mouth , nose or vagina . wash your hands thoroughly after each application . you can wash these areas thoroughly with mild soap and water . how long mirvasa should last for you will find this information when deciding on the correct dose . for adults , the recommended dose is one pea - sized amount of gel per day , which you will need to take on the day of the treatment . it may take a few days or up to one week before your symptoms get worse . the maximum daily dose of 1gram (
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects are : severe skin irritation or inflammation , skin rash ( which may cause skin pain or discomfort ), dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects include : worsening of rosacea and stopping the treatment if symptoms persist ( see section 2 under " warnings and precautions "), contact allergy , allergic reaction including rash , rare angioedema ( a serious allergic reaction which may be life - threatening ). the frequency of this event cannot be estimated from the available data . if you experience any of the following , tell your doctor or nurse immediately : - allergic reaction with rash and / or skin pain with or without discomfort , dry skin with warm skin feeling of ting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the tube and pump after exp . store in the original package in order to protect from moisture .
what mirvaso contains - the active substance is brimonidine . each gram of gel contains 3 . 3 mg of brimoninidine , followed by 5 mg / 0 . 5 ml deltoid . - this product is released slowly into the bloodstream by a single - use carbomer , containing methylparahydroxybenzoate ( as phenoxyethanol ), glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water . see section 2 for further information on the contents of the perforated syringe ( s ) of the parahydroethylsalicylic acid , propane glycol and ammonia ( ph - 171 ) ( see end of section 2 under ' mirvas
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the immune system , the body ' s natural defences ). it is used in adults to help defend the body from infection and cancer . by attaching to the vegf protein , it helps to grow within the blood vessels , allowing blood vessels to expand and provide more oxygen to the tumour . once attached to these receptors the receptors are activated , tumour growth is prevented by blocking their action . this new protein is then released into blood vessels where it can provide the nutrients and oxygen . vvasi is also a medicine used for the treatment of adult patients with advanced cancer in the large bowel . it is usually found in the colon or the bowel where it has spread
do not use this medicine - if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ). - are allergic (" hypersensitive ") to chinese hamster ovary ( cho ) cell products or to other recombinant human or humanised antibodies . warnings and precautions talk to your doctor , pharmacist or nurse before using mvasi . this is important as it may increase the risk of developing holes in the gut wall . - have conditions causing inflammation inside the abdomen ( such as diverticulitis , stomach ulcers , colitis associated with chemotherapy ). the risks of developing an abnormal connection or passageway between two organs or vessels are greater in patients who are at high risk for developing connections between the vagina and any parts of the gut . your doctor will discuss this with
dosage and frequency of administration the dose of mvasi needed depends on your body weight and the kind of cancer to be treated . the recommended dose is 5 ml , 7 . 5 mg , 10 mg or 15 mg / kg . your doctor will calculate the dose that is right for you . for your dose , the usual dose is based on your general condition and body weight . you will be treated at the same dose and frequency as for other tumour types . if you are given a higher or lower dose than you should , you may be given another dose . dose adjustments are necessary to keep you on the course of treatment . it is recommended that you continue with this medicine for as long as you are getting benefit from the treatment , as well as preventing your tumour growing . how the medicine is given your doctor may decide to continue to monitor the growth of your tumour and to prevent it from growing
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . most side effects were mild in nature and short term . the side effects listed below were seen when mvasi was given together with chemotherapy . you should be aware of the possibility of experiencing these side effects whilst you are being given mvai . allergic reactions - in rare cases an allergic reaction may be recognised as difficulty in breathing or chest pain . some patients have experienced redness or flushing of the skin or a rash . your doctor may also experience chills or shivering , feeling sick ( nausea ) or being sick ( vomiting ). the following side effects have also been reported : very common side effects ( may affect more than 1 in 10 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . this medicinal product does not require any special temperature storage conditions . store in a refrigerator ( 2 8 ). do not freeze . keep vial in the outer container in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 oc , but should not be put back in the refrigerator . when diluted in the sterile environment , chemical and physical in use stability has been demonstrated for 30 minutes at 2 - 8 followed by 48 hours below 30 . remove any particulate matter or discolouration prior to administration
what mvasi contains - the active substance is bevacizumab . each ml of concentrate contains 25 mg of bevacitab ( corresponding to 1 . 4 to 16 . 5 mg / mL when diluted as recommended ). each 4 mlitre vial contains 100 mg or 100 mg bevaizum b if diluted at 1 : 4 %, 16 % and 400 mg ( 8 . 0 mg ) of bevizumib compared to 16, 5 . 6 mg . the other ingredients ( excipients ) are trehalose dihydrate , sodium phosphate , polysorbate 20 , water for injections ( see section 2 ). what vvasi looks like and contents of the pack mvai is a concentrate for solution for infusion . its colourless to slightly yellow
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . it belongs to a group of medicines called ' autologous anti - cd19 - stimulated mcl+ cells '. these are called b - lymphocytes and are made up of your own white blood cells , which are then recombinant ( b lymphocyte - positive ) and then grown ( relapsed ) to make them into your own blood , enabling your own immune system to attack and destroy them . tecARTus is used in adults , adolescents and children whose disease has come back or has not improved after several years . the active ingredient in this medicine is called epidermal growth factor receptor ( egfr ), which is involved in the development of man ' s immune system . this means that the
do not use tecartus - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). you may be allergic to peanut or soya . warnings and precautions talk to your doctor , pharmacist or nurse before using the medicine if : - you have a reduced number of white blood cells in your blood ( lymphodepleting chemotherapy ) ( see section 3 , ' if the medicine is not suitable for you '). - your doctor will have to keep a record of the batches produced , stored and used in a controlled clinical setting . - the number of reconstituted and autologous use is not known ( frequency cannot be estimated from the available data ). tests and checks your doctor and / or nurse will do regular checks of your lungs , heart , kidney and blood pressure , as well as
tecartus is made from your own white blood cells . your cells will be collected from your blood using a catheter placed in your vein ( a procedure call leukapheresis ). if you have a shortage of your white blood cell , your blood will be pumped out of your vein , usually over a period of 3 to 6 hours . if there are more than 3 hours left in your blood , you will have to wait for a different time period . medicines you will need to take before and for at least 2 to 3 days to get a better response . the number of infusions you may receive is the same as for other types of lymphodepleting chemotherapy . these will be given to you by a doctor or nurse . they will keep you in regular contact with your body for 30 to 60 days . you may also be given other medicines to help prevent in
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss your side effects with you and will explain the potential risks and benefits of tecartus . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical attention : the following side effects have been reported during the Tecartus infusion . very common ( may affect more than 1 in 10 people ): - fever , chills , reduced blood pressure , symptoms such as dizziness or lightheadedness , fluid in the lungs , which are all symptoms of a condition called cytokine release syndrome . - loss of consciousness , decreased level of consciousness may be associated with confusion , memory loss , or confusion . these may be signs of nerve damage in the hands or feet . not known ( frequency cannot be estimated from the available
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the container label and infusion bag . store frozen in vapour phase of liquid nitrogen 150 for a single period of not more than six months . this medicine contains genetically modified human blood cells . any unused medicine or human - derived material should be disposed of in accordance with local requirements 36
what tecartus contains - the active substance is autologous anti - cd19 - stimulated d3 + cells , produced by recombinant dna technology . each patient - specific single infusion bag contains a dispersion of anti , 68 t cells in 2 ml of solution ( corresponding to a concentration of 106 x 106 anti ) at the date and time of calibration . the other ingredients are sodium chloride , human albumin , and water for injections ( see section 2 ' tecARTus contains sodium '). what Tecartus looks like and contents of the pack tecArtus is a clear to slightly opalescent , colourless to pale yellow dispersant , solution for infusion , supplied in a glass vial surrounded by a metal cassette . 
januvia contains the active substance sitagliptin which is a member of a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 5 inhibitors ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type2 diabetes . you should take this medicine in addition to certain other medicines ( insulin , metformin , sulphonylureas , or glitazones ), which also lower blood sugar from your diabetes and help prevent it from getting worse . do not stop taking sugar just because you feel better . it is important that you continue to follow
do not take januvia : - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . inflammation of the pancreas ( pancreatictitis ) has been reported in patients receiving  Januvia ( see section 4 ). it is possible that you may have blistering of the skin that looks like a sign for a condition called bullous pemphigoid . if any of these apply to you , tell your doctor or pharmacist before taking janusvia . your doctor may want to investigate the reasons why this medicine has been prescribed for you . you should not take the medicine if : you have been told by your doctor that you suffer from a disease of the panas , such as Pancreatiti
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual recommended dose is : one 100 mg film - coated tablet 63 once a day by mouth if your doctor thinks you may have kidney problems , your doctor may prescribe lower doses ( such as 25 mg or 50 mg ). your doctor will prescribe this medicine alone . this medicine can be used alone or with certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar better . it is important that you continue to take januvia until your doctor tells you to stop taking this medicine . do not stop taking the medicine without talking to your doctor first . if this medicine does not work well enough , you may find it easier to take it at the same times every day . you should continue to follow your food and exercise plan while taking this
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects you may need urgent medical attention : severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatictitis ). a serious allergic reaction ( frequency not known , cannot be estimated from the available data ) that may include rash , hives , blisters on the skin ( peeling skin ) and swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing . you should stop taking this medicine and contact your doctor or seek medical help immediately , since this medicine may not work as well as it should 
what januvia contains - the active substance in each film - coated tablet ( tablet ) is sitagliptin phosphate monohydrate , equivalent to 25 mg sitaglitin . the other ingredients are : in the tablet core : microcrystalline cellulose ( e460 ), calcium hydrogen phosphat , croscarmellose sodium , magnesium stearate and sodium stearyl fumarate . in addition , the tablet film coat contains : poly ( vinyl alcohol ), macrogol 3350 and talc , titanium dioxide , red iron oxide , and yellow iron oxide [ e172 ) [ bmi [ cmd ] and tan [ sda 35a ] ( ph - 173b ). what ianauvia looks like and contents of the pack round shaped , pink film
what xultophy is and how it works the active substance of xULTOphy , insulin degludec , is a long - acting basal insulin that lowers blood sugar . it is used when diabetes - related conditions such as liraglutide or glp - 1 are not enough to provide adequate insulin during meals . how xültophy works the body makes better use of its own insulin when it is not needed . when used in adult patients , the level of sugar in the body cannot be controlled by diet , exercise and exercise . both of these active substances work in the same way and work in different ways to improve your blood sugar levels . in combination with diet and exercise the insulin that your body makes does not work as well as it should . your doctor may prescribe insulin degoût , a longer - working basal Insulin , which
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 39 talk to your doctor , pharmacist or nurse before taking this medicine if : you 39 are taking a sulfonylurea such as glimepiride or glibenclamide . your doctor may need to change your sulphfonicurea dose , as it may affect your blood sugar levels . you should continue to follow the advice on diet and exercise that your nurse or doctor has given you . if any of these apply to you , tell your doctor or pharmacist before taking the medicine ; you have type 1 diabetes mellitus or ' ketoacidosis ' ( a condition which occurs more frequently in women ). x
always use this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . xultophy is not recommended for use in people who are blind or have poor eyesight . your doctor will test your blood sugar level . you should not use more than your doctor tells you to use . use in children and adolescents the recommended starting dose of xULTOphy is 41 mg once a day . read the user manual carefully as well as the patient alert card provided in the carton . the dose counter for the pen contains 1 mg insulin degludec and 0 . 036 mg liraglutide . how to use the pen see the user ' s manual for step - by - step instructions for using the pen . do not try to use it if it has not worked for you or if there are any problems 
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects with xultophy are low blood sugar ( very common , may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out ( become unconscious ). serious hypoglycaemia may cause brain damage and may be life - threatening . if you are caught up in the below , you must talk to a doctor immediately . for more information , see the box at the end of this leaflet . serious allergic reaction ( anaphylactic reaction ) has been reported ( frequency not known ) but you must report it to your doctor as soon as possible . this includes any possible signs of a serious allergic response . not known ( frequency cannot be estimated from the available data ): - local reactions where the injection is given , and 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , on the blister and on the label of the vial after exp . this medicinal product does not require any special storage conditions . after opening : chemical and physical in - use stability has been demonstrated for 8 hours at room temperature ( up to 30 ). from a microbiological point of view , the product should be used immediately . however , xultophy can be stored at 2 - 8 for up to 21 days , but not beyond 21 days from the date on which it should be discarded .
what xultophy contains - the active substances are insulin degludec and liraglutide . each ml contains 100 units of insulin deGludec , corresponding to 3 . 6 mg / mL . when reconstituted , each 3ml ampoule contains 300 unit(s ) of insulin dégluDEc at a concentration of 10 . 8 % iu ( international units ) ( 0 . 5 %) solution for injection ( see section 2 ) for further information on insulin and glycerol . the other ingredients are : phenol , zinc acetate , hydrochloric acid , sodium hydroxide ( for ph adjustment ) and water for injections . see also section 2 for important information about sodium . pack sizes of 1 , 3 and 5 vials ( for
giotrif is a medicine containing the active substance afatinib , which blocks the activity of two proteins called egfr [ epidermal growth factor receptor 2 ]) and her2 [ erbb1 ]- 3 . her2 receptors are involved in the growth and spread of cancer cells . by blocking the action of these proteins , they help cancer cells grow and multiply . this medicine can slow down the growth of these cells and slow down their growth , allowing it to work more effectively in the long - term , and eventually kill them . in this way this medicine works by blocking their action . it is used to treat a certain type of cancer of the lung ( non - small cell lung cancer ). you will receive gioTRIf as your first treatment in patients who have not received prior chemotherapy treatment ( for patients of squamous type 
do not take giotrif if : you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) you have low body weight less than 50 kg you have kidney problems . talk to your doctor if you think any of these apply to you . he may need to adjust your dose . this is because it may increase your risk of side effects . you have lung inflammation ( interstitial lung disease ). you have liver problems and your doctor may do some liver tests before and during treatment with this medicine you have a severe liver disease you have eye problems , such as severe dry eyes , inflammation of the transparent layer at the back of the eye ( cornea ) or ulcers in the front of your eye . warnings and precautions talk to you doctor , pharmacist or nurse before taking this medicine if your doctor thinks you have any problems with your liver
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one 40 mg tablet once a day . swallow the tablet whole with a glass of water . do not chew , crush or split the tablet . this medicine can be taken with or without food . you should continue taking this medicine for as long as prescribed . your doctor will tell you exactly how many tablets of this medicine to take . the daily dose depends on how much medicine you should take and for how long you need to take it . for adults , adolescents and children weighing at least 1 year and above , your doctor may prescribe a lower or higher dose to a maximum of 3 tablets per day depending on how you respond to giotrif . to benefit from this medicine , you can take the tablets at any time of the day ,
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects may happen with the start of treatment : diarrhoea ( very common , may affect more than 1 in 10 people ): tell a doctor straight away if you get an early warning of diarrachoeal , which may be life - threatening or even fatal . see also section 2 " warnings and precautions ". severe diarhoaea may lead to fluid loss ( commonly seen in at least 1 in every 10 patients ). low blood potassium may be a factor in worsening kidney function . contact your doctor as soon as possible if it occurs . if your doctor notices diarrhea , stop taking the medicine and seek medical help immediately . your doctor will discuss with you the most appropriate antidiarr
what giotrif contains - the active substance is afatinib . - each film - coated tablet contains 20 mg of a fat inib ( as mesilate ).  the other ingredients are : lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate ; hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 , carnauba wax , white to off - white , round shape with " gsi " on one side and " nvr " on the other side ; water for injections ( see section 2 ), and water for injecting " otsuka " and aqua regurgitated on the next day of the month . what 
orkambi contains two active substances , lumacaftor and ivacastor . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults and children from the age of 6 years with a f508del mutation , which is required to change the name of a protein in the lungs . the mutation causes the body to produce its own protection ( capillary - derived ) protein , called a " cosmopolitan peptide ". the active substances in the medicine work together with other proteins in the body , to increase the amount of protein in your body . this will increase your ability of the abnormal fftr protein to work more normally , and to improve your breathing and your lung function . as a result , your body will not be as good as normal at
do not take orkambi : - if you are allergic to lumacaftor , ivacaftar , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking any other medicine . do not start taking ork Ambi unless your doctor has told you that you have the f508del mutation or a ' f ' in the gene used to make the medicine work . your doctor will check that the medicine is working for you . if the product does not work as well as it should , you should contact your doctor . talk to you doctor if any of these apply to you : you have liver or kidney disease you have not tested for this gene before deciding on the dose of orkaambi . you have abnormal blood tests of the liver before and during treatment with ork
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage for children aged 6 to 12 years : the recommended orkambi tablet is one tablet once a day in the morning and one tablet in the evening . do not take more than one tablet each day . use in children aged between 6 and 11 years is the same as for adults . the recommended dose of ork Ambi is 100 mg or 2 tablets in the afternoon and 2 tablets once in the night . children aged 2 to less than 12 years the recommended starting dose of a new patient is 200 mg . method of administration take the tablets with food or between meals . swallow the tablet whole with a drink such as water , yogurt or apple sauce , apple juice , coffee or tea . it is best to take the tablet at the same time each day and not to crush or chew the tablet 
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects seen with orkambi being taken in combination with ivacaftor are similar but may be more serious . tell your doctor immediately or go to the casualty department at your nearest hospital if you get any of the following serious side effects while being treated with Orkambi : - raised levels of liver enzymes in the blood , which may increase the risk of liver injury - pre - existing severe liver disease - the worsening of liver function uncommon side effects ( may affect up to 1 in 100 people ) - pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the whites of your eyes - loss of appetite - diarrhoea - nausea or vomiting - rash - increased levels of bilirubin in the
what orkambi contains - the active substances are lumacaftor and ivacastor . - each of the three active substances of orkaambi 100 mg / 125 mg are taken orally . each capsule contains either 100 mg or 105 mg lumаcaftors ( with a nominal nominal vwf of 125 iu ivacaftore ) or 108 , 500 micrograms ( as prasugrel ). - either a tablet contains 200 mg , 125 microgram ( as pre - filled ) tablets , or 114 - 180 ( as monoclonal ). each capsule of 200 mg contains a total of 129 - 140 ( as megabellar - sulfatase ). the other ingredients ( excipients ) are : o tablet core
what lynparza is and how it works lyinparza contains two active substances : olaparib .  okarib is a type of cancer medicine called a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ]). people who have mutations ( changes ) in the gene that make brca ( breast cancer gene ) grow out of control . cancer patients who don ' t respond well enough or are infertile . parp inhibitions can lead to death of cancer cells . how lyndparza works the body can make an enzyme that helps to repair dna , which is needed to repair the disease . the active substance in this medicine helps the body to make its own medicines work . what allynparaza is used for in adults , ly
do not take lynparza - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor , pharmacist or nurse before or during your course of 2 months before starting treatment with the recommended dose . read the " instructions for use " for the complete list of ingredients . if there is anything you do not understand , ask your doctor or pharmacist for advice . do not stop taking the medicine unless your doctor tells you to . you may be more likely to have low blood cell counts . your doctor will do testing to make sure that you have low counts of red or white blood cells , or low platelet counts , see section 4 " possible side effects ", in section 75 for a list of signs and symptoms . fever , infection , bruising or bleeding more serious problems with the bone
always take lynparza capsules exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take your doctor will tell you exactly which strength of lyinparza to take and how long you should continue to take it . the usual dose is two 100 mg capsules twice a day . your doctor may decide to increase your dose to 150 mg once daily . do not divide , crush or chew the capsules , as each has a different colour and content of the capsule . tablets should not be divided into equal doses . swallow each capsule whole with a glass of water . it is best to take the whole capsule with or without food . to reduce the risk of side effects , you can take the capsule content with food or between meals . for adults , adolescents and children aged 8 years and above , the recommended starting dose
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): - feeling short of breath , feeling very tired , having pale skin , fast heart beat . these are symptoms of a decrease in the number of red blood cells ( anaemia ) . uncommon ( might affect up to 1 in 100 people ); - allergic reactions such as hives , difficulty breathing or swallowing , dizziness . signs and symptoms suggestive of hypersensitivity reactions . other side effects include : very common : may affect most people . if any of these side effects causes you problems , talk to your doctor . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . any lynparza capsules should be stored in the original carton in order to protect from light and moisture and do not remove until the day of opening . - if you are not able to take lyngparza at home , you may store them outside the refrigerator at temperatures up to 30 and use them within 3 hours . throw away any capsules that are not used or disposed of in accordance with local requirements . these measures will help protect the environment .
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg / 0 . 5 ml of okarib ( astrazeneca logo ). - other ingredients are : - capsule content : lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black and water for injections . what LYnparaza looks like and contents of the pack this hard capsule is a white , opaque , hard capsule printed with " olarib 50 mg " in black ink on one side and " nvr " in white on the other side . the capsule is imprinted in black with the company logo and ' gx11 ' in black on the
the active substance naloxone , which is used to treat opioids such as heroin , methadone ( e1201 ), fentanyl , oxycodone , buprenorphine or morphine . nyxoid is administered as a nasal spray for the emergency treatment of opioid overdose . opioid overload can occur within 14 days of the first dose . an overdose can lead to breathing problems and severe sleepiness . these effects are not known , but they can be serious and need urgent medical care . you should know that you have an opioid overload , and that you are liable to receive opioids and you need emergency medical care at all times .
do not use nyxoid : - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . you should be aware of the extra risks , including access to emergency medical care and emergency services , and the signs and symptoms of an opioid overdose . read the information under ' the headings ' for more information . - you can still be treated with an opioid overload with this nasal spray . after 2 to 3 weeks , you should use a new nasal spray as soon as you can , if needed , for at least the first time . this medicine is not recommended for use in adults who are physically dependent on opioids . opioids include heroin , methadone ( fentanyl ), oxy
always use nyxoid nasal spray exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is 1 spray ( 2 sprays in the morning and evening ) by spraying the shoulders and ears together with the breastbone and sternum , near the ear . use a fingernail to help clear the mouth and nose of any blocksages . it may take a few minutes for your mouth to get used to the inside of the nose . 1 . when you are breathing is the chest moving , keep your chest still . this may make you hear breathing sounds or smells , or breathe on the cheek . overdose may reduce your response to touch or sounds and may lead to slow uneven breathing .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine . stop taking nyxoid and see a doctor straight away if you notice any of the following acute withdrawal symptoms , which may be signs of opioid drugs : symptoms include fast heart rate , high blood pressure body aches and stomach cramps feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering or trembling changes in behaviour ; violent behaviour , nervousness , anxiety or agitation . tell your doctor and go to the casualty department at your regular time . your doctor may want to reduce your dose . common side effects ( may affect up to 1 in 10 people ): dizziness coughing up of blood or blood clots
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . after opening , nyxoid should be used immediately . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray delivers 1 . 8 ml of solution to kill the fungal bacteriae . -the other ingredients are : - in the powder : trisodium citrate dihydrate , sodium chloride , hydrochloric acid ( e507 ), sodium hydroxide and purified water ( see section 2 ). - nanoide 0 . 1 mg solution for nasal spray in a pre - filled nasal spray and a single dose container . the contents of the spray are white to off - white , round , flat , bevelled edge , clear , colourless to pale yellow solution , containing no other sprays , or a spray without needle . not all pack sizes may be marketed 
ovaleap contains the active substance follitropin alfa , which is a gonadotropin , a type of hormone that plays an important role in human fertility and reproduction . fsh is needed for the growth and development of the sacs ( follicules ) in the ovaries for the production of sperm . it is important that you get a mature egg cell that is ready for treatment . this medicine contains a medicine called " clomifene citrate " which is used in assisted reproductive technology procedures ( procedures that can help you to become pregnant ). this medicine is used together with another medicine named " lutropin allfa ". it may be used either alone or in combination with another gonadotrophin called " latinising hormone " ( lh ). it may also be used in adults who are infertile because they
do not use ovaleap : - if you are allergic to follitropin alfa ( female sex hormone ) or to any of the other ingredients of this medicine ( listed in section 6 ). -if you have a tumour in your hypothalamus or pituitary gland ( both are parts of the brain ). in women , large ovaries or sacs of fluids line the inner chambers of your womb ( ovarian cysts ) and unexplained vaginal bleeding . ovulation with or without tumors of the oocytes , or a reversible pattern of growth . warnings and precautions talk to your doctor , pharmacist or nurse before using ovaleavesp . you and your partner ' s fertility should be examined at regular intervals . discuss with your doctor the benefits and
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how is ovaleap given and much should i take ? this medicine is given as an injection into the tissue just under the skin ( subcutaneous injection ). women of childbearing age should take this medicine for the first 7 days of their menstrual cycle . the medicine will be given to your child for a single period of 75 to 150 minutes . your doctor will decide how much medicine you should take and for how long . if your child weighs less than 75 kg your child will receive this medicine over 7 days and for 14 days ( weighing 37 . 5 kg or more ), you will receive 75 mg of this medicine ( total daily dose of 225 mg ). the dose will be adjusted by your child ' s doctor to achieve the best results for hcg 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : serious side effects in women allergic reactions such as skin rash or raised itchy areas of skin . severe allergic reactions may include weakness , drop in blood pressure , difficulty breathing and swelling of the face 37 very rare ( may affect up to 1 in 10 , 000 people ) if you have this type of reaction , your ovaleap injection must be stopped immediately . talk to your doctor , pharmacist or nurse immediately , as this medicine may not be suitable for you . some patients have experienced the following types of reactions : lower stomach ache , nausea and vomiting . these may be the symptoms of ovarian hyper - stimulation . if these symptoms occur , they may not go away and may get worse . tell your doctor immediately if they occur
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the pen after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . you may remove this medicine from the refrigerator and store it not above 25 for a single period of maximum 3 months when stored at room temperature ( below 25 ). if you have the impression that the effect of this medicine is too strong or too weak , talk to your doctor or pharmacist . if it is not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 days below 25 and should be discarded . once the cartridge has been removed from the pen , it should be used within 28 days when stored above 25 .
what ovaleap contains - the active substance is follitropin alfa - one cartridge contains 300 iu in 0 . 5 ml of solution . each cartridge contains 30 micrograms ( 300 microgram ) corresponding to 22 microgram ( g ) ( 16 . 0 microgram per mlitre ). - another cartridge contains 450 ichu ( 15 . 7 microgram each ) or 450 microgram (3 . 3 microlitres ) in total , compared to 33 microgram (" fl ") in all , which is equivalent to a vial . not all pack sizes may be available in your country . your doctor will prescribe the right type of solution for injection based on your individual needs . ovaleep 900 microgram solution for infusion in the form of infusion . in each cartridge
the active substance voriconazole , which contains an antifungal medicine , belongs to a group of medicines called ' fungal medicines '. it works by killing or stopping the growth of the fungi that cause infections . it is used for the treatment of patients ( adults and children over the age of 2 ) with : invasive aspergillosis ( a type of fungal infection due to Aspergillus sp ), candidaemia ( another type of FUNgal infection caused by candida spp ) in non - neutropenic patients ( patients without abnormally low white blood cells count ), serious invasive candida sepsis infections , when a fungus is causing the infection . fluconazoles ( another antifungals medicine ) is another medicine to treat serious fungal infections caused by scedosporium s
do not take voriconazole accord : - if you are allergic to vorikonazole or any of the other ingredients of this medicine ( listed in section 6 ). this medicine is not to be used in combination with any other medicines , even those that are obtained without a prescription . it is preferable to take herbal medicines instead , because the medicines in the following list must not be taken at the same time , and must be taken under the supervision of a doctor . warnings and precautions talk to your doctor , pharmacist or nurse before you are given vorigale accord treatment : 46 terfenadine ( used as an allergy ) astemizole ( used for allergy ), cisapride ( used to treat stomach problems ) pimozide ( for treatment of mental illness ) quinidine ( used in adult patients with irregular heart beat ) 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine your dose depending on your weight and the type of infection you have . the usual dose is 40 mg per kg body weight for the first 24 hours . after that , you will receive a single dose of 400 mg every 12 hours for 24 hours ( equivalent to 200 mg per kilogram body weight ). after 12 hours , the single dose is given twice a day , equivalent to 24 hours in the morning and 200 mg every 100 mg daily . depending on how you respond to treatment , your doctor may increase your dose to 300 mg every two weeks . use in children and adolescents voriconazole accord is indicated for the treatment of mild to moderate cirrhosis in patients from the age of 2 to less than 12 years and at least 14 years of age , who weigh 50 kg
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , most are likely to be minor and temporary . however , some may be serious and need medical attention . serious side effects stop taking voriconazole accord and see a doctor immediately : - rash - jaundice - changes in blood tests of liver function - pancreatitis other side effects very common : may affect more than 1 in 10 people - visual impairment ( change in vision including blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision ), night blindness and swinging vision . not known : frequency cannot be estimated from the available data - allergic reactions , including hives and swelling of the face , lips , tongue or
what voriconazole accord contains - the active substance is impotent ( essentially ' food pipe '). - each 50 mg film - coated tablet contains impotence ( inversely to the ' 50 mg ' used in the form of tablet core ) and contains 200 mg imitat ( almost identical to the 200 mg tablet ) imitated on the tablet ' s surface . -- the other ingredients in the tablet core are : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone ( k25 ), magnesium stearate . film coating : hypromellose ( e464 ), titanium dioxide [ e171 ], lactoses monohydrate and triacetin . in the core of the film  - coating is a white to off
mvabea is a vaccine used to protect you against ebola virus disease in the future . it is given to individuals aged 1 year and older who could potentially infect others . your doctor will tell you how many days of a 2 - dose course of vaccinations to be given . you will be given two courses of vaccination to protect yourself from getting a different type of evasion called ' zabdeno vaccine '. this is given at least one week apart and covers two years . if you have not been in close contact with someone who may have been in direct contact , tell your doctor , nurse or pharmacist . this vaccine works by causing the body to produce its own protection ( antibodies ) against two different types of filovirus . none of the ingredients in this vaccine can cause your body to make antibodies to the zaire ebavirus and / or
you and your doctor will decide on the vaccination course . mvabea should not be given if you or your child have ever had a severe allergic reaction to any of the active substances listed in section 6 . you have previously had , or are suspected to have , a strong or , weak reaction to an antibiotic called ' gentamicin '. the vaccine may not fully protect everyone who is vaccinated . warnings and precautions talk to your doctor , pharmacist or nurse before you are given the vaccine if : you have had : - a serious allergic reaction after any other vaccine injection you have ever fainted with an injection you are currently having a fever or an infection you are taking medicines that affect the immune system such as high - dose corticosteroids ( such as prednisone ) or chemotherapy ( cancer medicines ) you have a weak
mvabea is given to your child by a doctor or nurse as a single dose into a muscle ( intramuscular injection ) in the upper arm or thigh or a blood vessel . the first vaccination with zabdeno vaccine will be given 8 weeks later . if you or your child misses a scheduled dose , the second vaccine ( s ) may be given after an interval of at least four weeks . see section " information for healthcare professionals " for the complete list of recommended doses . your child will receive either the first or second vaccine , either first and second vaccine at a lower dose ( 0 . 5 ml of solution ). primary vaccination first vaccination ( with zabadeno red cap vial ) followed by second vaccination with the same dose ( 2 x 125 micrograms / kg body weight ) at least 8 weeks
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ) pain , warmth , or swelling where the injection is given feeling very tired muscle ache joint pain common : may affect up to 1 in every 10 people being sick ( vomiting ) itching where you are given the injection uncommon : might affect upto 1 in 100 people redness , skin hardness where you have the injection , generalised itching . if any of the side effects gets serious , tell your doctor , pharmacist or nurse . not known ( frequency cannot be estimated from the available data ) swelling of the face , lips , tongue or throat that may cause difficulty in swallowing or breathing ( angioedema ) injection site reactions ( such as rash , it
what mvabea contains - the active substance is zaire ebolavirus , 29 micrograms ( 0 . 7 ml ) of tai forest ébola virus nucleoprotein marburg , not less than 108 iu / kg of chicken embryo fibroblast cells . this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections , and hydrochloric acid ( for ph adjustment ). what villian looks like and contents of the pack this vaccine is a suspension for injection in a single - dose glass vial with a rubber stopper and yellow cap . pack size of 20 vials .
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . bondronates is used in adults and prescribed to you if you have breast cancer that has spread to your bones ( called ' bone ' metastases '). it helps to prevent your bones from breaking ( fractures ) it helps also to prevent other bone problems that may need surgery or radiotherapy bondronate can help to reduce a raised calcium level in your blood because of a tumour . calcium is also lost from your bones . as a result , your bones become weaker .
do not use bondronat : - if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) - when you have low levels of calcium in your blood . do not receive this medicine if any of these apply to you . warnings and precautions a side effect called osteonecrosis of the jaw ( onj ) ( bone damage in the jaw ) has been reported very rarely in the post - marketing setting . there are no studies on the use of bondronate in patients with cancer - related conditions . onj can also occur after stopping treatment . it is important to try and prevent onj developing as it is a painful condition that can be difficult to treat . in order to reduce the risk of developing osteonocroses of the mouth , there are some precautions you should take . before receiving
this medicine bondronat is normally given by a doctor or other medical staff who have experience with the treatment of cancer . it is given as an infusion into your vein . your doctor may do regular blood tests while you are receiving Bondronat . this is to check that you are being given the right amount of this medicine . how much to receive your doctor will work out how much you will be given depending on your illness . if you have breast cancer that has spread to your bones , the recommended dose is 3 mg per kg body weight , given 3 - 4 hours after your last dose . you will usually be given an asan infusion in your vein over at least 15 minutes , provided you have a raised calcium level in your blood over 1 hour and 2 hours , depending on the severity of your illness and how well the medicine is working for you , as is recommended by your doctor . however , 
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a nurse or a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain and inflammation new pain , weakness or discomfort in your thigh , hip or groin . you may have early signs of a possible unusual fracture of the thong bone . very rare ( might affect less than 1 in 10 ,000 people ). you may get pain or sore in your mouth or jaw , as this may be a sign of severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone ). talk to your doctor , pharmacist or nurse about ear pain and discharge from the ear . these could be signs of an ear infection .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . after dilution the infusion solution can be stored up to 24 hours at room temperature ( 20 ). do not freeze . store this medicine in the original package in order to protect from light .
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial of concentrate is used as a concentrate for solution for infusion . one vial contains 2 mg infra - containing sodium monohydrate , sodium chloride , acetic acid ( e334 ), sodium acetate , water for injections . see section 2 for further information about some of the ingredients of bondronate . there are 1 or 2 vials ( type i ) in a glass vial with a bromobutyl rubber stopper .
what zeposia is and what it is used for ZEposia belongs to a group of medicines that affect the production of white blood cells ( lymphocytes ). it is made specially for you to help your body make better use of its medicines . you have relapsing remitting multiple sclerosis ( rrms ), which is an active disease in which the body ' s defenses are not working . white blood cell count is important for the nerves in your brain and spinal cord , and for the body to use its own weapons effectively . this results in symptoms such as numbness and difficulty in walking . not known ( cannot be estimated from the available data ): ms is a disease which affects the immune system , making the body less able to fight its own defences . when a patient is racked up , white blood
do not take zeposia : - if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have a severely weakened immune system you have ever had a heart attack ( such as angina , stroke , mini - stroke or transient ischemic attack ( tia ) you have severe heart failure in the last 6 months you have or have had irregular or abnormal heartbeats ( arrhythmias ) your heart does not work normally enough to stop treatment , or you develop severe infection ( hepatitis , tuberculosis ), cancer , severe liver problems you are pregnant , breast - feeding and fertility you are breastfeeding . if any of these apply to you ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the amount of zeposia that you take will depend on your heart rate . you will be given a ' treatment initiation pack ' with orange capsules containing 0 . 23 mg of ozanimod once a day for 1 week . after 4 weeks of treatment , your doctor may increase your dose to 3 mg / kg , corresponding to a maintenance pack . this will be added to your regular dose . thereafter , the usual maintenance pack will be provided with a lower dose , which will also include a new set of instructions for your doctor , pharmacist or nurse . how much to take adults , adolescents and children 3 years of age and older - the recommended starting dose is 0. 46 mg , to be taken once daily 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor , pharmacist or nurse straight away if you notice any of the following side effects very common ( may affect more than 1 in 10 people ) slow heart rate , urinary tract infection ( blood pressure lowering ) uncommon - may affect up to 1 in 100 people allergic reaction . the signs may include a rash . other possible side effects talk to your doctor or pharmacist as soon as possible . these side effects include : very common : may affect any person from 10 years of age or older , including : infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) or voice box ( larynge ) caused by viruses . a type of white blood cell called lymphocytes common ; may affect less than 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . zeposia is for single use only . once reconstituted , the solution is clear and colourless . the seal is essentially ' tan - free ' and should not be used if it is damaged or shows signs of tampering ( for example , if the pack is damaged ). do not throw away any medicines via wastewater or household waste . these measures will help protect the environment .
what zeposia contains - the active substance is ozanimod . zeposa 0 . 23 mg hard capsule : each capsule contains 0. 23 mg of oznimod ( as hydrochloride ). zoposia 00 . 46 mg Hard capsule - Each capsule contains 0 0. 46 mg / 0x00 / 1x00 ( 20x10 ) / 5x10 ( 21x11 )/ 20x11 ( 212  10 ) or 1x100 ( 200x1 ) .  the other ingredients are : capsule content : imidazole , maize starch , manganese , talc ( e553b ), proline , chloride . capsule shell : zhoudaib , debossed with "
what temybric ellipta is and what it is used for the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . fluticasséfuroate belongs to a group of medicines called corticosteroids ( also known as steroids ). the three active substances umecilidinium brochuremide şi vilantérol belong to  a groupe of medicines known as bronchodilators . what the heck is this medicine used for temibric flatulence is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles responsible for breathing difficulties relax and the airways tighten . this makes it easier for air to get in and out of the house .
do not use temybric ellipta : - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before using the product . don ' t use the product after the expiry date which is stated on the carton and the sachet after exp . this medicine does not require any special storage conditions . asthma . take special care with tembric it is recommended not to use it in patients with asthma , as it may be harmful to others . heart problems or high blood pressure . liver problems . tuberculosis ( tb ) of the lung , and any long standing or untreated infections . tell your doctor or pharmacist 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use temybric ellipta regularly it is very important that your doctor , pharmacist or nurse shows you how to use it for as long as your condition is getting worse . - when you are sick , take it right away and then take your next dose at the usual time . it does not matter whether you use it on its own . however , if your copd symptoms are not getting worse ( for example , breathlessness , wheezing , cough )
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties : if your breathing or wheezing gets worse straight after using this medicine , stop using it and get medical help immediately pneumonia ( infection of the lung ) in copd patients ( common side effect ) tell your doctor if you get any of the following after using temybric ellipta : symptoms of a lung infection : fever or chills increased mucus production , change in mucuses colour increased cough or increased breathing difficulties common side effects ( may affect up to 1 in 10 people ): sore throat , runny nose , coughing , indigestion , stomach pain , diarrhoea , feeling sick ( nausea ), vomiting , itching , increased blood sugar , high blood sugar ( hyperglyca
what temybric ellipta contains - the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 micrograms ( the equivalent of 65 microlitres ) umeklidinium brmide , which is equivalent to 55 microgram ( 0 . 5 ml ) von vilantrol ( as trifenatate ) the other ingredients are lactose monohydrate ( see section 2 under ' important information about some of the ingredients of tetanus ') and magnesium stearate . what the ellipinta inhaler looks like and contents of the pack the ellipta intohaler consists of a light grey plastic body ,
what zinforo is this medicine is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called ' cephalosporin antibiotics '. what it is used for it is given in adults , adolescents and children over one month of age to treat infections of the skin or the tissues below the skin . this is known as an infection of the lungs , known as ' pneumonia ', in adults and children aged two years and older . how  Zinforo works zin foro works by killing certain bacteria , which can lead to serious infections .
do not take zinforo : - if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). you may also be allergic to other cephalosporin antibiotics . warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment if : you have had previous severe allergic reactions to other antibiotics such as penicillin or carbapenem . your doctor will decide if this applies to you . you will be carefully checked by your doctor before you start treatment with zin foro . if any of these apply to you ( or you are not sure ), discuss with your doctor the precautions needed to avoid infecting other people . children and adolescents do not give this medicine to children or adolescents under 18 years of age . there is limited experience in children and teenagers with kidney problems .
the recommended dose of zinforo is 600 mg given every 12 hours . your doctor may increase your dose to 600 mg every 8 hours if you have some infections that cannot be controlled by treatment at the start of treatment ( see section 5 " instructions for use "). the dose may be increased by up to 60 mg or 120 mg depending on how you respond to the treatment . the maximum recommended dose is 14 mg for skin infections and 5 to 7 mg for pneumonia . doctor also recommends giving you a lower dose to reduce the risk of kidney problems . patients with kidney problems may be more likely to get rid of them . if your doctor recommends that you have a higher dose than you should , your doctor will check that your dose is working and will inform you about the possible risk of having a dip in the blood stream to check how well your kidneys are working and to adjust the dose your doctor should give you the lowest possible dose
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : tell your doctor straight away if you notice any of these symptoms as you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems . these may be signs of a serious allergic reaction ( anaphylaxis ), diarrhoea , stool , blood or mucus . during treatment with zinforo , you may be given medicines to slow bowel movement . this is common ( may affect up to 1 in 10 people ). your doctor may ask you to have a blood test called a ' coombs test ' before starting antibiotic . your doctor will perform this test to find out how well your condition is working .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions : do not store above 30 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is 600 micrograms ceftaroline fosamil . the other ingredients are arginine , maize starch , and st . john ' s wort , shellac , yew trees , iron oxide reddish and light yellow powder for concentrate for solution for infusion in a vial . each vial contains 10 ml of powder .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neuropathy pain the active substance of pregabalsin ppfizer is used for the treatment of long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neuropath pain , such as diabetes or shingles . there have been reports of pain sensations that are described as hot , burning / throbbing , shooting , stabbing / sharp , cramping , or aching . it is also used to relieve tingling and numbness . this is different to the stresses and strains of everyday life . the most common complaints are : headache , fatigue , chills , fever , and clammy or sweaty 
do not take pregabalin pfizer : - if you are allergic to pregabalsin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking pregabaltin ppfizer it is important that you inform your doctor or pharmacist of any potential signs or symptoms of an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat , as well as diffuse skin rash . should you experience any of these reactions , you should contact your physician immediately . pregabaalin has been associated with dizziness and somnolence , which could increase the occurrence of accidental injury ( fall ) in elderly patients . therefore you should be careful until after you are used to any effect the medicine might have , or worsen . before you are given pregab
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is for oral use only . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder : take the number of capsules as instructed by your doctor . the dose , which has been adjusted for you and your condition , will generally be between 150 mg and 600 mg each day . your doctor will determine the dose you should take . for two different doses , you will find a combination of two capsules in the morning and one capsule in the evening , 59 shortly after you wake up . you should swallow the capsule whole . do not split , crush or chew the capsules . once opened , do not swallow them . it is recommended that you take pregabaltin ppfizer either twice or
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): dizziness , drowsiness , headache . common ( might affect up to 1in 10 people): increased appetite . feeling of elation / confusion / disorientation / decrease in sexual interest / irritability . disturbance in attention . lack of motivation / lack of memory . tremor . change in perception of self , others noticing things which are not there , problems with thinking , balance , and / or understanding . difficulty with speaking , increased level of tingling feeling . not known ( frequency cannot be estimated from the available data ). in children , the side effects listed below have been observed . they are usually mild and affect from 1 to 10 users in 100 
what pregabalin pfizer contains each hard capsule contains 25 mg , 51g , 50 , 75 , 100 , 150 , 200 , 225 or 300 micrograms / ml . the other ingredients are lactose monohydrate , maize starch ( maize ), talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica , black ink , ( printed with " e904 ", shellac / black iron oxide [ e172 ], propylene glycol , potassium hydroxide )) and water for injections . each bottle contains 75 mbq ( 100 mg / 200 mg ) or 225 mg ( 300 mg ). the other excipients are : carnauba wax
xadago is a medicine that contains the active substance safinamide . it increases the amount of dopamine in your brain . this helps to increase the activity of your brain and improves the condition of parkinson ' s disease . parkinsons ' disease can cause sudden switches in your ability to move . if you have difficulties moving at all , you may need help from a doctor or go to a hospital immediately . the medicine also contains levodopa , which is used in combination with other medicines that are also used to treat parkinSON 's disease in adults .
do not take xadago if : you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). you are taking the following medicines : monoamine oxidase ( mao ) inhibitors : selegiline , rasagiline ; moclobemide ; phenelzine , isocarboxazid ; or tranylcypromine ( used for treatment of parkinson ' s disease and depression ); pethidine ( a strong pain killer ). if this applies to you , wait at least 7 days before you start xamago treatment and discuss with your doctor whether you need to stop treatment with mao inhibitors other than petheidine ( see section 4 ); if you think you may be at risk of developing resistance to x
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of xadago is 50 mg taken once a day by mouth . your doctor may prescribe a lower dose of 100 mg . do not take more than your doctor tells you to take . patients with moderately reduced liver function should take the lowest dose of 50 mg twice daily . you should swallow the tablets with some water or other non - alcoholic drink . it is , therefore , recommended that you take the tablets whole with a glass of water . if your doctor thinks that the effects are too strong or too weak , talk to your doctor about other ways of obtaining the desired benefit . take x ad preferably at the same time each day . this will help to get the best results for your health . try to take
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure ) may lead to collapse . neuroleptic malignant syndrome ( nms ): - confusion , sweating , muscle rigidity ( hyperthermia ), increase level of enzyme creatine kinase in your blood ( serotonin syndrome ), which may cause confusion . - hypertension ( muscle stiffness ), hallucinations ( fits ), hypotension . other possible side effects of parkinson ' s disease may occur with the combination of safinamide and levodopa . the frequency of these effects is not known ( frequency cannot be estimated from the available data ). some patients have experienced the following side effects while taking xadago : very common ( may affect more than
what xadago contains - the active substance is safinamide . each 50 mg or 100 mg film - coated tablet contains a methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating - hypromellose , macrogol , titanium dioxide , iron oxide red ( e172 ) ( see section 2 ), sunset yellow fcf [ e110 ] and sunset yellow [ sbc [ gsi ]) ( ph - 50 mg and 100 mg ] ( see sdcb [ pfizer ]), titanium dioxide [ iu ], talc ( a type b ], and iron oxide black ( ii )). what
zytiga is a medicine that contains the active substance abiraterone acetate . it is used to treat adult men with prostate cancer that has spread to other parts of the body , when other medicines have not worked or when testosterone is not removed from certain prostate cancer patients , who have agreed to be treated for their disease and who are not able to respond to hormone therapy ( a treatment that lowers testosterone ( androgen deprivation therapy ). it is taken in combination with another medicine , prednisone or predNisolone . high blood pressure has been shown to be caused by high levels of pressure in the body because of fluid retention ( build - up of water in your blood ).
do not take zytiga : if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). if there is still a possibility that you can get pregnant , talk to your doctor . warnings and precautions talk to you doctor , pharmacist , or nurse before and while taking this medicine if : you have severe liver damage you have prostate cancer . your doctor will decide if this medicine is suitable for you . you should not use this medicine when you are not sure . before you take this medicine you will have to take special care of your health . tell your doctor about any of your medical conditions , including any medical conditions you have had before , such as liver problems , high blood pressure , heart failure , low blood potassium ( see section 4 ), heart rhythm problems or other heart or blood vessel problems you have
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once daily . you should not take more than one tablet of this medicine per day . take the tablet at the same time each day ( for example , one tablet in the morning and one in the evening ). this medicine is for oral use . swallow the tablet whole with a glass of water . zytiga can be taken with or without food . do not chew , crush or split the tablet before swallowing . how to take take zytigea with food ( see section 2 under ' what you need to know before you take the medicine '). do not take it with grapefruit or grapefruit juice . to help you remember to take it , do not crush or chew the tablet . when to take with food , take 
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact a doctor immediately if you experience muscle weakness , muscle twitches , or a pounding heart beat ( palpitations ), as these may indicate that the level of potassium in your blood is low . your doctor will tell you how to deal with potassium . other side effects very common ( may affect more than 1 in 10 people ): - build - up of fluid in your legs or feet as this may indicate low blood potassium , as shown in liver function test , high blood pressure , urinary tract infection , diarrhoea and vomiting . common side effects are : may affect up to 1in 10 people increase in the amount of water in your urine . this may make it harder for you to get stools , which may make
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg amylase ( abréviation ) in each tablet . - other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate ( e487 ) ( see section 2 under ' important information about some of the ingredients of the tablet '). what zetiga looks like and contents of the pack - zytigea tablets are white to off - white , oval tablets of 9 . 5 mm diameter , embossed with " gsi " on one side . the tablets are packed in a plastic bottle with 
hefiya contains the active substance adalimumab . it is a medicine used for the treatment of the following inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis paediatric plaque psoriasis , paediatic crohn ' s disease , and paediatri non - infectious uveitis in adults . the active ingredient in ms dpd contains a substance called a monoclonal antibody , which is designed to recognise a specific target on the surface of certain proteins in the body called tumour necrosis factor ( tnf ), which is involved in the immune ( defence ) system and is thought to play a key role in these processes . by attaching to the target , the target of mnemab
do not use hefiya : - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before using the medicine if : you have a severe infection , including tuberculosis , sepsis ( blood poisoning ) or other opportunistic infections ( unusual infections associated with a weakened immune system ). it is important that you tell your doctor about any signs or symptoms of infections ( e . g . fever , wounds , feeling tired , dental problems ). you have moderate or severe heart failure . you have had or have had a serious heart condition ( see section 4 ). allergic reaction : some people get allergic reactions with symptoms such as chest tightness ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . hefiya is available as a 40 mg pen as well as 20 mg and 40 mg pre - filled syringes for patients to administer a full 20 mg or 40 mg dose . polyarticular juvenile idiopathic arthritis age and body weight how much and how often to take ? notes children , adolescents and adults from 2 years of age weighing 30 kg or more 40 mg every other week not applicable children and adolescents between 2 and 10 kg 30 mg and 20 mg each other week do not take enthesitis - related arthritis age or body weight why should i have to take more than once a week . children and adolescent aged 6 years and older who weigh 30 kg to less than 40 kg first dose of 40 mg .
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . side effects may occur at least up to 4 months or more after the last hefiya injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash / hives ; swollen face , hands , feet ; trouble breathing , swallowing ; shortness of breath with exertion or upon lying down or swelling of the feet . tell your doctor as soon as possible ; signs and symptoms of infection such as fever , feeling sick , wounds , dental problems or cough . not known ( frequency cannot be estimated from the available data ): oral thrush , sore throat , runn
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label / blister / carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . alternative storage : when needed ( for example when you are travelling ), hefiya may be stored at room temperature ( up to 25 ) for a maximum period of 14 days be sure to protect it from light and therefore must be used within 14 days or discarded , even if it is later returned to the refrigerator . you should record the date of first use ( when you first open it ) and the date after which it should be discarded ( no more than 14 days from the time of first opening ). you should consult your doctor for further
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg / 0 . 4 ml of solution for injection , equivalent to adipic acid , citric acid monohydrate , sodium chloride , mannitol ( e421 ), polysorbate 80 , hydrochloric acid and sodium hydroxide . in the water for injections , the concentration may need to be adjusted . what HEfiуa looks like and contents of the pack hefieya 20 mg solutions for injection ( injection ) in pre  181 ( 3 - layer ) solution for infusion is supplied as a clear , colourless to slightly yellowish solution . it is supplied in a single - use clear type i glass 
the active substance in ritemvia is called rituximab . this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritsima babbles onto this cell , the cell dies . your doctor will then give you a copy of the gene that gives the gene . the gene may then use to destroy the damaged cell . if this happens to you , it must be given to you by your doctor for the treatment to benefit from your own immune system . use in children and adolescents ritemevia can be used in children ( 2 years of age and older ) for the initial treatment in children with granulomatosis with polyangiitis or microscopic polyangitis ritamvia can also be used for the
do not take ritemvia : - if you are allergic to rituximab , other proteins which are like ritsimabe , or any of the other ingredients of this medicine ( listed in section 6 ) - when you have a severe active infection that your doctor thinks is important . warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment if ( as of yet unrelated note ) you have been told by your doctor that you suffer from a weak immune system , as a result of severe heart failure or severe uncontrolled heart disease , granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . if any of these apply to you , tell your doctor before you are given this medicine . your doctor may want to monitor you more closely 
how it is given ritemvia will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . it is important to note that this medicine is given as a drip ( intravenous infusion ). medicines given before each ritememvia administration before you are given the dose , you will receive a free consultation with your doctor . your doctor will advise you on which other medicines ( pre - medication ) you may be taking at the same time . to prevent or reduce possible side effects your doctor may decide to change your dose . when you first receive your treatment for non - hodgkin ' s lymphoma if you are having a first treatment with ritamvia alone rite mamma is given once a week for
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , people may also develop pain at the site of infusion , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat tightness . not known : frequency cannot be estimated from the available data . if you get any of these signs , tell your doctor , nurse or pharmacist . common : may affect up to 1 in 10 infusion sites , swelling of the face , lips , tongue or throat , difficulty
what ritemvia contains - the active substance is rituximab . each ml of concentrate contains 100 mg ( 300 mg ) of ritsimabe . one vial of the concentrate contains 10 mg ( 1 , 000 iu ) ( 900 international units ), - in the other ingredients ( s ): sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritamvia looks like and contents of the pack this medicine is a clear , colourless solution , supplied as a concentrate for solution for infusion in a glass vial . pack size of 2 vials
capecitabine teva belongs to the group of medicines called " cytostatic medicines ", which stop the growth and spread of cancer cells . capеcitabine to be taken by mouth is given to you by a doctor or nurse as an initiation into the treatment of colon , rectal , gastric , or breast cancers . furthermore , it is used after the complete removal of the tumour by surgery . at the same time a larger number of patients have been diagnosed with the presence or spread of colon cancer , the doctor may recommend that the doctor decide to take other medicines , including those obtained without a prescription .
do not take capecitabine teva : - if you are allergic to capcitabine or any of the other ingredients of this medicine ( listed in section 6 ). you must inform your doctor if your doctor thinks you may have an allergy or over - reaction to this medicine . warnings and precautions severe reactions have occurred in patients receiving fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ), pregnant women or breast - feeding , women with low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ), severe liver or kidney problems , or individuals with reduced levels of the enzyme dihydropyrimide dehydrogenase ( dpd ) ( complete dppd deficiency ). children and adolescents do not give this medicine to
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you , so you should take the best dose for you at the same time each day . dose the dose and dose of capecitebine teva is based on your body surface area . this is calculated from your height and weight . the usual dose for adults is 1250 mg / m2 of body surface surface area taken two times daily ( morning and evening ). two examples are provided here : a person whose body weight is 64 kg and height is 1 . 64 m has a body area of 1  . 7 m2, and should take 4 tablets of 500 mg and 1 tablet of 150
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva immediately and contact a doctor if any of these symptoms occur : diarrhoea : if you have an increase of 4 or more bowel movements compared to your normal bowel movement each day or any diarrhea at night . vomiting : when you vomit more than once in a 24 - hour time period . nausea : you lose your appetite , and the amount of food you eat each day is much less than usual . stomatitis : your doctor will tell you what you can take to ease pain , redness , swelling or sores in your mouth and / or throat . hand - wash your hands thoroughly afterwards . this is important to get the best results for your health .
what capecitabine teva contains - the active substance is capecitebine . - capsule content : each bottle contains 150 mg film - coated tablets each film  syringe contains 150 milligrams ( mg ), of which at least one third is made of sugar . the other ingredients are : tablet core : cellulose , lactose , microcrystalline cellulose ( e460 ), hypromellose , croscarmellose sodium , magnesium stearate in the tablet coat : macrogol 400 ( 6000 ), in the film coating : pegyrexample - size : carnauba wax , indigo carmine yellow , red iron oxide , and in the printing ink : shellac , iron oxide red , titanium dioxide , yellow iron oxide and red iron
silodosin recordati belongs to a group of medicines known as alpha1a - adrenoreceptor blockers . silonodostin recordsati is selective for the receptors located in the prostate , bladder and urethra . by blocking these receptors , it causes smooth muscle in these tissues to relax . this makes it easier for you to pass water and relieves your symptoms . what siloudoti is used for silokasin recordingi is intended for use in adult men to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as : difficulty in starting to passage water , a feeling of not completely emptying the bladder , an abnormal sensation in the abdomen , or a more serious side effect to your bladder .
do not take silodosin recordati : - if you are allergic to the active substance , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and during your trip to the hospital . before you go to bed , you should avoid sitting or lying down until you feel better . during cataract surgery , it is important that you inform your doctor that you have cloudiness of the lens ( cataract ). this is because some surgeons have been instructed to leave the hospital for a short time . 26 during the course of treatment with this type of medicine , there may be a loss of muscle tone in the iris ( the coloured circular part of the eye ) after such a surgery . the doctor will take appropriate precautions with regard to medicine and surgical techniques to be used . tell the doctor
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one capsule of silodosin recordati 8 mg per day by oral administration . take the capsule always with food , preferably at the same time every day . do not break or chew the capsule , but swallow it whole , even if it may be taken with a glass of water . patients with kidney problems if your doctor considers this appropriate , you may use a different dose , depending on what medicine you have been taking , or on whether it is for use in children and adolescents . in special patient groups , patients with moderate kidney problems may be able to take the dose suited to their needs . for this purpose siloudousin recordingati can be taken orally with or without food . if
like all medicines , this medicine can cause side effects , although not everybody gets them . some of these effects may be serious . seek medical attention immediately if you experience any of the following allergic reactions : swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives the following side effect has been reported with silodosin recordati : dizziness , which may be accompanied by dizzyness when standing up , and occasionally fainting . it is important to know that dizzy or that you are feeling weak or dizzy at the onset of the symptoms listed above . if any of these occur , seek medical advice straight away . you may be required to sit or lie down straight away until the symptoms have disappeared . in some cases , fainting may occur and should be treated at home . the doctor may decide to keep you
what silodosin recordati contains - the active substance in this medicine is siloudolosin . each capsule contains 8 mg of silodysin , while the other ingredients are : capsule content : mannitol , magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). capsule shell : silokarov k29 / 32 4 mg hard capsules - one hard capsule contains silojidone , and four times faster than the usual dose . capsule shells : gelatin ( titanium dioxide , yellow iron oxide , red ) and amber glass vials . what silizodosti looks like and contents of the pack the hard capsule ( capsule ) is a white to almost white powder . sil
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angioTENsin Ii is a substance produced in your body , which causes your blood vessels to narrow , thus increasing your blood pressure . kinzimono blocks the effect of the substance , and makes it less likely to happen . because of this effect , the blood vessels relax , meaning that less pressure is exerted upon you . the result of this is high blood pressure on a regular basis , so you can continue to drive and do other activities that help to keep you free of stress on your own . what is essential hypertension ( high blood tension ) - for adults , high blood temperature , - can damage blood vessels in several organs which could lead sometimes to heart attack , heart or kidney failure , stroke , or blindness 
do not take kinzalmono if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). if there is still a possibility that you may be more than 3 months pregnant , you must not become pregnant while taking this product ( see pregnancy section ). If you have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or any other severe liver disease . if your doctor determines that you have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren . it is not known if this medicine passes into human milk . warnings and precautions talk to your doctor , pharmacist or nurse before taking kinzonzono . your doctor may decide to temporarily or permanently stop treatment with 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many kinzalmono tablets to take and how long you should continue to take them . the tablets should be swallowed whole with some water or other non - alcoholic drink . it is important that you take kinszalmonio every day until your doctor tells you otherwise . you should not take more than the recommended dose . try to take the tablet at the same time each day . this will help you to remember to take it . if your doctor feels that the effect on your condition is too strong or too weak , talk to your doctor about other ways to take kinzumono . for treatment of high blood pressure , the usual starting dose of kinzialmona for most patients is one 40 mg tablet once a day
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention you should see your doctor immediately if you experience any of the following symptoms : sepsis * ( often called " blood poisoning ", is a severe infection with whole - body inflammatory response ), rapid swelling of the skin and mucosa ( angioedema ); these side effects are rare ( may affect up to 1 in 1 , 000 people ) but are extremely serious and patients should stop taking the medicine and see their doctor immediately ( see also section 2 ). if these effects are not treated they could be fatal . possible side effects of kinzalmono common side effects ( affects 1 to 10 users in 100 ) are : low blood pressure ( hypotension ) in users treated for reduction of cardiovascular events . uncommon side effects(
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . you should store your medicine in the original package in order to protect the tablets from moisture . remove your kinzalmono tablet from the blister only directly prior to intake . any unused medicine should be discarded . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg tevidone ( 0 . 5 ml ), meglumine , sodium hydroxide , sorbitol ( e420 ) and magnesium stearate . what kinszalmonio looks like and contents of the pack kinzelmono 20 mg tablets are white to almost white , round tablets engraved with the code number ' h1 ' on one side and plain on the other side . kzalmondo is available in blister packs containing 14 , 28 , 56 or 98 tablets . not all pack sizes may be marketed in your country .
what afstyla is a human clotting ( coagulation ) factor viii product , produced by recombinant dna technology . the active ingredient in this product is lonoctocog alfa ( e421 ). what ' s important ' are the important components of bleeding episodes in patients of all ages with haemophilia a ( inborn factor vii deficiency ). patients who lack sufficient factor  vii are at an increased risk of bleeding . patients with an increased tendency to bleed because they do not have enough factor vi1 in their blood . in patients from all age groups , the ability to clot is increased . what ? in adults and children from the age of 4 - 17 years is not expected to be affected by the lack or insufficient production of factor ixi .
you should not be given afstyla - if you have ever had an allergic reaction to the active substance . warnings and precautions talk to your doctor , pharmacist or nurse before you are given orally , or after you have been given , in particular if : you are allergic to hamster proteins 46 you are breast - feeding you are advised not to be given the wrong dose if any of the following applies to you : 46 - you are not likely to benefit from the treatment of your doctor as you may need to be monitored carefully for the batch number . please also read the " instructions for use " at the end of this leaflet . you should keep your treatment diary ( this is important for you ) until you have recovered . if more than one dose has been prescribed , you may not be able to take a full dose of : a fs
your treatment should be supervised by a doctor who is experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . the recommended dose of afstyla is based on your disease the site and the extent of the bleeding your clinical condition . reconstitution and administration general instructions the powder must be mixed with the solvent ( liquid ) provided in the vials and reconstituted with water for injections . for aseptic conditions , the concentration of  is dependent on the condition of your patient and on the type of treatment you are receiving .  if the solution is clear or slightly opalescent it should not be administered . after reconstitution , you should use the solution immediately , even if it is clear to see particles or is distinctly different from the eye . do not
like all medicines , afstyla can cause side effects , although not everybody gets them . please contact your doctor immediately if you have symptoms of allergic reactions . allergic reactions may include the following symptoms : hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness , anaphylaxis ( a severe complication of bleeding ). patients who have been previously treated with factor viii medicines : inhibitor antibodies ( see section 2 ) may form very commonly ( more than 1 in 10 patients ). if this happens to you , tell your doctor straight away . very commonly , your doctor will check you for inhibitors ( see also section 2 " warnings and precautions "). common ( may affect up to 1in 10 people )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . this medicinal product does not require any special temperature storage conditions . store in a refrigerator ( 2 8 ). do not freeze . the afstyla powder can be kept at room temperature ( up to 25 ) for a single period not exceeding 3 months . keep the vial in the outer carton in order to protect from light . use the reconstituted product immediately after reconstitution . any unused medicine or waste should be disposed of in accordance with local requirements .
what afstyla contains the active substance is lonoctocog alfa . each ml of solution contains 250 micrograms or 2 . 5 milligrams . after reconstitution by adding water for injections the solution contains 100 microgram ( 0 . 25 mg ) of lonoctcog allfa per vial . if this is not possible , the solution may be stored at room temperature ( up to 25 ) for up to 20 -minute periods . when used for once - daily dosing , each vial provides approximately one million international units ( miu ) in the form of a pellet , and each time you inject yourself with the solution , you will receive a single dose of 200 microgram( 00  3000 iu ). when used by single use only , two vials of 2 
the doctor treating you will have prescribed praxbind for one of your special needs : idarucizumab , the active substance of praxxbind , i darucizum ab as a reverse agent . dabigatran ( pradaxa ), a blood thinner medicine that helps to prevent blood clot formation , will be given to you by your doctor . your doctor will decide on the correct dose of the medicine , depending on your condition and on how well it works for you . the doctor will tell you how to use the tablet to help you to remember to take it . you may find it helpful to know that the tablet has been taken out of the body for a long time , and that it will not work as well as it should . if you have any further questions on the use of this product , ask your doctor or pharmacist .
do not take praxbind : - if you are allergic to idarucizumab or any of the other ingredients in this medicine listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you suffer from a genetic disease called hereditary fructose intolerance ( hfi ) or the substance sorbitol ( see section 4 ). this medicine may increase the risk of serious adverse reactions and may require medical attention . if any of these apply to you , tell your doctor or pharmacist . you are not sure , ask your doctor for advice . before you take this medicine you will be given dabigatran , and other medicines that help to prevent blood clots . it is very important that you also read the package leaflets of all medicines that you take for prevention of blood 
praxbind will be given to you in a hospital or clinic under the supervision of an experienced doctor . the recommended dose is one 5 mg vial of 2 . 5 mg dabigatran per day . you will receive this medicine in two 5 mg injections . this medicine will be injected into a vein . your doctor will decide how many treatments you need . if you miss an appointment call your doctor right away to reschedule your appointment . it is very important that you do not miss any doses of this medicine . during your treatment , you will be monitored for signs of blood clot formation . in the event of an accidental miss , your doctor may decide to stop the use of dabig atran for at least 24 hours . do not stop using this medicine without talking to your doctor first , as you may not be able to receive the full benefit of this
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains the active substance is idarucizumab . the other ingredients are sodium acetate trihydrate ; acetic acid , sorbitol ( e420 ), polysorbate 20 and water for injections . what the solvent vial looks like and contents of the pack the concentrate for solution for injection is a clear to slightly opalescent and colourless to slightly yellow solution . it is supplied in a glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . tem momed ac is used for the treatment of specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme ; - alone or in combination with radiotherapy ( concomitant phase of treatment ) and after that alone ( monotherapy phase of treating ) all three groups . there are at least 3 patients in each patient group whose tumours have spread beyond the original tumour , but are not spread to other parts of the body . in two separate cases , g - globulonephritis ( granulomatosis ) has been reported in two phases . these phases are one treatment cycle of therapy . patients in children 3 years and older and adult patients with malignant
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . if certain kinds of blood cells are severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood cells help your body to fight infection and for proper blood clotting . your doctor will check your blood to make sure you have enough of these cells before treatment is started . warnings and precautions talk to your doctor , pharmacist or nurse before taking temac and during treatment if : you have a low number of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac . this is based on your size ( height and weight ) and whether you have a recurrent tumour and have had chemotherapy treatment in the past . you may be given other medicines ( anti - emetics ) to take before and / or after taking temac to prevent or control nausea and vomiting . patients with newly - diagnosed glioblastoma multiforme : - you will start treatment at the start of treatment together with radiotherapy ( concomitant phase ) followed by treatment with temokac ( monotherapy phase ). initially , your doctor and nurse will decide on your dose and duration ( frequency not known ). the usual dose of
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you have any of the following : - a severe allergic ( hypersensitive ) reaction ( hives , wheezing or other breathing difficulty ) - uncontrolled bleeding - seizures ( convulsions ), - fever , - chills - severe headache that does not go away . temomedac treatment can cause a reduction in certain kinds of blood cells . this may cause you to have increased bruising or bleeding , anaemia ( a shortage of red blood cells which may cause fever ) and reduced resistance to infections . the reduction in blood cell counts may be severe , and may lead to a very rare but serious problem . in some cases , it may be prolonged . you may experience increased bleeding when you stand up
keep this medicine out of the sight and reach of children , preferably in a locked cupboard . accidental ingestion can be lethal for children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store below 30 in order to protect from moisture . tell your pharmacist if you notice any change in the appearance of the capsules .
what temomedac contains - the active substance is temozolomide . temokac 5 mg film - coated tablets : each tablet contains 5 mg of temizolomide ( as mesilate ). temac 20 mg films : every tablet contains 20 mg temazolomide [ as sulphonylsalicylic acid ] ( as simeticanesianesimiasanidac 100 mg movies ): every single tablet contains 100 mg ( as tsh ). the maximum recommended daily dose of the three tablets is 140 mg , corresponding to one 140 mg tablet . the maximum daily dose in the case of the two tablets consists of one 180 mg tablet that contains 180 mg of the four 180 mg tablets that contain one trzecin ' s drug ( as naphtheria nodule 
cialis is a treatment for adult men with erectile dysfunction ( also known as impotence ). this is when a man cannot get , or keep a hard , errect penis suitable for sexual activity , at the same sexual level . you and your partner will need to engage in sexual activity for a period of time , even if it is not possible . ciali contains the active substance tadalafil which belongs to a group of medicines called phosphodiesterase type 5 inhibitors . by doing so , you will be able to relax the blood vessels in your penis . this will allow the flow of blood into the penis where the sex drive and enjoyment of sexual activity continues . the result of this is increased , with a high level of sexual stimulation . your doctor will help you to get a sexual partner .
do not take cialis : - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). - the active substance is nitrate . - it belongs to a group of medicines called " nitric oxide donors ". such as amyl nitsrite . this is a substance that is normally made by biotechnology . it is given to you by your doctor for the treatment of angina pectoris (" chest pain ") in adult patients . you should not be given cialisé if any of these medicines are not recommended . your doctor will discuss with you whether you need to take a higher or lower dose of natrate ". serious heart disease or recently had a heart attack within the last 90 days . or you are elderly . have recently suffered from a stroke in the last
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . cialis tablets are for oral use . swallow the tablets with a glass of water . the tablets can be taken with or without food . how much to take the recommended dose is one 5 mg tablet taken once a day . your doctor may adjust your dose to 2 . 5 mg based on how you respond to the medicine . you should not take more levitra than your doctor tells you to . do not try to take levitrais more often than once daily . it is important that you continue to take it for as long as prescribed by your doctor . sexual activity when sexually stimulated , for example after a meal , at any time point during the day , and for up to 24 hours afterwards , it is very important for you to keep having sexual intercourse 
like all medicines , this medicine can cause side effects , although not everybody gets them . these effects are normally mild to moderate in nature . if you experience any of the following side effects stop using the medicine and seek medical help immediately : allergic reactions including rashes ( frequency uncommon ). chest pain has been reported in men using nitrates ( frequency rare ). priapsim may cause a prolonged and possibly painful erection after taking cialis ( frequency not known ). you should contact a doctor immediately , if he / she gets any side effects not listed in this leaflet . you should also tell your doctor about any problems you may have after taking the medicine ( see section 4 ). unusual behaviour ( such as a sudden loss of vision ) ( frequency cannot be estimated from the available data ). other side effects have been reported common ( affects 1 to 10 users in
what cialis contains - the active substance is tadalafil . - each tablet contains 2 . 5 mg of t dal afil ( as besilate ).  the other ingredients are : tablet core : lactose monohydrate ( see end of section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose ( e460 ), sodium laurilsulfate , magnesium stearate . film - coat : shellac , lactating agent : hypromellose , triacetin , titanium dioxide [ e171 ], iron oxide yellow , iron oxide red ] and talc . what you need to know before you start to take the tablets , the tablets are colourless to light yellow . they are marked with
enyglid is an oral antidiabetic medicine that contains the active substance repaglinide . it helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancréas does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . the insulin that your body makes does not work as well as it should .  Enyglide is used to control type2 diabetes in adults as an add - on to diet and exercise : treatment is usually started if diet , exercise and weight reduction alone have not been able to control ( or lower your ) blood sugar . an additional dose of eninessglid can be given in combination with metformin , which is also used for diabetes .
do not take enyglid : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have type 1 diabetes . if the acid level in your blood is raised ( diabetic ketoacidosis ). you have a severe liver disease . you take gemfibrozil ( a medicine used to lower increased fat levels in the blood of people with liver problems ) or moderate liver 28 disease ( see section 2 . what you need to know before and during treatment with Enyglide ), you are more likely to develop a serious liver disease or kidney problems . your doctor may want to monitor you more closely while you are taking eninessglid and for a long time you are having major surgery or you have
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will work out your dose . the normal starting dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before a main meal ( e . g ., a 4 hour meal ). the maximum recommended daily dose is 30 mg once a day . do not exceed this recommended dose of 16 mg . depending on how you respond to enyglid , your blood sugar may become too low . this may lead to a hypo . you should not take more than the prescribed dose , or if someone else takes your medicine , contact a doctor or hospital for advice immediately . show them the pack of this leaflet . it is important that you carry on taking en
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the following side effect has been reported with enyglid : very common ( may affect more than 1 in 10 people ) - hypogycaemic reactions are generally mild / moderate . however , some patients may experience hypoglecemia unconsciousness or coma . - allergy allergy is very rare ( might affect up to 1 in every 10 , 000 people ). symptoms can include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this may be a sign of anaphylactic reaction . other side effects are common : may affect upto 1 in the 10 - hour stomach pain . these may be signs of a possible rupture . stomach pain may be severe and may require immediate medical attention . not known ( frequency
what enyglid contains - the active substance is repaglinide . each tablet contains 0 . 5 mg ( 1 mg ) or 2 mg ( 2 mg ), of which at least 1 mg is known . the other ingredients are : microcrystalline cellulose ( e460 ), calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine and poloxamer . - printing ink : shellac , yellow iron oxide ( d ) only in the 1 mg tablets and red iron oxide( e 172 ). the 2 mg tablets are yellow , round and biconvex with bevelled edges . they are approximately 1 mm in diameter , pale brown - yellow - white to off 
the active substance in this medicine is azacitidine mylan . it is an anti - cancer agent which contains the active substances , pegylated polyphenol - 2 ( e221 ). the active ingredient in pegmylated liposome belongs to a group of proteins called cytokines , and is made up of several proteins . the proteins are arranged in such a way that they can be used together with other medicines in the body . what azacitamidine mylan looks like and contents of the pack the medicinal product is a white to off - white lyophilised substance called ' zoster '. azacritidine myLAN is used in adults who are not able to have a stem cell transplantation to treat : - higher - risk myelodysplastic syndromes ( mds ). 
do not take azacitidine mylan : - if you are allergic to azacitatidine or any of the other ingredients of this medicine ( listed in section 6 ). if there is still a possibility that you may have advanced liver cancer , tell your doctor . warnings and precautions talk to your doctor or pharmacist before taking aza citidine myLAN : some patients have had decreased counts of platelets , red or white blood cells . this may be a sign of kidney disease or liver disease . if this is the case you have ever had a heart condition or heart attack or any history of lung disease you will be asked to have blood test . your doctor will do blood tests before you start treatment and regularly during treatment . you will usually be stopped at the end of a ' cycle '. this is to check that you have enough blood cells and that your liver and kidneys
before giving you azacitidine mylan , your doctor may give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor will decide your dose of this medicine , depending on your general condition , height and weight . you will be given azacitamylan once a day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will be repeated every 4 weeks , for up to 6 cycles . - you will normally receive this medicine by giving it to your child as an injection under the skin ( subcutaneously ) by your doctor , nurse or doctor . it may be given under your skin on your thigh , tummy or upper arm . for further information on the dosing cycle , please read the section " instructions for use ".
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure and can be life - threatening . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting and reduced appetite . symptoms may include : confusion , restlessness , fatigue and difficulty in carrying out physical activity . if you experience any of these symptoms , tell your doctor immediately . common ( may affect up to 1 in 10 people ): diarrhoea , indigestion , flatulence ( wind ), constipation , dry mouth , loss of appetite , weight loss ,
your doctor , pharmacist or nurse knows how to store azacitidine mylan properly . keep this medicine out of the sight and reach of children . - do not use this medicine after the expiry date which is stated on the vial label and the carton after exp . this medicine does not require any special temperature storage conditions . once the suspension has been prepared it should be administered immediately , but no longer than after preparation . storage times and conditions prior to use are the responsibility of the user . however , this medicine is for single use only . when prepared as directed by your doctor or nurse , you or your carer can store the suspension below 25  30 ml in the refrigerator ( 2 - 8 ). if refrigerated , the suspension must be used within 8 hours when stored in the original package in order to protect from light . for additional instructions on how to prepare the aza
what azacitidine mylan contains - the active substance is azaсitidine . one vial of powder contains 100 mg zk19 . - after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / 30 g z zitidine ( 0 . 25 % w / v ). -the other ingredient in the powder is mannitol ( e421 ) ( see section 2 ). WHAT azacionidine melan looks like and contents of the pack azacitamylan is a white powder for suspension for injection and is supplied in a glass vial containing 100 mg ( 1 mg ) aza citidine ). each pack contains 1 or 7 vials . not all pack sizes may be marketed .
duotrav eye drop solution contains a combination of two active substances , travoprost and timolol . travondr is a prostaglandin analogue that is used in the eye to reduce pressure within the eye when it is high - pressure - induced by an illness called glaucoma - it can help to reduce this pressure .
do not use duotrav : - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . respiratory problems including asthma , severe chronic obstructive bronchitis , or severe lung disease which can cause wheeziness or difficulty in breathing , especially after long - standing cough . breathing problems include severe hay fever , with a slow heartbeat or heart failure or a disorder of heart rhythm ( irregular heartbeat ). the cloudy part of the eye can become cloudy after you inhale the contents of the vial . do not swallow the desiccant . if any of these apply to you 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop in the affected eye or eyes , once a day in the evening . use duotrav at around the same time each day . it does not matter whether you use it for both eyes . if your doctor tells you to , do not use more than one drop each time . only use eye drops after the expiry date which is stated on the carton . how much to use your doctor will tell you how much medicine to use ( for adults , adolescents , children and adolescents ): 1 2 3 4 how to use a bottle 1 wash your hands . twist off the bottle cap . hold the bottle , pointing down , between your thumb and fingers . tilt your head back . pull down your lower eyelid with a clean
like all medicines , this medicine can cause side effects , although not everybody gets them . you can usually carry on taking the drops , unless the effects are serious . just after using duotrav , you should contact your doctor . very common side effects ( may affect more than 1 in 10 people ): effects in the eye eye redness . common side effect( may affect up to 1 to 10 in a 10 % of people ), effects inthe eye eye eye surface inflammation with or without surface damage . if you experience eye pain , blurred vision or abnormal vision , dry eye , itchy eye or eye discomfort , signs and symptoms of eye irritation , such as burning or stinging , are not known ( frequency cannot be estimated from the available data ). uncommon side effects are : effects on the eye surface irritation or surface damage and / or irritation . reporting of side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store below 30 . throw away the vials 4 weeks after first opening , to prevent infections . write the date of opening on the carton and the blister card label , if you notice that the solution is not clear or contains particles . duotrav does not require any special storage conditions . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what duotrav contains - the active substances are travoprost and timolol . each ml contains 40 mg / 0 . 5 mmol of TRAVOPROSt / 1 . 0mmol / 2 . the other ingredients are : polyquaternium - 1 , mannitol , propylene glycol ( e1520 ), polyoxyethylene hydrogenated castor oil 40 , boric acid , sodium chloride / sodium hydroxide ( a type of hydrochloric acid ) and purified water ( see section 2 ). the content of the product is a clear , colourless to pale yellow solution . it is supplied in glass vials . sodium hydrogenated ( h2o ) is also contained in the vial ( type i ). hydro
nplate ' s active ingredient , romiplostim , is a protein that is used to reduce low platelet counts caused by immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is not a disease that affects your body  s immune system , which makes you produce more platelets . platelets are cells in your blood that help to form blood clots . very low platelets counts can lead to bruising and serious bleeding ( see section 1 ). to have your spleen removed , in patients with chronic itp who have not previously taken corticosteroids or immunoglobulins , with no effect on your immune response . your doctor will discuss this with you . if you have any further questions on the use of this product , ask your doctor or pharmacist .
do not use nplate - if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . - you may be allergic to other medicines that are used to eradicate escherichia coli ( e. coli ). warnings and precautions there could be some reasons why this medicine may not be suitable for you . talk to your doctor or pharmacist before you are given n plate if : you have a low blood platelet count ( thrombocytopenia ). you are not sure if any of these apply to you or your doctor , ask your doctor for advice . you are taking n Plate because of the low count of white blood cells ( platelets ). blood clots : your doctor may want to monitor you more closely to prevent blood
children and adolescents ( aged 1 month to 17 years ): your doctor will tell you how much nplate you will need to have and for how long . - the dose depends on how much you weigh and your body weight . adults : you should not be given more than your doctor tells you to . you should be given an injection under the skin ( subcutaneous ). the recommended dose is 1 ml ( 4 g of n plate ) once a day . your doctor may decide to give you more ( 5 g in weight ) to start at a low dose . how often to use your doctor can tell you whether or not you need to use an injection . children ( from 1 year of age and older ) if you are breast - feeding , you can take the tablets at any time of the day , with or without food . use in children ( 6 months to 17
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with nplate : itp has been reported commonly ( may affect up to 1 in 10 people ) in patients with headache . it is possible that this may be a sign of allergic reaction / upper respiratory tract infection ( see section " warnings and precautions "). it is also common ( might affect more than 1 in10 people ), with bone marrow disorder ( increased bone mamma fibres ). trouble sleeping ( insomnia ) dizziness , tingling or numbness of the hands or feet ( paraesthesia ), migraine , redness ofthe skin and flushing . not known ( frequency cannot be estimated from the available data ) vomiting . if you get any of these symptoms , tell your doctor straight away . nausea and vomiting have also been reported
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicinal product does not require any special storage conditions . nplate can be stored for up to 30 days at room temperature ( at or below 25 ). do not freeze . keep the blister in the outer carton in order to protect from light .
what nplate contains - the active substance is romiplostim . one ml of solution for injection contains 225 mg of romoplost . each vial contains 125 mg / 0 . 25 mL of solution ( corresponding to a deliverable amount of 125 mbq at the date and time of calibration ). if you are injecting a volume of 500 mg , you must use n plate to make up for a missed dose . alternatively , your doctor may prescribe you a second dose of 250 mg ( equivalent to 375 mg v ). when you have been treated for more than one 250 mg dose , each time you receive a new one . - your doctor will decide the correct dose based on the weight of your child . not all pack sizes may be available in your country . the quantity of 
this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : - a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult .. this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of control . once you have used this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using tovanator breezehaler as this may affect your ability to inhale the active substance . - patients with kidney problems if your doctor determines that you have an eye problem called narrow - angle glaucoma , or difficulty passing urine , your doctor may decide to reduce your dose or stop treatment temporarily or permanently , if any of these apply to you . when using the product you should tell your doctor immediately if : - you experience tightness of the chest , coughing , wheezing or breathlessness immediately after using the tablet , as the user may experience bronchospasm .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to use one inhalation every day because you will be inhaling this medicine 24 hours after you have taken your dose . do not use more than your doctor tells you to use . elderly ( age 75 years and over ) you should take this medicine as directed by your doctor . this medicine is contained in a blister . in this pack , you will find an inhaler and capsules ( in blisters ) that contain the medicine as inhaled powder . the capsules should remain in the blister until they need to be used . please read the instructions for use at the end of this leaflet for more information about how to use
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyrnium brmide ( equivalent to 50 microgramms glycopronium ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram ( g ) of glyco Pyronium at the date and time of inhalation .  the other ingredients in the capsule content are lactose monohydrate and magnesium stearate . see the end of this leaflet for further information about some of the ingredients of the brewing powder , which are ethanol free , and sodium - free in the morning , after breakfast , at mid - day ( thawing ) and vitamin b12 ( if you are not sure about anything ), ask your doctor or
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it affects the activity of a chemical in the brain called dopamine and serotonin . this helps to calming effects and relieving aggressive behaviour ( acute symptoms of mild - to - moderate agitation ). it is used in adults of all ages with schizophrenia and bipolar disorder , diseases characterised by symptoms such as schizophrenia hearing , mistaken beliefs , incoherent speech and behaviour and emotional flatness . people with this condition may also feel depressed , guilty , anxious , or tense . the active ingredient in this medicine can help you to remember to take a balanced and balanced dose , which you have been given in response to an activity that is unusual for you and you cannot resist the impulse , drive or temptation to carry out certain
do not take adasuve : - if you are allergic to loxapine , amoxapin , or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . some patients have experienced symptoms such as wheezing and shortness of breath , which were common in some patients with lung problems like asthma , chronic obstructive pulmonary disease ( copd ), which caused narrowing of the airways ( bronchospasm ). in these patients , wheeze , cough , chest tightness or shortnessof breath can be signs 25 of neuroleptic malignant syndrome ( nms ). it is not known if these symptoms are caused by antipsychotic medicines . these symptoms include high fever , rigid muscles and increased sweating
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg once a day . your doctor may prescribe you a lower or higher dose of 2 mg or 4 . 5 mg depending on your condition . wash your hand before and after swallowing the tablet . do not put the tablet in your mouth . if the device is not working properly , it may take some time for you to notice the following symptoms : extreme tiredness , sleepiness , trouble breathing , low blood pressure , throat irritation , a bad taste in the mouth , or muscle or eye movements that are not controlled . you should rinse your mouth thoroughly with water , even if this does not last long . contact your doctor , pharmacist or nurse as soon as possible to reschedule your treatment .
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any breathing symptoms ( wheezing , cough , shortness of breath , chest tightness ) or if it gets worse ( irritating ), your airways may get narrower , which may cause asthma or copd . light - headedness , fainting or a lowering of your blood pressure . worsening agitation , confusion , fever and muscle stiffness . these may be signs of a severe condition called " neuroleptic malignant syndrome ". other side effects include : very common ( may affect more than 1 in 10 people ): diarrhoea , nausea , vomiting , abdominal pain , distension , dry mouth , indigestion , pain in your arms or legs , loss of appetite . common
keep this medicine out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and blister after exp . store in the original package in order to protect from moisture . an open or torn pouch should not be used if there is any visible sign of physical damage .
what adasuve contains - the active substance is loxapine . each single - dose inhaler delivers 5 micrograms ( 4 . 5 microlitres ) of loxаpine over a period of approximately 5 days . this delivered dose is 1 microgram ( 0 . 25 millilitre ) ( 6 . 7 milliliter ), delivering 3 . 4 milligram ( 8 . 9 milligramm ) lox apina . what the adsuve looks like and contents of the pack aadosuve is supplied as a 4.5 mg inhalation kit , which is a clear , colourless to pale yellow solution , delivered in a blister ( 270 ) clear plastic pouch . it is available in packs of 1 or 5 inhalers . not all pack sizes may be 
what azacitidine betapharm is and how it works the molecule itself consists of a substance called an anti - cancer agent . it belongs to a group of medicines called ' long - acting proteins '. the active substance in this medicine is a protein produced by recombinant dna technology ( rdsct ). the substance in the tablet contains a particular active substance called zoster ' s own protein . zantidine betrapharm contains an active substance ( s ) which is involved in the normal cell production of cells . what exactly is the reason for this medicine being made from your own stem cell transplantation ? it is used to treat patients with higher - risk myelodysplastic syndromes ( mds ). it is also used in adults to treat chronic myeloidocytic leuka
do not take azacitidine betapharm : - if you are allergic to azacitabine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment if : you have advanced liver cancer . you are breast - feeding . while you are being treated for this medicine , you may be at risk of decreased counts of platelets , red or white blood cells , due to kidney disease or liver disease you have been told you have a heart condition or heart attack or any history of lung disease . blood test you will have blood tests before you start treatment with this medicine and regularly during treatment ( so - called a ' cycle '). you will be monitored carefully for signs that you have enough blood cells and that your liver and kidneys are working properly . your doctor may decide to reduce the
before giving you azacitidine betapharm , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . use in children and adolescents the recommended dose is 75 mg per m2 body surface area . the doctor will decide your dose of this medicine , depending on your general condition , height and weight . you will be observed while you are being given aza citidine betatapharm and for at least 3 weeks after your last dose . this " treatment cycle " will be repeated every 4 weeks . it will usually be given to you in two cycles , i . e . from day 6 onwards , you will normally receive this medicine as an injection under the skin ( subcutaneously ) by your doctor , nurse or other health care professional ( s ) for as long as your doctor considers it necessary . your doctor may inject this medicine under
like all medicines , this medicine can cause side effects , although not everybody gets them . the most common side effects are drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure and can be life - threatening . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting and reduced appetite . symptoms may include : confusion , restlessness , fatigue . if any of these side effects causes you problems , talk to your doctor or pharmacist . very common : may affect more than 1 in 10 people : diarrhoea , pain in the abdomen , indigestion , heartburn , loss of appetite , weight loss , constipation , dry mouth 
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the carton and vial after exp . this medicine does not require any special storage conditions . your doctor , pharmacist or nurse will throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment . for single use only . when necessary , the suspension should be administered within 45 minutes after it is prepared and given to you . alternatively , when using later on in life - style storage times and conditions prior to use are the responsibility of the user and would normally not be longer than four hours at 2 to 8 , unless dilution has taken place in controlled and validated aseptic conditions ). when switching from the controlled use to injections using the suspension once it has been
what azacitidine betapharm contains - the active substance is azaсitidine . one vial contains 100 mg zd . a corresponding to a molecular level ( mmol ) of 225 % dna . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / 0 . 5 mg  aza citidine .  the other ingredient in the suspension is mannitol ( e421 ) if you have any further questions on the use of this product , ask your doctor or pharmacist . what you need to know before you are given azacitaitidine betatapharm ? the pack of azacriitidine bedtapharm is a white to off - white powder for suspension for injection in a glass vial containing 100 mg
cerdelga contains the active substance eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher Disease type 1 is an inherited condition in which a substance called glucosylceramide is not removed from your body ( spleen , liver and bones ). eglustat works by reducing the amount of glucosquillaramide in your affected organs . this medicine can also be used in children . if you have any questions about how this medicine works or why this medicine has been prescribed for you , ask your doctor . you may be prescribed this medicine by mouth and by injection into a muscle fibre called ' gylcyp3a4 '. the recommended dose is one tablet per day . the tablet can be taken at the same time each day by taking two tablets in the morning
do not take cerdelga - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). this is particularly important : - when you are taking medicines known as moderate cyp2d6 inhibitors ( e . g . quinidine or terbinafine ), 31 - once daily - moderate cyst3a inhibitors , such as erythromycin or itraconazole . these medicines reduce your body ' s ability to break down and repair damaged cells . do not give this medicine to you if this happens because it may reduce your ability to do normal daily activities . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you are using medicines whose body uses a poor metaboliser such as medicines with strong cyst
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how much cerdelga to take , when to take it and how often . the usual dose is one tablet a day . metaboliser : take one tablet each day , at the same time , for example , one tablet in the morning and one in the evening . this will help you remember to take the tablet as well as it can be taken with food , 84 hours apart . swallow the tablet whole , with a glass of water . do not break , crush or chew the tablet . how to take take the tablets with or without food . open the blister / wallet - the sleeve should be folded in half with your thumb and index finger . push the tablet through the foil . when you
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache , dizziness , change in taste ( dysgeusia ), palpitations , throat irritation and heartburn ( dyspepsias ), feeling sick ( nausea ), diarrhoea constipation abdominal pain and stomach ache ( upper abdominal pain ), acid reflux disease ( gastrooesophageal reflux disease ), bloating ( abdominal distension ), inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dyspeptic ulcer ) uncommon : may affect up to 1 in 100 people : weight loss ( gout ), high blood sugar ( hypoglycaemia ), weight gain , low blood sugar , vomiting , feeling unwell , indigestion
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , sleeve , and wallet after " exp '' keep it in the outer carton in order to protect from light and moisture . this medicine does not require any special temperature storage conditions . cerdelga is for single use only . discard any unused medicine via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what cerdelga contains - the active substance is eliglustat . each hard capsule contains 84 mg / 0 . 5 ml solution for injection ( corresponding to 6 iu / kg ).  the other ingredients are : capsule content : microcrystalline cellulose ( e460 ); lactose monohydrate ( see section 2 , ' important information about some of the ingredients of this medicine '); hypromellose ; glycerol dibehenate . capsule shell : gelatin , potassium aluminium silicate , titanium dioxide , yellow iron oxide and indigotine . printing ink : shellac , black iron oxide , propylene glycol and ammonia solution , concentrated , clear to opalescent , colourless to pale yellow , opaque to pale brown
what zoledronic acid hospira is and what it is used for it is a substance derived from the bone . it belongs to a group of substances called bisphosphonates . zoleric acid works by attaching itself to the bone and slowing down the rate of bone change . It is used : - to prevent bone complications , e - g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to another bone ). what is tumour - related hypercalcaemia ( tih ), a condition in which the body is breaking down the calcium in the form of calcium , which is increased by the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium from bone is increased . this condition is known as tumour- induced hypercalcauemia (
follow carefully all instructions given to you by your doctor . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment at regular intervals . you should not be given zolédronic acids per injection , if you are breast - feeding . do not use , or think you may be , allergic ( hypersensitive ) to the active substance or any of the other ingredients in this medicine ( listed in section 6 ). if this applies to you , tell your doctor as soon as possible . warnings and precautions talk to your doctor or pharmacist before you are given this medicine if : you have or have had a kidney problem ( signs may include pain , swelling or numbness of the jaw , feeling of heaviness in the jaw or loosening of a tooth ). you may need a
zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously , i . e . through a vein , (' iv ' administration ). your doctor will recommend that you drink enough water before each treatment to help prevent dehydration . carefully follow all the other instructions given to you by your doctor , pharmacist or nurse . how much to receive - the usual single dose given is 4 mg .- if you have a kidney problem , your doctor may give you a lower dose if your kidney problem is not being controlled by the way that you are being given the dose . the recommended dose is one vial in each patient ( see section 2 ). - o nauseous administration : o you will be told how to handle the vial and how to prevent bone complications due to bone
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common ones are usually mild and will probably disappear after a short time . tell your doctor about any of the following serious side effects straight away : common ( may affect up to 1 in 10 people ): - severe kidney impairment ( will normally be determined by your doctor with certain specific blood tests ). - low level of calcium in the blood . uncommon ( will affect less than 1 in 100 people ), - pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth ( jaw discharge ) - numbness or a feeling of heaviness in the jaw or loosening of a tooth . these could be signs of bone damage in the teeth ( osteonecrosis ). tell your
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly ( see section 6 ). they are responsible for the correct storage of the medicine before and during its use , as well as for its correct disposal .
what zoledronic acid hospira contains - the active substance in this medicine is zodronic acids . one vial contains a total of 4 mg zolezonic acid ( as monohydrate ).  the other ingredients are : mannitol , sodium citrate , water for injections . see ' information for the doctor and the pharmacist ' at the end of this leaflet . what z zoleric acid hospirtona looks like and contents of the pack zzoledonic acid whistling is a liquid concentrate for solution for infusion ' ( also known as ' sterile concentrate '). each pack contains 4 ml of concentrate . not all pack sizes may be marketed .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) when having cancer treatment chemotherapy . chemotherapy destroys the nerve cells that control the brain . this causes vomiting , which can be very harmful , as it makes you feel sick . being sick , having fun is a very common symptom of cancer . rolulapitant works by killing these nerve cells , helping to prevent nausea and vomiting .
do not take varuby : - if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment . this medicine is an herbal medicine containing st john ' s wort ( hypericum performatum ) used for depression and / or difficulty sleeping ( see section 2 , " how to take this medicine "). - 27 - use in children and adolescents with severe liver or kidney problems . - take certain medicines , such as rifampicin ( used to treat tuberculosis and other infections ) or carbamazepine ( used for epilepsy and nerve pain ) and phenobarbital ( used in epileptic patients ) - the active substance in vagina is 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one 180 mg tablet once a day . your doctor may decide to increase your dose to 90 mg . swallow the tablet whole with a glass of water . you can take varuby with or without food . do not crush or chew the tablet . take it at least 2 hours before you start your chemotherapy cycle . when you are having chemotherapy , you are more likely to experience sickness . to help prevent sickness , it is important to keep taking this medicine during your chemotherapy and during your next chemotherapy cycle as advised by your doctor . it is very important that you keep having chemotherapy for as long as you are sick , as it helps to keep you off your usual dose . don ' t let this medicine pass on its own . talk to your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : rare side effects ( may affect up to 1 in 1 , 000 people ) if you get symptoms of an allergic reaction such as sudden shortness of breath , swelling of the lips or tongue , change in taste or swelling of skin or tissue , sudden rash , fever and faster heartbeats , tell your doctor immediately and stop using varuby . your doctor will decide if and when appropriate treatment may be needed . other possible side effects are listed below : very common : may affect more than 1 in 10 people headache , constipation and feeling tired . uncommon : might affect upto 1 in 100 people diarrhoea , nausea , vomiting and dizziness . not known : frequency cannot be estimated from the available data
what varuby contains - each tablet contains 90 mg of rolapitant . - the other ingredients are : - tablet core : lactose monohydrate ( see section 2 under ' vacumy contains lactoses '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate - film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . ink : shellac , red , 100 mg , marked with ' v100 ' on one side . the other side is a polyvineyl chloride - free polychlorotrifluoroethylene / aluminium foil lined blister .
what enerzair breezhaler contains the active substances are : - indacaterol - glycopyrronium - mometasone furoate indabacaterol and / or glycopronium belong to a group of medicines called bronchodilators . they work in different ways to relax the muscles of the small airways in the lungs . this helps to open the airways and makes it easier for air to get in and out . when they are taken regularly , they help to open more airy and airy spaces , making it easier to breathe easier for people who are unable to breathe because they have not been able to take their daily doses . Mometainsone furodyate belongs to the group of medicine called corticosteroids ( also known as steroids ). corticostoids reduce the swelling and irritation ( inflammation 
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate , or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before you are given this medicine because you may be allergic to all of the ingredients . warnings and precautions talk to your doctor , pharmacist or nurse before and during your treatment if any of these apply to you as you may not be fully protected from light . take special care with enersair b . c . heart problems , including an irregular or fast heartbeat , have ever been told you have thyroid gland problems . you have diabetes or high blood sugar . your doctor may want to monitor you more closely , and treat you with seizures ( fits ). you have
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because your asthma is not getting better . your doctor will talk to you about ways to use enerzair breezhaler , and what to do if your symptoms do not improve after one hour . do not use more than your doctor tells you to . try to use an inhaler and capsules to help you remember to use it . this will make sure that you get the full dose of the medicine that you use . only use the capsules that are supplied in the pack to help control your asthma . once your symptoms are controlled , the next dose should be used soon after you have used the pack . it is important that you keep
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious stop using enerzair breezhaler and get medical help immediately if you have any of the following : common : may affect up to 1 in every 10 people - difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other possible side effects include those listed below . if these side effects become severe , please tell your doctor , pharmacist or nurse . very common ( may affect more than 1 in10 people ) - sore throat - runny nose - sudden difficulty breathing and feeling of tightness in chest with difficulty breathing - feeling tiredness - burning sensation when passing urine - joint pain - low blood pressure uncommon ( may
- keep this medicine out of the sight and reach of children . - do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture . do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ) and mometasone furoate . each delivered dose ( the dose leaving the mouthpiece of the inhaler ) contains 150 micrograms of indаcaterol( as ace ), 63 microgram ( equivalent to 0 . 5 microgram ) glycoproteomyelitis , equivalent to 50 microgram( 1 / 5 ), respectively , and 160 microgram [ 2 - o ] ( corresponding to 134 g ]) of glycopronium / 160 microgramm ( equivalent  5 / 10 ) ( respectively ). each individual dose ( s ) corresponds to a concentration of 104 microgram of indigo car
the active ingredient clopidogrel belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process known as thrombosis ). by limiting the activity of this medicine , you can help your body to make blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis . it is thought to be one of the most serious adverse events , such as stroke , heart attack , or death . you should know that : you have been prescribed the right type of medicine to help prevent this condition .
do not take clopidogrel acino pharma gmbh : if you are allergic ( hypersensitive ) to the active substance , or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and during your treatment with chromozyme if : you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . you have severe liver disease . if any of these apply to you , you may not be able to pass on the medicine whilst you are taking this medicine . take special care with the chromone sulphonylurea ( csf ): you should tell your doctor before you start to take c . in the event of a problem you have been told not to take
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg film - coated tablet per day to be taken orally with or without food , and at the same time each day ( for example , one tablet in the morning and one in the evening ). it is very important that you continue the diet and lifestyle advice given to you by your doctor whilst you are taking this medicine . do not take a double dose to make up for a forgotten tablet , but a later tablet should be taken as soon as possible and continue as before . if your doctor decides that you should continue with your diet and / or work out the dose you should take , contact your doctor , pharmacist or your nearest hospital emergency department because of the increased risk of
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effect affects 1 to 10 users in 100 ) uncommon ( impact affects less than 1 per 10 user in 1 , 000 ) rare ( impact impacts 1 to10 users in10 ,000 ) not known ( frequency cannot be estimated from the available data ) contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or eyes ( jaundice ), or a decrease in the number of red blood cells ( anaemia 
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special temperature storage conditions . if you notice any visible sign of damage of blister or film - coated tablets , please tell your pharmacist . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains the active substance is crospovidone , a castor oil , hydrogenated film - coating : macrogol 6000 ethylcellulose ( e462 ) titanium dioxide (e 171 ) what cpr - crospividone looks like and contents of the pack cppa754 75 mg tablets are white to off - white , marbled , round and biconvex . they are supplied in cardboard cartons containing 14 , 28 , 30 , 50 , 64 , 90 or 100 tablets . not all pack sizes may be marketed .
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults . it belongs to a group of medicines called ' antiretroviral medicines '. it contains two active substances : doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine , and a nuclear medicine doctor (' nuclear medicine specialist ', also known as a nuclioside analogue reverse transcriptor sti and tenofovir disoproxil ), which is another type of medicine called a neurostylated polymyxin - tetanus , (' nrdi '), all three active substances have been shown to increase the level of hiv infection in people 18 years of age
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil , or any of the other ingredients of this medicine listed in section 6 . if this applies to you , tell your doctor immediately . also , some patients may be taking the following medicines : carbamazepine ; oxcarbazepine ( e1200 ); phenobarbital and phenytoin ( medicines to prevent seizure ); rifampicin and riifapentine ( medicines for tuberculosis )); st john ' s wort ( hypericum perforatum ) ( a herbal remedy used for depression and anxiety ) or products that contain mitotindopa 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much delstrigo to take the recommended dose is a complete regimen . it is taken as a single tablet to treat hiv infection in adults , adolescents and children aged 1 year and above who are taking certain medicines , such as doravirine ( a class of medicines to lower your cholesterol ). taking this medicine swallow the tablet whole with a glass of water . this medicine can be taken with or without food . take the tablet at the same time each day . you can take your tablet at any time of the day and night . do not change the time of day you take it unless your doctor tells you to . your doctor will tell you exactly how long you need to take this medication . if your doctor decides to stop your treatment with del s
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor straight away if you notice any of the following very common ( may affect more than 1 in 10 people ): abnormal dreams ; difficulty in sleeping ( insomnia ); headache ; dizziness ; sleepiness ; cough ; nasal symptoms ; feeling sick ( nausea ); diarrhoea ; stomach pain ; vomiting ; wind ( flatulence ); hair loss ; rash muscle symptoms ( such as pain or stiffness ); feeling tired ; pain in the joints ; muscle pain ( tummy pain , back pain ); muscle spasms ; joint pain . uncommon : may affect up to 1 in 100 people : feeling cold ( fatigue ); constipation ; dry mouth ; excessive sweating ; skin rash 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after " exp ". this medicine does not require any special temperature storage conditions . keep the bottle tightly closed in order to protect from moisture . this medicinal product does not contain any preservatives . delstrigo is for oral use only . once the bottle has been opened , the medicine should be used immediately . discard the opened portion of the bottle after first opening or if there are particles present . any unused medicine must be disposed of in accordance with local requirement .
what delstrigo contains each tablet contains 100 mg doravirine , 300 mg lamivudine and 245 mg tenofovir disoproxil ( as fumarate ) in the form of granules . the other ingredients are : tablet core : croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate ( e470b ), microcrystalline cellulose e460 , silica , colloidal anhydrous , and sodium stearyl fumаrate . film - coating : carnauba wax e903 / mpa . st . louis - john ' s wort , iron oxide yellow , lactose monohydrate , titanium dioxide e171 ,
spravato contains the active substance esketamine . this belongs to a group of medicines called anti - depressants . you have been given this medicine to treat your depression . it helps to control the symptoms of depression , including feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities , feeling of being slowed down . if you have the impression that the effect of another antidepressant is too strong or too weak , talk to your doctor or pharmacist . see section 2 under ' do not use '. it is important to note that all of the above applies to you and include all medicines you bought without a prescription .
do not take spravato - if you are allergic to esketamine ( also known as ketamine ). - during anaesthesia , you should not receive this medicine for more than 6 weeks . if there is still a possibility that you may have an aneurysm ( a weak spot on a blood vessel wall ) that bulges out , or if bleeding in the brain has recently had a heart attack within 6 weeks or a temporary increase in blood pressure . this may increase the risk of serious complications in these conditions . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have been told that you have a serious heart problem or poor blood flow to the blood vessels you are in close contact with someone who is unable to keep blood vessels open or blocked . your doctor will have to check
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the spravato nasal spray is for use in adults only . the nasal spray device can be divided into two equal doses . use in children and adolescents the recommended dose is 1 spray in the morning , 2 sprays in the evening and 3 nasal spray devices at the same time . there is no need to increase the dose . you can use one nasal spray approx . 4 times a day for up to 4 weeks . your doctor will tell you how long your treatment will last . do not change your dose without talking to your doctor . for children , adolescents and adults , the recommended maintenance dose for children is 2 to 17 years of age . using this medicine it is unlikely that you will be given too much , however , treatment will usually last for at
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ) feeling disconnected from feelings and things around you feeling dizzy , headache , change in sense of taste feeling sleepy , decreased feeling or sensitivity , especially in your mouth area spinning sensation , vertigo , vomiting nausea common : may affect up to 1 in every 10 people feeling extremely happy ( euphoria ), feeling agitated , lack of motivation , difficulty concentrating , changes in taste rash , skin redness , joint pain , back pain muscle spasms , pain in your joints , muscle pain or pain in joints . not known : frequency cannot be estimated from the available data swelling of the face , lips , tongue , throat or other parts of
what spravato contains - the active substance is esketamine . each nasal spray device delivers a single dose ( 0 . 5 ml of solution ). each dose of esesketamine hydrochloride contains 28 mg eeketamine at the date and time of calibration .  the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections . what ravato looks like and contents of the pack s Pravato is presented as a nasal spray solution for application . this medicine is a clear , colourless solution supplied in a multi - use nasal spray unit . one sprinkler provides a colourless and clear solution when it is applied by spraying directly into the nostril using the sprayer . the sprayers are packaged in
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery if you have cancer with a change ( mutation ) in a gene responsible for producing certain proteins in the body , called cytokines , and / or cells that are involved in the growth and spread of mel
do not take zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash , or fainting sensation . warnings and precautions talk to your doctor , pharmacist or nurse straight away if : you have ever had allergic reactions . allergic reactions occur more frequently in women than in men , and most cases are mild to moderate and usually go away within a few days . you have never had any symptoms of an allergic reaction , such as : - swelling ofthe face - lips or tongue which may cause difficulty breathing or rash which may go away - fainting sense , severe skin peeling , itching , redness or itching of the skin . if any
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one 4 mg tablet once a day . your doctor may decide to increase your dose to 8 mg once daily , up to a maximum 4 mg dose in the morning and back , preferably in the evening . the dose may be increased or decreased by your doctor , depending on the side effects you experience and on how you respond to your treatment . do not stop taking zelboraf unless your doctor tells you to . in case of vomiting , take your tablet as soon as possible and then take your next scheduled tablet at the usual time . it is very important that you continue with your treatment at the same times every day , as this will help prevent you from becoming dehydrated . swallow the tablet whole with a glass of water . you
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions may occur , including swelling of the face , lips or tongue , difficulty breathing rash fainting sensation has been reported in some patients treated with zeloraf . talk to your doctor immediately if you notice any of the following while receiving radiation treatment : side effects related to radiation some patients may be exposed to a higher risk of being exposed to radiation while receiving zelmoraf treatment . you should be aware that some of the effects of radiation could be serious . these include : very common : may affect more than 1 in 10 people an increased risk of getting radiation to the skin , episophagus , bladder , liver , rectal , and lungs . tell your doctor or seek medical attention immediately . contact your doctor if your child develops any of
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and the blister after " exp ". store in a refrigerator ( 2 8 ). do not freeze . discard if the solution is discoloured or you can see particles floating in the solution . if you do not see any change in the appearance of the capsules , tell your pharmacist or nurse .
what zelboraf contains - the active substance is vemurafenib . each film - coated tablet contains 240 mg of VEmurafieb ( as a co - precipitate of v415 ) in a single layer . the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium ; hydroxypropyl cellulose , magnesium stearate film coating : iron oxide red ( e172 ), macrogol 3350 , polyvinyl alcohol ( part . ethanol ), talc and titanium dioxide (  e171 ). what the heck is the name of the drug is a white to off - white , capsule shaped , biconvex , pinkish white to
duoplavin contains two active substances , clopidogrel and acetylsalicylic acid ( asa ). these belong to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , it prevents the blood vessels from forming and preventing them from clots forming ( an process called atherothrombosis ). the active substances in duopolivin are used to prevent blood coagulation in hardened arteries ( a process known as atherathrombotic events , such as stroke , heart attack , or death ). duaplavin is taken together with a meal . you should eat at least one hour before or two hours after your meal , to reduce the risk of blood
do not take duoplavin : - if you are allergic to clopidogrel or acetylsalicylic acid ( asa ) or any of the other ingredients of this medicine ( listed in section 6 ) if this applies to you , tell your doctor before taking this medicine . - also if your doctor thinks you may be allergic to other products , including non - semen - related inflammatory products . warnings and precautions painful and / or inflammatory conditions of muscles or joints have been reported in patients treated with a medical condition such as asthma , nasal discharge , runny nose , polyps ( a type of growth along the inside of the nose ). talk to your doctor , pharmacist , or nurse before taking the medicine if : you have or are currently bleeding , such as a stomach ulcer or bleeding
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . duoplavin is for oral use . swallow the tablets with a drink of water . you can take the tablet with or without food . try to take your medicine at the same time each day . it is very important that you continue to take duunplavin until your doctor tells you otherwise . if there is anything you do not understand , do not take more than the prescribed dose . tell your doctor , pharmacist or nurse , as you may have an increased risk of a heart attack . in case of an emergency department , your dose may be reduced , and you may be monitored more carefully . keep the tablet bottle with you so that it is clear what medicine is in your body and what it is used for . do not change the tablet dose without talking to your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the whites of the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' what you need to know before you take duoplavin '). - swelling in the mouth or skin disorders such as rashes and itching , blisters ofthe skin . this may be the signs of an allergic reaction . the most frequently reported side effects are described below : very common side effects ( may affect more than 1 in 10 people ): diarrhoea , nausea 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . store below 25 . this medicine does not require any special storage conditions . notice any visible sign of deterioration do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains the active substances are clopidogrel and acetylsalicylic acid ( asa ) ( 75 mg / 5 , 800 iu )  ctrol ( e421 ),  magnesium stearate ,  calcium - free ' ( i . e . hydrogen sulphate ) and  70 % ( 0 . 75 mg [ e339 ]) ctosan . the other ingredients are mannitol , macrogol 6000 and microcrystalline cellulose ; low substituted hydroxypropylcellulose , maize starch , hydrogenated castor oil . see also section 2 ' duo plavin contains hydrogenated castler oil ' for further information .
simbrinza contains two active substances , brinzolamide and brimonidine tartrate . brinzolidine belongs to a group of medicines known as carbonic anhydrase inhibitors . brimoniidine saltrate belongs to another group of medications called alpha - 2 adrenergic receptor agonists , which work in different ways to reduce pressure within the eye and so lower the pressure . simbrINza is used to treat eyes in adults ( 18 years of age and older ) to treat eye conditions such as glaucoma and ocular hypertension ( high pressure in the eyes ) in adult patients .
do not take simbrinza : - if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may be allergic to sulphonamides , medicines used to treat diabetes or infections , diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors ( medicines used for depression or parkinson ' s disease ), certain antidepressants ( see " taking " below ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking this medicine if : you have severe kidney problems you have too much acidity in your blood ( hyperchloraemic acidosis ) you have less than 2 years of age . you are taking a special diet low calcium levels in your
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop in the affected eye or eyes , once a day in the evening . use in children simbrinza can be used in adolescents , adolescents and adults . it is best to use it at the same time each day , preferably in the morning . wash your hands before you start . step 1 - step 2 - remove the bottle cap and snap collar . if the medicine has been opened , use it right away . twist off the cap . after the cap is removed , snap collar is loose , and the medicine should not be used . hold the bottle , with both fingers , in a straight line . pull the bottle out with your thumb and fingers . tilt your head back and pull down your lower eyelid with 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine . if you have a reaction to the medicine ( frequency not known ), you may need medical attention . an allergic reaction may include severe skin reactions ( rash , redness and itching all over your body ) or eyes trouble breathing , chest pain or irregular heart beat tell your doctor immediately extreme tiredness and dizziness . side effects of simbrinza may also occur with other medicines . to reduce the risk of brinkling , please also read the package leaflets for each medicine you are taking . they may include : very common ( may affect more than 1 in 10 people ): - severe allergic reaction ( if this happens to you or to your child ) - blurred vision or other changes in the way the medicine works . not known (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after ' exp '. this medicinal product does not require any special storage conditions . after opening the bottle , use within 4 months to prevent infections and use a new bottle . write down the date you opened the bottle in the space on each carton box . this information will help to protect your medicine from moisture and reduce the risk of infections . keep the bottle tightly closed in order to protect from moisture , and do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . - one ml of suspension contains 10 mg / 0 . 5 mg of brinzolam and 2 mg of brimonididine saltrate equivalent to 1 . 3 mg b . the other ingredients are benzalkonium chloride ( see end of section 2 under ' important information about some of the ingredients of simbrINza '): - benzoate salt ( e211 ) - propylene glycol , carbomer 974p , boric acid , mannitol ; sodium chloride ; tyloxapol ; hydrochloric acid and / or sodium hydroxide , purified , concentrated , and distilled water . not all ingredients are listed in this leaflet .
what filgrastim ratiopharm is and why it is important to know how it works when it comes to making new blood cells . this is particularly important if you are a patient with escherichia coli . it is very similar to a natural protein ( granulocyte - colony stimulating factor [ g - csf ]) that is produced by your own body . filgraskastim stimulates the bone marrow ( the tissue where new blood cell are made ) to produce more blood cells ( mostly white cells ). white cells are important as they help your body fight infection . what is filgrasestim ratiophenpharm used for filgra' styrosine phosphate ( a type of protein ) that helps your body make more white blood cells than it should . you may be given filgranstim ratiopharm when your
do not use filgrastim ratiopharm : - if you are allergic ( hypersensitive ) to filgraştim or any of the other ingredients of filgrasestim . if this applies to you , tell your doctor and do not take filgrassen ratioparm . warnings and precautions talk to your doctor , pharmacist or nurse before and during your treatment with filgrastortim ratioppharm , if : you experience a cough , fever and difficulty breathing . it could be a consequence of a pulmonary disorder . you may experience side effects related to sickle cell disease 57 you get left upper abdominal pain or pain at the tip of your shoulder . this may be due to a so - called spleen disorder , which may increase your risk of side effects . your doctor may do regular blood tests while you are being treated with filgranstim
always use filgrastim ratiopharm exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . your doctor will tell you how many copies of your own work are due to you or your child ' s doctor . do not share this medicine with anyone else . tell your doctor about all your medical conditions , including your age , weight and how long you need to keep using it . the usual dose of filgratim ratioppharm to be taken by patients who have received chemotherapy , the usual starting dose is 0 . 5 million units ( 60 kilograms ) per kilogram body weight . this will be given to you once a week for at least 30 days . sometimes your doctor may decide that you should receive your treatment over a period of 14 days , depending on the type of treatment you are receiving . in some disease types , however ,
you should not be given filgrastim ratiopharm : if you have sickle cell disease . tell your doctor or nurse immediately if : 56 you get left upper abdominal pain or pain at the tip of your shoulder . it could be a consequence of a spleen disorder ( see section 4 . possible side effects ). your doctor will do regular blood tests while you are being treated for this . you will have tests to check how well your medicine is working and to count the number of neutrophils , a type of white blood cells . your doctor may test your blood before , during and after treatment . this is to check if it is working . using other medicines please tell your physician , pharmacist or nurse if this is a problem you are using or have recently used any other medicines , including medicines obtained without a prescription . pregnancy and breast - feeding ask your doctor
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . before use , inform your pharmacist if the solution is cloudy or contains particles . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgristim . each millilitre of the concentrate for solution for infusion contains 60 million international units [ miu ] ( 600 microgram ) of filgranstim at the date and time of calibration ( corresponding to 30 micrograms / 0 . 5 ml ). - each 30 microlitre vial contains 300 microgram ( 300 microlitre ) filgraStim at a moment when processing the solution for injection . if you are switching from another formulation to a different formulation , you may need to use it for up to 48 hours in a single use vial , and in 48 hours after reconstitution . the other ingredients are : sodium hydroxide , glacial acetic acid , sorbitol ( e420 ), polysorbate 80 , water for injection
what riluzole zentiva is and why it is important : the active substance in rilsuzola is remdesivir . it acts on the nervous system to help make decisions about what to do . and how much to take ? rilluzolе zentivea is used in patients with amyotrophic lateral sclerosis ( als ). als is a form of motor neurone disease where attacks of the nerve cells responsible for sending instructions to the muscles lead to weakness , muscle waste and paralysis . the destruction of nerve cells in motor neuropathy may be caused by too much glutamate ( a chemical messenger ) in the brain and spinal cord . if you have not received a dose , it will be given to you by a doctor who is specialised in the manufacture of this medicine . derived from the gluta
do not take riluzole zentiva : - if you are allergic to rilsulazole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and during your treatment , if : you have any liver disease or increased blood levels of some enzymes of the liver ( transaminases ). you are pregnant or breast - feeding . you should not be given this medicine if either of the above apply to you . if so , your doctor may want to monitor you more closely while you are taking the medicine , and you are more likely to get any liver problems . yellowing of your skin or the whites of your eyes ( jaundice ), itching all over , feeling sick , being sick - your kidneys may not work very well -
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . it does not matter at what time of the day you take your tablet but taking the tablet by mouth , at least 12 hours after your last dose of riluzole zentiva , you should take it at the same time each day ( for example , one tablet in the morning and one in the evening ). you should swallow the tablet whole with some water . do not chew or break the tablet . if your doctor cannot take the tablet or if someone else takes your tablet , contact your pharmacist or your nearest hospital emergency department immediately for advice . keep the tablet bottle with you so that you can easily describe what you have taken , and for how long you should continue with your normal daily dosing schedule , as described above 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever ( increase in temperature ) . riluzole zentiva may cause a decrease in the number of white blood cells . your doctor will take a blood sample to check if there are any changes in the numbers of whiteblood cells that help to fight infections . you may experience one or more of the following symptoms : yellowing of your skin or the white of your eyes ( jaundice ), itching , feeling sick or being sick , because you may have liver disease ( hepatitis ). you will need regular blood tests to make sure that you are getting the correct dose . some patients may experience cough , difficulties in breathing or swallowing . other side effects may include : very common side effects ( may affect more than 1
what riluzole zentiva contains - the active substance is rizole ( as besilate ).  the other ingredients are :  tablet core : anhydrous dibasic calcium phosphate , micro crystalline cellulose ( e460 ( i ); 98 %, 112 % and 168 % tablets .  film - coating : maize starch , croscarmellose sodium ; hypromellose , macrogol 6000 , titanium dioxide , and carnauba wax , all in the bottle . not all the pack sizes may be marketed . what if you have any questions about the contents of the pack the tablets are white to off - white , oval tablets , debossed with " r " on one side and " 50 " on the
emgality contains the active substance galcanezumab , a medicine that lowers the levels of calcitonin gene - related peptide ( cgrp ), which is involved in migraine , and helps to improve your quality of life .
do not use emgality : - if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have a serious cardiovascular disease . your doctor has told you that you have serious cardiovascular diseases . this medicine may not be suitable for you . there have been rare reports of allergic reactions . some of these reactions may be serious and may affect up to 40 people . you have the hla - alkaline phosphatase gene , which is a protein produced by the human body . if such signs occur , please see " serious allergic reaction " in section 4 . children and adolescents this medicine is not recommended for use in children or adolescents under the age of 18 years . other medicines and / or 
always use emgality exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended dose for adults is one 240 mg subcutaneous injection ( injection of 0 . 5 ml ) once a month . your doctor will tell you when you should inject more ( subcutaneous ) doses . instructions for proper training are provided at the end of this leaflet . if your doctor prescribes more egality than he or she can give you more ( or less ) more ( than you should ), you may be instructed not to inject more than the dose you have been told to inject . in case you have not received proper training , your doctor may decide to give your dose at a lower dose , or may instruct you to give the dose at an increased dose . read the " instructions for use " for instructions on how
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality have been reported uncommonly ( may affect up to 1 in 1 , 000 people ) and often include : difficulty breathing or swallowing , low blood pressure ( which may cause dizziness or light - headedness ), swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , which may appear as a red rash or raised bumps . other side effects tell your doctor , pharmacist or nurse if you notice any of the following : very common side effects may affect more than 1 in 10 people : injection site reactions ( including pain , itching , redness or swelling ) reporting of side effects 23 if any of these side effects gets serious , talk to your doctor or pharmacist 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . this medicine does not require any special storage conditions . emgality can be stored for up to 8 hours at room temperature ( up to 7 ) or up to 30 minutes at 2oc 8oc . store in the original package in order to protect from light . once reconstituted , the medicine must be used immediately .
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcanab in 1 ml solution ( corresponding to 0 . 5 iu / millilitre ).  the other ingredients ( excipients ) are l - histidine ( e339 ), l- histhidine hydrochloride monohydrate , polysorbate 80 , sodium chloride , and water for injections . what the emegality looks like and contents of the pack egality is a solution for injection in a clear glass syringe . the solution is clear , colourless to slightly yellow , free from visible particles . not all pack sizes may be available in your country . your doctor or nurse will show you how to use the s
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hvvd ) in adults , in which the blood vessels in the liver become damaged and blocked by blood clots . this is when medicines prior to a stem cell transplantation are not possible because of the lack of a protein in the blood , which allows the body to work harder to break down and transplant the stem cells . defetide is given to prevent blood vessels from separating and binding to the hvad and blocking its action , thereby reducing the number of blood clumps forming . if you have any questions about this medicine , please ask your doctor .
do not use defitelio : - if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) or to other medicines used to prevent blood clots ( e . g . tissue plasminogen activator warnings and precautions , medicine used to treat bleeding or preventing heavy bleeding , or needing a blood transfusion after surgery , if your doctor determines that you have problems with blood circulation or a constant blood pressure which cannot be controlled . children and adolescents do not give this medicine to children under the age of 1 year , because it has not been studied in this age group . other medicines : tell your doctor or pharmacist if they are taking , have recently taken or might take any other medicines which may increase the risk of blood coagulation , such as acetylsal
the treatment with defitelio will be started by a doctor who is experienced in stem cells transplantation . it will be given to you through one of your veins ( called an ' intravenous infusion ' or drip ). this treatment will take about 21 hours . your doctor will decide how long you should be treated . if your symptoms do not improve after this time , your doctor may give you a lower dose . use in children and adolescents ( aged 18 years and over ) the recommended dose is one tablet per day for each kilogram of body weight , given at about the same time each day , in a different place , by different means of : - nurse - doctor - pharmacist - or - your child ' s doctor will determine the appropriate dose for your child and - adolescent . you may be monitored while you are being treated
like all medicines , defitelio can cause side effects , although not everybody gets them . when treating patients with defeilio the following side effects can be seen , and the frequency of these side effects is not known . tell your doctor immediately if you experience any of the following : very common ( may affect more than 1 in 10 people ): low blood pressure common : may affect up to 1 in10 people : bleeding in general bleeding ( including the nose bleeding , the brain bleeding ) and the gut vomiting not known ( frequency cannot be estimated from the available data ) : blood bleeding in the lungs bleeding ; blood in the urine ; the mouth bleeding due to the skin coagulopathy ( disturbance in blood clotting ) reporting of side effects 24 . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . the infusion storage should be completed within 24 hours of preparation . however , chemical and physical in - use stability has been demonstrated for 2 hours at room temperature . from a microbiological point of view , the product should not be used if it is cloudy or distinctly brown .
what defitelio contains - the active substance is defibrotide . each 2 . 5 ml vial contains 200 mg of defibrototide in a vial . after dilution , each mml solution contains 80 mg / 0 . 56 mmol of concentrate .  the other ingredients are : sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ) and water for injections . see section 2 " defit elide contains sodium " for further information on sodium ". - concentrate for solution for infusion : each pack contains 10 vials of 2 , 5 mg of concentrate and one vial of solvent . not all pack sizes may be marketed .
daklinza contains the active ingredient daclatasvir . it is used to treat hepatitis c , an infectious disease that affects the liver , caused by the hpv virus . this medicine works by stopping the heptic c virus from multiplying and infecting other cells of the body . the virus can be removed from your blood over a period of time , and your doctor may decide to keep you under closer observation of your doctor , who will decide on other medicines to take for you . if you are not sure about any of the other medicines in this list , please talk to your doctor or pharmacist .
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) or to any other medicine ( oral or oral ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment : - take these medicines as prescribed - phenytoin , carbamazepine , oxcarbazepine or phenobarbital - for epileptic seizures - torifampicin / rifabutin & / or riapentine - antibiotics for tuberculosis - dexamethasone ( a steroid used for allergic and inflammatory diseases ) - medicines that contain st . john
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of daklinza is one 60 mg tablet once a day . it does not matter what time of day you take your tablet but taking it at the same time each day will help you remember to take it . this is because some people may take it less often than they should because they have a very unpleasant taste . do not chew or crush the tablet . you may need to take other medicines whilst you or your caregiver may also take da Klinza . if this happens to you , tell your doctor straight away . your doctor will tell you how long you should continue to take daklinag . taking these medicines with food is important to help your body use its own blood and its immune system ( the body ' s natural defences ) better
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is taken in combination with sofosbuvir and ribavirin , the following side effects have been reported : very common ( may affect more than 1 in 10 people ) headache fatigue common ( might affect up to 1in 10 people not known ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles during treatment with daclinza , when taken in conjunction with sofranximus , sometimes with or without sildenafil or pioglitazone alone . not known ( frequency cannot be estimated from the available data ) tender muscles when taken together when taken at the same time as daklinez , but when taken alone , it may not work as well as it should . if
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg debossed on one side of the tablet . the other ingredients are dihydrochloride , anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide and magnesium stearate in the tablet core as well as hypromellose , titanium dioxide , macrogol 400 , indigo carmine aluminium lake , yellow iron oxide ( e172 ) 51 in the film coating the tablet is a blue , oval , biconvex , 51 mm engraved with the company logo and " bms 51 " in black ink on the body . one year of manufacturing a new product and one year after the marketing pharyngitis 51 is
proquad is a vaccine to prevent measles , mumps , rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection ( antibodies ), which help to protect the skin , from the meases , bumps and rubella . as well as helping to protect you against rubella ( and var ) and chickpea - related diseases , these viruses can become resistant to the vaccine and cause them to become active again , and the effects of these viruses may disappear completely after 12 months , even if there is still some change in the way the vaccine works . proqd is intended for use by adults , adolescents and children aged 9 months and over , in accordance with official recommendations for national vaccination .
do not receive proquad : - if you are allergic to any varicella vaccine , to measles , mumps , rubella vaccine or any of the other ingredients of this vaccine ( listed in section 6 ) or to neomycin . warnings and precautions talk to your doctor , pharmacist , or nurse before or during treatment . if your doctor has told you that you have a blood disorder or type of cancer that affects the immune system , treatment with medications that weaken your immune system ( such as low - dose corticosteroid therapy , asthma or replacement therapy ). if the doctor thinks you may be at risk of a weakened immune system due to a disease ( including aids ), such as congenital or hereditary immunodeficiency , lack of immune competence or active untreated tuberculos
proquad will be given to you by a doctor or nurse as an injection into the muscle of the upper thigh or upper arm . the recommended doses are two injections into the same muscle , administered in the corresponding joint of the thong area and upper arm area . your doctor will decide which vaccine to give you . if you have a blood clotting disorder or low levels of platelets , the vaccine will not be given under the skin . this will reduce the risk of bleeding and improve the blood supply to the muscle . it is important that you are trained and trained by your doctor , nurse or pharmacist how to prepare the vaccine for injection . before proqd is given to your child , it is unlikely that it will get into the blood vessel or into the lining of a person , for example a family member , friend or a close friend . however ,
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions such as hives have been reported very rarely . some of these reactions may be serious and may lead to difficulty in breathing or swallowing . if you have an allergic reaction , tell your doctor straight away . other side effects of proquad may affect more than 1 in 100 people : seizures ( fits ) with a fever rare ( may affect up to 1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , and unsteadiness with walking ). the following side effects have also been reported for the marketing of another vaccine containing human antibodies . these can include : very common ( these may affect less than 1 person in 10 ) : injection site complaints ( including pain , swelling , redness and swelling ) these can also occur during the
what proquad contains the active substances are : measles virus1 , edmonston strain ( 3 . 00 mbq at reference time ) mumps virus1 ( jeryl lynn TM - level b ) strain ( 4 . 30 micrograms ) rubella virus2 , varicella virus3 and merck strain , all . 1 . 9 ml mrc - 2adsorbed on tissue culture , plaque - forming units ( pfu ) 1 produced in chick embryo cells ( fh ) and fibroblasts ( mmv ) by recombinant dna technology . the other ingredients in the powder are ; powder sucrose , hydrolysed gelatin , and urea , sodium chloride ,
jylamvo is an anticancer medicine which works by blocking specific receptors in your body ' s immune system ( e . g . to prevent unwanted reactions from occurring ).  it is used as an immunosuppressive agent with an anti - inflammatory effect jyermvo is used to treat rheumatic and skin diseases :  in adults with active rhusatoid arthritis or polyarthritic forms ( where joints are affected )  severe juvenile idiopathic arthritis ( jia ) in patients 3 years of age and older , who have tried unsuccessfully and were not adequately treated with non - semen / sulphonylsalen ( nsaids ) and inadequate o severe and disabling psoriasis , when treatment with phototherapy ( p
do not take jylamvo if : you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) you have a severe kidney impairment or a liver impairment you have blood disorders ( e . g . bone marrow hypoplasia , leukopenia or thrombocytopenia ) or significant anaemia 34 you are a weakened immune system you suffer from a serious infection such as tuberculosis or hiv . you have ulcers in the stomach or intestines or an inflammation of the mucous membrane of the mouth , including mouth ulcers , which are not caused by non - oncologic indications . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : have diabetes - related kidney impairment have or have had
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jylamvo is for long - term use . your doctor will decide how many treatments you need , and how often . depending on your response , your doctor may find it easier to take the medicine at a lower dose . severe side effects may be life - threatening or even death have been reported . the treatment can be started by a doctor with experience in the treatment of rheumatoid arthritis , or severe juvenile idiopathic arthritis . patients with severe psoriasis should be treated at once , either for one or two years , while maintaining a healthy body weight . for severe ppsoriatic arthritis the recommended starting dose of the prescribed daily dose of 1 ,500 mg is one m
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching ( especially affecting your whole body ). the most common side effects are : breathing problems , feeling of illness , dry , irritating cough , shortness of breath and difficulty in breath ( with or without chest pain or fever ), spitting or coughing blood , serious peeling or blistering of the skin . uncommon side effects include : very common ( may affect more than 1 in 10 people ): diarrhoea , constipation , stomach pain ( indigestion ), nausea , vomiting , loss of appetite , dizziness when getting up , coughing , stuffy nose 
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the vial label and carton after exp . store below 25 . the medicine must be used immediately in order to prevent accidental spillage . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and should not exceed 3 hours . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotredxate ( as mesilate ).  the other ingredients are : macrogol 400 , glycerol , orange flavour , sucralose, ethyl parahydroxybenzoate ( e219 ), sodium methyl parahydroxybehoate (" e1200 "), citric acid , tri - sodium citrate , purified water . see section 2 " jujujutsu / s ( juncture information ): " hdpe bottles : ", " sdp - 2 " on the right side of the bottle and " mcg - 6 ". the bottle contains a brown glass bottle containing 60 hard capsules
what enurev breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what Enurev is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties caused by a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . these muscles make breathing difficult .this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary airways . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using the product if : you have kidney problems you have an eye problem called narrow - angle glaucoma you have difficulty passing urine at the start of treatment . if this applies to you , tell your doctor immediately and take the next dose at its regularly scheduled time . you can still pass urine and swallow the capsules with food , drink and milk . do not swallow the desiccant contained in the capsule . children and adolescents do not give this medicine to children under 18 years of age because it has not been studied in this age group . tell the doctor immediately if any of these apply . tightness of the chest ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to inhale the recommended dose is two capsules twice a day in the morning and evening . the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . elderly ( age 75 years and over ) you should take this medicine at the same time each day . you will be given this medicine as an inhaler and capsules ( in blisters ) that contain the medicine as inhalation powder . only use the capsules with the inhaled dose that is supplied in this pack ( enurev breezhaler inhalers ). please read the instructions for use at the end of this leaflet for more information . instructions for inhaling the medicine once you have been trained , you should follow the instructions
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia : typical symptoms include excessive thirst and hunger and frequent urination ) rash , itching , hives , difficulty breathing or swallowing , dizziness ( signs of allergic reaction ) swelling mainly of the tongue , lips , face or throat ( possible signs of angioedema ). if you get any side effects not listed in this leaflet , please tell your doctor or pharmacist . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyrrronium brmide ( equivalent to 50 microgramms glycopronium ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram ( 109 microgram ) / 0 . 5 million iu ) of glycopirronium at the date and time of writing the capsule ( corresponding to the date of writing on the capsule ) and contains no other ingredients . the other ingredients ( excipients ) are lactose monohydrate e339 , magnesium stearate , water for injections ( see section 2 under ' important information about ingredients ' in this package leaflet ) for the preparation of the capsules . what 
the active substance in riximyo is called rituximab . this is a type of protein called a " monoclonal antibody ". it sticks to a target protein in a kind of white blood cell called " b - lymphocyte ". when this target is found in the blood , the b product of ritsimabe sticks to the surface of this cell . your doctor will stick to the cell and tell you how to fix it . if you do not respond well enough to this medicine , your doctor may give you a lower dose . you may receive up to 2 years after the initial treatment . in patients with a ) non - hodgkin ' s lymphoma this est a disease of the lymph tissue ( part of the immune system ) that affects a particular type of whiteblood cell called 
do not take riximyo - if you are allergic to rituximab , other proteins which are like those made by the body , or any of the other ingredients in this medicine ( listed in section 6 ). you have a severe active infection at the moment and you are at risk of developing a weak immune system . you have severe heart failure or severe uncontrolled heart disease and have granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . if any of these apply to you , tell your doctor , pharmacist or nurse before you are given r . warnings and precautions talk to your doctor or pharmacist before you or your carer is needed if : you have ever had a hepatitis infection . your doctor may want to monitor you more closely while you are being treated
how it is given riximyo will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given a single dose ( a drip ) of intra - venous infusion ( i . e . one vial at a time ). medicines given before each rximyon administration before you are given the first dose , you may be given other medicines ( premedication ) to prevent side effects from occurring . how much to take your treatment will be decided by your doctor . for patients with non - hodgkin ' s lymphoma who are not able to tolerate the dose . who are unable to swallow the tablet ( s ). who have received 
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , people may also develop pain at the site of infusion , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , fever and chills . not known : frequency cannot be estimated from the available data . if you get any of these symptoms , tell your doctor or nurse immediately . your doctor may decide to keep you under closer observation or change your dose of riximyo . the following side effects have
what riximyo contains - the active substance is rituximab . each 10 ml vial contains 100 mg of ritsimamab ( 10 mg / 0 . 5ml ). the 50 m / 1 , 500 mbq at the date and time of calibration are used . -the other ingredients are sodium citrate , polysorbate 80 ( e433 ), sodium chloride , sodium hydroxide and hydrochloric acid ( see end of section 2 for further information about some of the ingredients in this medicine ): water for injections ( see section 2 ). this medicine is a clear to slightly opalescent and colourless to slightly yellowish solution . it is supplied as a concentrate for solution for infusion . pack sizes of 2 or 3 glass vials , each containing 1
the active substance topotecan , which belongs to a group of medicines called ' cisplatin '. each medicine contains an anti - inflammatory substance called tasonermine ( tsa ) which is used to treat adults with small cell lung cancer that has come back or has not responded to chemotherapy . a second treatment is planned for patients with advanced cervical cancer if surgery or radiotherapy is not possible . in this case topotécan actavis treatment will be combined with medicines containing a medicine called cistapolatin .
do not take topotecan actavis : - if you are allergic to to potecan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor will check your blood cell counts regularly to make sure that you are not getting too low . if this applies to you , tell your doctor straight away . do not give this medicine to anyone else . children and adolescents this medicine should not be given to children under 18 years of age . tell your pharmacist if any of these apply to your child . other patients and their doctor will also tell you how to do so in case you are elderly . you can still be given the medicine , although the risk is lowered by effective anti - hiv medicine known as ritonavir . there is little information available on
topotecan actavis will be given to you by a doctor with specialist experience in treating the disease . your doctor will carry out blood tests before you start treatment and will adjust your dose based on your response to treatment . adults small cell lung cancer : the usual dose is 1 . 5 mg per square metre of body surface area once daily for 5 days . this treatment cycle will normally be repeated every three weeks . cervical cancer - the usual starting dose is 0 . 75 mg per m2, once daily , for 3 days , until you have reached the recommended treatment cycle . in combination with another anticancer medicines containing cisplatin . if you are not sure , talk to your doctor . patients who are not able to swallow tablets may be more likely than others to develop a higher risk of being treated for impaired kidney function and your doctor may need to monitor your kidney
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away , if you notice any of the following , as you may need urgent medical attention : a few patients have experienced serious sides . - infections ( very common : may affect more than 1 in 10 people ): - fever - this may be a sign of your general condition - local symptoms , such as sore throat or burning sensation when urinating - severe stomach pain , fever and possibly diarrhoea ( rarely with blood ) - bowel inflammation ( neutropenic colitis ) while taking topotecan actavis , your doctor will monitor you for signs of your ability to fight infections - lung inflammation , seen rarely ( may affect up to 1 in 1 , 000 people ), including difficulty in breathing 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicinal product does not require any special temperature storage conditions . keep the container in the outer carton in order to protect from light . after reconstitution and dilution chemical and physical stability of the concentrate has been demonstrated for 24 hours at 25 and 2 ° c . from a microbiological point of view , the product should be used immediately . however , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours when stored in a refrigerator . the product is stable for 2 - 8 c and has a shelf life of up to two decades . for the drug product solution , chemical stability after dilsution in solutions for infusion ( nacl
what topotecan actavis contains - the active substance is topotenecan . each vial contains 1 mg or 4 mg of topotécan ( as hydrochloride ). after reconstitution 1 ml of solution contains approximately 1 mg to potecan ( 0 . 5 %). - other ingredients ( excipients ) are mannitol ( e421 ), tartaric acid ( see section 2 ), water for injections , and other ingredients in the concentrate are ethanol ( alcohol ) ( ethanol ). - solvent for solution for injection contains sodium hydroxide , essentially ' sodium - free '. cenauba wax and white wax are used to adjust the temperature of the skin , providing a clear , colourless solution for inhalation of the extract from the vial and grey bromobuty
the active substance of rivastigmine hexal is rivascagmine . rivazatigmine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson 's disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivagetigmine works by blocking one of the enzymes that break down the molecule forming the criterion - type c , which are involved in the synthesis of the three groups : - acetolcholines ; - butyrylcholineserase . by blocking these enzymes , the result is a clearer and more frequent release of ace
do not take rivastigmine hexal : - if you are allergic to rivassimine ( the active substance in rivascamin hydrochlorothiazide ) or any of the other ingredients of this medicine ( listed in section 6 ). - in case of a previous skin reaction suggestive of allergic contact dermatitis with any other recombinant dietary supplement ( e . g . salmonella , ramipril , japanese ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking rivageage , and during treatment , you should be observed carefully and follow the instructions for use . take special care with riving , as you may be at increased risk of having irregular or slow heartbeat . you should also tell your doctor about any active stomach ulcer .
always take this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . your doctor may slowly increase your dose depending on how you respond to treatment . the highest dose that should be taken is 6 . 0 mg twice a day . my doctor will regularly check if the medicine is working and will also monitor your weight whilst being treated . taking this medicine it is important that you tell your doctor what you are taking , and what you can do to help you stay on the diet and exercise that you have been taking for more than three days . take all the tablets with some water . you may find it easier to swallow the tablet ( s ) with food . do not take
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often when you start your medicine or when your dose is increased . usually , the side effects will slowly go away as your body gets used to the medicine . very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ), diarrhoea common : may affect up to 1 in every 10 people anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling difficulty falling asleep feeling sleepy or drowsy feeling confused or lack of energy headache joint pain feeling restless uneven heartbeat feeling tired tired tiredness feeling tired tummy pain inability to get or keep still legs pain when getting up from a lying or sitting position headache
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . store below 30 . keep the blister in the outer carton in order to protect from moisture .
what rivastigmine hexal contains 64 - the active substance is rivassimine hydrogen tartrate .  the other ingredients are : hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ) and titanium dioxide , which are printed in black ink on the cap . all capsules have the following imprints : shellac . one capsule of each bordel contains 1 . 5 mg ( 15 mg ) or 1 , 5 mg of rivatmine . the other ingredient is : one capsule debossed with " r33 " on one side and " nvr " on the other side . each rivainstigmine hisxal 3 mg hard capsules contains 3 mg ( 25
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat adults with kidney cancer ( renal cell carcinoma ) or liver cancer when a specific anticancer medicine , called sorafenib ( s ) , is available . what cabômetyxx is used for  cabombyx works by blocking the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the growth of cells and the development of new blood vessels that supply them . these proteins can be present in high amounts in cancer cells . by blocking their action ' s action , the ttrt is able to carry out its normal function and to help to cut off the blood supply that the cancer needs . if you have any questions about how 
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and during your treatment with cabrometyc , if : you have high blood pressure you have or have had an aneurysm ( enlargement and weakening of a blood vessel wall ) or a tear in ablood vessel wall you have diarrhoea you have a recent history of significant bleeding you have had surgery within the last month you are having surgical procedures ( including dental surgery ). you have experienced inflammatory bowel disease ( such as crohn ' s disease or coccidioidomycosis ) you have been told by your doctor that you have an increased risk of infection
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will monitor you and adjust your dose . this will help you get the best results and lower the risk of serious side effects . you should stop treatment with cabometyx and take the tablets at the same time each day . the usual dose is 60 mg ( two tablets ) taken once a day , but your doctor may recommend a higher dose , such as two tablets in the morning and one tablet in the evening . how long to take - take the tablet before bedtime , at least 2 hours before you take it , and at least 1 hour after taking the medicine . - swallow the tablets whole with a glass of water . do not chew , crush , or break the tablets as this may affect the way the medicine is absorbed and the effect may
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss your side effects with you and will explain the potential risks and benefits of taking cabometyx with other medicines . sometimes your doctor may also want to reduce the dose , or stop your treatment for a short time . tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : symptoms such as pain in the abdomen , nausea ( feeling sick ), vomiting , constipation , fever or signs of a gastrointestinal perforation ( a hole that develops between the stomach and the intestine ). severe or uncontrollable bleeding , sometimes with symptoms like vomiting blood , black stomachs or red skin , often with fever . these side effects are usually mild to moderate and usually go away within a few days . talk to your
what cabometyx contains - the active substance is cabozantinib ( s ) ( as malate ). - one tablet of cabombometych 20 mg contains cabazantine (  ), malate ( 20 mg ) and is essentially free from the interaction between you and your doctor . - another tablet in the shape of a fortified tablet is called " cabonib 20 mg ". each tablet contains approximately 20 mg ( 6 mg ), or 40 mg ( 11g ), respectively . the other ingredients are : the tablet is a tablet in a bottle and is made up of two separate sachets to make up for a forgotten tablet . one tablet in each fortify and dissolves as a 40 mg tablet , containing approximately 40 mg , which is equivalent to the usual dose of
pemetrexed hospira is a medicine used in the treatment of cancer . pemetreexed hospiral , in combination with cisplatin , another anti - cancer medicine , is used as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy , has been given as the initial treatment . for patients with advanced stage of lung cancer , pemetreexed hoprazola can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy . edmontonabundant is also a treatment for patients of all ages whose lung cancer has progressed after other infusions has been used , or if other treatments
do not use pemetrexed hospira : - if you are allergic ( hypersensitive ) to pemetreexed or any of the other ingredients of this medicine ( listed in section 6 ). - when you are breast - feeding ; your doctor may decide to interrupt or discontinue breast  - feeding during treatment with pemetreexed . - once you have been given a vaccine against yellow fever , your doctor will tell you if this applies to you . warnings and precautions talk to your doctor or hospital pharmacist before you are given pemetreced out of the country you live in , or are travelling , to a country where yellow fever has been observed . you must not be given peméxeded as this may indicate that you have problems with your kidneys . before each infusion you will have samples of your blood taken to evaluate if
the dose of pemetrexed hospira is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area in square meter ( m2 ). your doctor will use this body surface area for working out the right dose for you . this dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . a hospital pharmacist , nurse or doctor will have mixed the pemetreexed homa powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution for injection before it is given to you , in accordance with local requirement . you will always receive pemetreexed hospira by infusion into one of your veins . the infusion will last approximately 10 minutes . when used alone , pemetre
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : fever or infection ( common ), especially if it has a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . signs include : chest pain ( uncommon ), with a fast heart rate ( uncommon not known ). pain , redness , swelling or sores in your mouth ( very rare ). allergic reaction : signs may include skin rash ( very commonly referred to as burning or prickling sensation ), and fever . rarely , skin reactions may be serious and could be life - threatening . most cases of death have been reported after
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton . this medicine does not require any special storage conditions prior to reconstitution or infusion solution . the product should be used immediately . when prepared as directed , chemical and physical in - use stability of reconstituted and infusion solutions of pemetrexed were demonstrated for 24 hours when stored in a refrigerator ( 2 - 8 ). the refurbished solution is for single use only . parenteral medicines should be inspected visually for particulate matter and discolouration prior to administration . if this medicine is made from biotechnology , it is recommended that every time that the solution is prepared , the user must dispose of this medicine . any unused solution must be disposed of in accordance with local requirements .
what pemetrexed hospira contains - the active substance is pemetreexed . one ml of pemetreexed has been prepared by recombinant dna technology . - one jar contains 100 milligrams ( millilitre ) ( equivalent to 100 micrograms ) delamanitahydrate . the other ingredients are mannitol ( e421 ), hydrochloric acid , sodium hydroxide , and sodium chloride in the solution . this medicine contains ethanol ( alcohol ) and sodium hemipentahydrate ( see section 2 ). - each glass sachet contains 500 millimetrex d ( echivalent to 500 microgram ( 0 . 5 milliliter )) delevant to be taken orally , along with hydrogen stearyl fuma
ganfort contains two active substances , bimatoprost and timolol , which work together to reduce pressure in the eye . bimatophorost belongs to a group of medicines called prostamides . it is a prostaglandin analogue and it works in exactly the same way as some other medicines ( called beta - blockers ). it helps to keep the eye moist and watery . when the eye drops are first used , they will release a clear , watery liquid that is constantly being drained , so the pressure inside the eye slowly builds up . this helps to stop glaucoma from getting worse . your doctor will ask you how to use one of these drops in the same eye , once they have been prescribed for you . ganfordt eye drops can also be used to temporarily reduce high pressure inthe eye
do not use ganfort eye drops - if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine : - for treating respiratory problems such as asthma , severe chronic obstructive bronchitis ( severe lung disease that causes wheeziness or difficulty in breathing ) or long - standing cough . heart problems ( such as low heart rate , heart block , or heart failure warnings , precautions ) this medicine is not recommended for use in patients with coronary heart disease ( symptoms can include chest pain , difficulty breathing , wheezing , difficulties in breathing or prolonged prolonged or prolonged cough ). it is also better to avoid prolonged contact with the
always use ganfort exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended treatment is one bottle in each eye . follow your doctor ' s instructions carefully , even if they differ from the general information contained in this leaflet . how to use the bottle hold the bottle tightly in the neck ( see section 5 ). instructions for use 1 . wash your hands . tilt your head back and look at the ceiling . 2 . pull down your lower eyelid until there is a small pocket on the top of the bottle . 3 . turn the bottle upside down and squeeze it until you can see the colour of the eye that you are using for treatment . 4 . lift the lid back and close the eye for about an hour . 5 . gently squeeze the bottle to release one drop of product into your eye by the finger .
like all medicines , ganfort can cause side effects , although not everybody gets them . you can usually carry on taking the drops , even if you are not sure . the following side effects have been reported with the use of one drop in the eye ( multi - dose twice a day or two drops in a row ): very common side effects ( may affect more than 1 in 10 people ) - the eye redness . commonside effects ( likely to affect up to 1 in 9 people and uncommonly reported , are :  the eye burning  itching  stinging  irritation of the conjunctiva ( the transparent layer at the front of the eye ), sensitivity to light , eye pain , sticky eyes , dry eyes  small break in the small light - exposure to light caused by small breaks in the corner of the field of vision 
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and the bottle label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . use immediately or store in the original package in order to protect from light . eye infections should not be rubbed on unopened bottles . throw away any unused solution via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what ganfort contains - the active substance is bimatoprost , 0 . 3 mg / ml solution for injection contains timolol . each bottle contains 5 g of solution ( corresponding to 6 . 8 %) in benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate ( e330 ), purified water , hydrochloric acid , and sodium hydroxide . - this medicine comes as a clear , colourless to slightly yellow eye drop ( opalescent ) and is supplied in a plastic bottle ; each pack contains 1 or 3 bottles with a screw - cap , 3 or 4 desiccants . not all pack sizes may be marketed .
the active substance gefitinib attaches to a protein called ' epidermal growth factor receptor ' ( egfr ). this protein is needed for the protein to work in the body , and to kill cancer cells . geFITINib mylan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan : - if you are allergic to gefiteinib , peanut or soya or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking gefit inib melan . some lung problems may be serious . your doctor may decide to lower your dose , or stop your treatment with geFITINib Mylan , if this applies to you . - you have or have ever had problems with your liver . talk to you doctor or pharmacist before you take geFITinig mylan ( see section 4 ). children and adolescents do not give this medicine to children or adolescents ( under 18 years ) because it has not been studied in this group of patients . other medicines and gefitib there is no information on the use of the following medicines 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 250 mg tablet per day . swallow the tablet whole with a glass of water . you can take the tablet with or without food . do not take antacids ( for example , if your stomach is empty ). after 2 weeks , your doctor may increase your dose to 1 tablet . take gefitinib mylan at about the same time each day , but do not change the dose unless your doctor tells you to do so . drink plenty of water during the day and always take the dose recommended by your doctor . try to take your medicine at the same times every day ; this will help to keep you going to sleep . it does not matter whether you take it with or after food , drink , or any other liquids 
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction ( characterised by symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives ( nettle rash ) and difficulty breathing . serious breathlessness or sudden worsening breathlessness accompanied by a cough or fever . this may mean that you have an inflammation of the lungs called ' interstitial lung disease '. this has been reported uncommonly ( may affect up to 1 in 100 people ). stop taking gefitinib mylan and tell a member of your family or carer that you are taking this medicine . severe skin reactions these may occur anywhere in the body as a result of taking other medicines .
what gefitinib mylan contains - the active substance is gefeinib . each film - coated tablet contains 250 mg of gefib ( as besilate ). the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose ( e460 ), crospovidone ( type a ), povidone( k30 ), sodium laurilsulfate , magnesium stearate . tablet coating : polyvinyl alcohol , macrogol 4000 , titanium dioxide , red iron oxide , and yellow iron oxide [ e172 ]). what geFITini B mylan looks like and contents of the pack geFITINib melan tablets are salmon - coloured , off - white to light brown , biconvex film coated tablets of 11 . 1 mm
reblozyl contains the active substance luspatercept and is used to treat myelodysplastic syndromes ( mds ) in adults and children and adolescents : - in patients with mellozyl syndromes , - if you have a family member who has a reduced or eliminated ability to make red blood cells become abnormal . signs and symptoms associated with a low red blood cell count ( anaemia ) can be listed below and help you to manage the need for red blood blood cell transfusions . reglazyl is used : to reduce the risk of anaemae in patients who do not have the capacity to donate blood during their lifetime . to increase the capacity of red blood platelets , patients may be given erythropoietin therapies . beta - lalassaemia ( b ): 
do not take reblozyl : - if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) or if - you are pregnant or planning to become pregnant ( see section " pregnancy and breast - feeding "). warnings and precautions talk to your doctor or pharmacist before taking this medicine if your doctor has told you that you have thalassaemia or have had your spleen removed . if there is still a possibility that you may have a blood clot , please discuss with your doctor the possibility of hormone replacement therapy , if this is the case . your doctor will discuss preventive measures and / or medicines you are taking at the same time , to reduce the risk of a new blood clumping together with other medicines you were taking . should you have the impression that the effect of
always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . your doctor will carry out blood tests and decide how much reblozyl you need to take . the dose you receive is based on how much you weigh and the results of your blood tests . you should not be given more than your doctor tells you to . do not change the dose without talking to your doctor or pharmacist . how to use reglazyl is given as an injection under the skin ( subcutaneously ). you will be given the injections about 1 . 0 mg per kilogram of body weight each week . this dose may be adjusted by your doctor depending on your blood pressure and on other factors such as : your doctor may tell you to increase or decrease the dose ( see section " warnings and precautions "). for myelodysplastic syndromes the maximum single dose is
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , especially if only on one side of the body , blurred vision and / or symptoms of a stroke caused by blood clots swelling of the area around the eyes , face and lips , mouth , tongue or throat allergic reactions including rashes and sores , which may be life - threatening . common side effects ( may affect up to 1 in 10 people ): diarrhoea , vomiting , nausea , constipation , flatulence ( wind ), indigestion , heartburn , dry
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and the carton after exp . this medicinal product does not require any special storage conditions . store in a refrigerator ( 2 8 ). after reconstitution , reblozyl can be stored at room temperature ( up to 25 ) for up to 24 hours . from a microbiological point of view , the product should be used immediately . any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains - the active substance is luspatercept . each vial contains either 25 mg or 75 mg ( 3 ml ) of solution for injection ( as directed by your doctor ). if you have not been able to take the tablets yourself , your doctor may give you a lower dose . the maximum recommended dose is one vial of solution ( 25 mg ) or of solution that contains 75 mg( 1 . 5 mg  ) ( 1 , 5 - 6 mg ). after reconstitution ( by reconstituted ) water for injection contains 50 mg ( 1 mg of luspatiercept per vial ). excipients are : citric acid monohydrate , sodium citrate , 80 mg , sucrose , hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( e524 )
fotivda contains the active substance tivozanib , which is a protein kinase inhibitor . tivolinib works by slowing down the growth of the cancer and slowing the rate at which cancer cells grow , and allowing growth of new blood vessels to be possible . in adults with advanced kidney cancer , other treatments ( alpha or interleukin - 2 ) may be considered to be more appropriate if they do not work well enough to control your disease .
do not take fotivda if : you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). you are taking st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor , pharmacist or nurse before taking fotiva . you have high blood pressure . it is very important that you are treated when you are being treated with fotiv da , to reduce your blood pressure over a long period of time . your doctor may want to monitor you more closely to make sure that you have enough blood pressure before you start taking a medicine , if it is not possible to do so . when it is time for your next dose , tell your doctor and follow - up if any of these apply to you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of fotivda is 1340 mg for every kg of body weight ( equivalent to 21 mg ). you will take 7 capsules ( 1 capsule ) once a day in the morning and 1 capsule ( 2 capsules ) in the evening . capsules should be swallowed whole with a glass of water or at least 4 hours after a meal . do not chew or crush the capsules as they may have unacceptable side effects . if severe side effects occur , your doctor may decide to reduce the dose , interrupt , or completely stop fotiva therapy . your doctor will decide how much you should take , when to start and for how long you need to take it . how much to take adults , adolescents and children weighing less than 890
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure : this is a common side effect that may affect up to 1 in 10 people . if you get this side effect , or it gets worse ( see section 2 " warnings and precautions "), talk to your doctor , pharmacist or nurse immediately . high blood blood pressure can be associated with symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor will monitor your blood pressure regularly while you are taking fotivda . it is important that you take the medicine exactly as your doctor tells you to , even if it does not seem to be the same as usual . you should take the tablet at the same time every day , to reduce the risk of high blood
what fotivda contains the active substance in fotiva 890 mg is tivozanib . each vial contains tivonib hydrochloride monohydrate , equivalent to 890 milligrams of tivokaib ( as mesilate ). the other ingredients are mannitol , magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine , yellow iron oxide , propylene glycol ( type a ) and strong ammonia solution . the printing ink contains titanium dioxide , tartrazine aluminium lake , and shellac ( containing propane glycol ) which are used to preserve the tablets . after reconstitution , the concentrate is a clear , colourless to pale yellow solution , with a blue imprint of ' t '
stribild contains two active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of the effects of elavitavir emtricitabine , which is an antiregular medicine named a nucleoside reverse transcriptaser inhibitor ( nrti ) and tenofovir disoproxil , also known as a nontrivial medicine called " nti ", and " tti1 " in the treatment of hiv - 1 - infected adults , adolescents and children . the active substances in sTRIbild are : combined with a single tablet regimen for the treatment in adult patients who are at high risk of developing hiv infection . s
do not take stribild - if you are allergic to elvitegravir , cobicistat , emtricitabine ( used to treat irregular heartbeats ) or tenofovir disoproxil , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking treatment with any medicine containing ten ofovir diproxil as your doctor may need to adjust your dose . your doctor will monitor your kidney function before and during treatment with these medicines . - alfuzosin ( for the treatment of an enlarged prostate gland ) amiodarone , quinidine ( for irregular heart beats ); 47 - dabigatran ( to prevent and treat blood clots ). - carbamazepine , tolbutamide ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is : adults : 12 to less than 18 years of age : one 35 mg tablet each day by mouth . take the tablet at about the same time each day . your doctor may adjust the dose of your medicine based on your response to the treatment . you may take medicines called oral supplements ( antacids ) or laxatives containing minerals ( such as magnesium , aluminium , calcium , iron , zinc ) taken for at least 4 hours ( see section 4 " how to take stribild "). you should swallow the tablet whole with a glass of water . do not chew , crush or split the tablet . it may take about 4 hours for a full tablet to make sure that you get the full dose . if
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood cholesterol sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether some of the unwanted effects are caused by stribild or by the hivi disease itself . however , serious side effects occur , which need to be treated immediately . you may experience lactic acidosis ( excess lactic acids in the blood ) which may be a serious side effect , especially if you take a large amount of some hiv medications at the same time . in some cases , a reduction in the level of normal blood sugar ,
what stribild contains - the active substances are elvitegravir , cobicistat , emtricitabine , and tenofovir disoproxil . - each sTRIbild film - coated tablet contains 150 mg of еlvitavir ( as s ) in the form of a 150 mg tablet , while in the other formulations it contains a 50 mg tablet ( a 200 mg tablet of empire ) and a 245 mg tablet( a 160 mg tablet)) of taftegrille . the recommended dose is 300 mg / 0 . 5 mg st . louis - johnson syndrome ( ds ). the dose is also higher if you are taking a 105 mg , 100 mg edgbq
zyprexa , which contains the active substance olanzapine , belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes ( a condition with symptoms of excitement or euphoria ) that lasts longer than a month . zy prexa has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olzine treatment . it is important that you also read the package leaflet for this disease .
do not take zyprexa : - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a wide - gestational stance ( including a very large number of swollen faces , particularly affecting the tongue ) or shortness of breath . if this has happened to you , tell your doctor straight away . you may have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor , pharmacist or nurse before taking zy prexa you or your carer notices that you are being treated for dementia . serious side effects some people taking medicines that affect the movements of the face or tongue may not notice that these are
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of zyprexa tablets is one 5 mg tablet once a day . your doctor may reduce your dose to one 20 mg tablet if your symptoms return but do not alter your dose unless your doctor tells you to . you should swallow your tablet whole with a drink of water . do not crush , chew or break the tablet before swallowing . when you take zypréxa it is best to take at the same time each day , but you do not need to take more than the daily dose . it does this by accident , and in some cases , even if the doctor thinks they are too strong or too weak , your symptoms may come back . if this happens to you , call your doctor right away .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : unusual movement ( a common side effect which may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( an uncommon side effect that may affect more than 1 in 100 people ), especially in the legs ( symptoms include swelling , pain and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if any of these symptoms occur , seek medical advice immediately . not known ( frequency cannot be estimated from the available data ): zyprexa has been associated with an allergic reaction . the following side effect has been reported in patients taking this medicine : common side effects ( affects 1 to 10 users in 100 ) include : a so
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . zyprexa should be used immediately after first opening and if not used immediately . you should record the date of opening on the bottle and the carton label in the space provided . this information is intended for doctors and pharmacists only ; they are responsible for the correct storage of the product both before and during its use , as well as for its correct disposal
what zyprexa contains - the active substance is olanzapine . each zyPrexa tablet contains either 2 . 5 mg , 5 mg ( with or without coating ), 7 . 5, 10 mg (with or without covering ) tablets , 15 mg or 20 mg in one tablet . the exact amount is shown on the carton and on the blister after " exp ". the ingredients of your zypresa tablet pack are lactose monohydrate ( see section 2 ), hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate . tablet coating : hypromellose ( e464 ), titanium dioxide , and carnauba wax . what the other ingredients are : the different zy prexa tablets strengths are engraved with ' olz ' on one side and
what prolia is and what it is used for the active substance in the medicine is denosumab . it is a type of protein ( monoclonal antibody ) that recognises and attaches to another protein . osteoporosis can occur in adult men , and in women , too much of a body can make them look weak . making the bone stronger helps to protect your bones . oestrogen , a hormone produced naturally by the body , is an important part of the bone and it helps to keep bones healthy . when women have the menopause , their level of oesterogen level drops , making bones thinner , thin and fragile . this can lead to osteoposseis . people with osteopochrome is likely to be at high levels of testosterone and / or glucocorticoids , which are also involved
do not use prolia : - if you have low calcium levels in the blood ( hypocalcaemia ). you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given orally ( by injection ). if any of these apply to you , tell your doctor immediately . before you can be given proton - filled syringes , read the information under ' dosing instructions ' at the end of this leaflet . do not try to inject yourself , unless your doctor has told you that you have an allergy to latex . the needle cover on the front of the pre - loaded sYringe contains a derivative of latex which contains calcium . it may not work properly when you are not sure .
always use prolia exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one pre - filled syringe of 60 mg ( 4 injections ) given 6 weeks apart , given as a single injection under the skin ( subcutaneous ). it can be injected into the thighs , abdomen or upper arm . if your doctor decides that you can use prolaia , he or she will also give you stickers , calcium and vitamin d supplements to help you remember to use them . read the " instructions for use " for the contents of the pack . do not use more than one injection per week . it is important that you follow your doctor , nurse , and pharmacist ' s instructions on how to do this . what to do when you need to use pro
like all medicines , this medicine can cause side effects , although not everybody gets them . prolia may cause skin infections ( cellulitis ). tell your doctor immediately if you develop any of these symptoms while being treated with proloa : - if your doctor notices that you have swollen , red area of skin on one side of your leg and feels hot and tender . these may be symptoms of fever which may be a sign that you may not be properly protected . pain in the mouth and / or jaw , swelling or non - healing of sores in the jaw or discharge , numbness or a feeling of heaviness in one or loosening of a tooth . this may be the first sign of bone damage in the other limb . - as with all medicines you should take this medicine with caution . you should contact your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . your pre - filled syringe may be stored at temperatures up to a maximum of 25 for a single period of up to six months . at the end of this six - month period the injection must be discarded . it must be used within 25 days or disposed of , even if it has not been stored at room temperature . you must record the date when the injection was given and the date at which it was first given to you , and also in the memory of the person who gave you the injection , as well as the date after which it should be used as soon as possible
what prolia contains - the active substance is denosumab . each 1 ml pre - filled syringe contains 60 mg desiccants ( 60 mg in the vial ). the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections ( see section 2 ). what prolaia looks like and contents of the pack prolisa is a clear to slightly opalescent , colourless to slightly yellow solution for injection , provided in a ready - to - use self - storage container , with or without a needle guard . only one pack per carton is available . not all pack sizes may be marketed .
ambirix is a vaccine used in infants , children and adolescents from 1 year up to and including 15 years to prevent two diseases , called hepatitis a and hepatis b . it is given to adults , adolescents and children of two years and older , who are at risk of infection with the hpa virus . the liver becomes swollen ( inflamed ) with the virus , causing the virus to multiply in an infected person . if the virus is found in faeces , serum or saliva , it can be collected and given back to you within 3 to 6 weeks of infection . you should tell your doctor if you feel sick , have a fever , or aches and pains and you notice any of these . very common ( affects more than 1 in 10 people ) infection in adults
you should not receive ambirix : if you are allergic to the active substance , or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if this has happened to you , tell your doctor immediately . you may have an allergic response to any vaccine you have recently received . warnings and precautions talk to your doctor , pharmacist or nurse before you are given the vaccine , if : you have hepatitis a and b diseases you have or have had a severe infection with a high temperature ( over 38 ). if the vaccine has been given you a minor infection such as a cold should not be a problem , but discuss it with your doctor first . it is not known if ambirx will cause a new
your doctor or nurse will give you ambirix as an injection into a muscle , usually in the upper arm . the injection will be given under the supervision of a doctor , nurse or pharmacist . it is important not to miss the scheduled dose . you or your caregiver will then be given a total of two injections . a second injection may be given within 12 months of the first injection . your doctor will decide how many additional doses you need , and when you may need future booster dosing . for adults , two separate injections should be given at the same time each year , depending on the body weight and the diseases being treated . they will decide when and how many injections are needed . each time you are given an injection , you will receive the second injection between 6 and 12 months . contact your doctor if you are concerned that you may have missed a dose and you may
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering and swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . side effects reported in clinical trials with ambirix : common ( may affect up to 1 in 10 people ) headache loss of appetite feeling tired or irritable pain in hands or feet increase in weight loss . reporting of side effects 23 if your child gets any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed
what ambirix contains 26 - the active substances are : hepatitis a virus ( inactivated ) 1 , 72 x 720 elisa units / 0 . 5 ml . - each recombinant ( dna ) product contains : human diploid ( mrc - 5 ) cells 1adsorbed on aluminium hydroxide , hydrated ( 05 . 065 milligrams al3 +) 3b . 1 produced in saccharomyces cerevisiae ( scleroderma ) and aluminium phosphate in the solvent . the other ingredients are ethanol ( alcohol ) ( see section 2 ). solvent : sodium chloride and water for injections ( see end of this leaflet for further information on ingredients ), solvent ,
the vaccine contains the active substance meningococcal group b . bexsero is a vaccine to protect against the bacteria neisseria meningitidis group bovine recombinant , a class of bacteria called ' genital oesophagus ' ( genus ) and , inactivated , can be used to treat adults , adolescents and children ( from 2 years of age ) against disease caused by the neptia meringitidic type b bacteria . these bacteria often cause infections such as meningits ( inflammation of the covering of the brain and spinal cord ), as well as sepsis ( blood poisoning ). when the vaccine is given , it can be given to individuals whose disease has become worse or can be fatal .
you should not receive bexsero if : you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the vaccine if you have a severe infection with a high temperature ( over 38 ). in such cases , vaccination will be postponed until you have recovered . a minor infection , such as a cold , may prevent vaccination . you have haemophilia or any other problem that prevents your blood from clotting properly , for example , by introducing blood thinners ( anticoagulants ), or by treatment which stops the immune system from working properly . there is also a risk of eculizumab , which will not prevent you from being vaccinated . while you are being treated with be
bexsero is given as an injection of 5 micrograms into a muscle of the upper thigh or upper arm . the number of injections you will receive is based on your age and body weight . your doctor , nurse or pharmacist will calculate the dose for you . from 2 weeks up to 5 years your doctor or nurse will give you three injections of the vaccine . you may be given an additional injection ( booster ) after the first injection . it is important that you follow this advice carefully . if your child misses an injection , you may need to be vaccinated again at least 2 months after the interval between injections . this is usually given every 2 months and will be capped at least once a year ( whichever is earlier ). your doctor will work out the exact dose of the booster . children aged 12 to 15 years and 6 months of age will receive one
like all vaccines , this vaccine can cause side effects , although not everybody gets them . when bexsero is given to your or your child , the following side effects may occur : very common ( may affect more than 1 in 10 people ): - pain / tenderness at the injection site - redness of the skin at the injecting site , swelling of the flesh around the injection location - hardness around the injected area - injection site side effects related to this vaccine are listed below according to how common they are . very common : may affect less than 1 person in 10 - fever - loss of appetite - diarrhoea - nausea and vomiting - increase in the amount of sugar in the blood ( anaemia ), as well as a need for medical attention . not known : frequency cannot be estimated from the available data - swelling of
what bexsero contains the active substance is recombinant neisseria meningitidis group b nhba fusion protein . each 1 , 2 or 3 ml vial contains 50 mg / 0 . 5ml of recominant noresorbeditivis type b norad . the other ingredients are : protein content : omv - derived from the pora p - 2 - attached to the intestines . proteins : one or more of the following proteins are present : either : 2 , 3 , 4 , 5 , 6 , 7 , 8 , 10 , 15 , 20 , 25 , 100 iu product : all three components are prepared from the same strain as the other , except for the 
what nitisinone mdk is this medicine contains the active substance nilinione . this medicine is used to treat adults and children with a rare disease called hereditary tyrosinemia type 1 in adults , adolescents and children ( in any age range ). in this disease your body is unable to completely break down the amino acid térosine ( amino acids are building blocks of our proteins ), forming harmful substances . the harmful substances are accumulated in your body . too much of this medicine will be taken by you , and you will need to take some time to recover . it is important that you continue to take this medicine until your doctor tells you exactly how long you need to keep taking it . how does this work ? your doctor will monitor how well this medicine works and to determine if it is the right treatment for you . low yrosine and 
you must not be given nitisinone mdk : - if your doctor has told you that you are allergic to nitsinone or any of the other ingredients of this medicine ( listed in section 6 ). check with your doctor if you think this applies to you . warnings and precautions talk to your doctor or pharmacist before you are given this medicine . pregnancy and breast - feeding there is no information to be gained from the use of the medicine in pregnant women . it is strongly recommended that every time , the name and batch number of the product are recorded in order to maintain a record of the batches used . do not give a dose to children under 6 years of age . this medicine should only be used in early pregnancy unless clearly necessary . your doctor will make sure that no data are available in this population . the doctor will monitor the condition of your eyes before and during 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine should be started and supervised by a doctor experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 mg per kg of body weight , given once a day . your doctor may adjust the dose , depending on how well the medicine works for you or your child . the dose may be increased or decreased by your doctor if the patient population is smaller than or equal to 20 mg / kg . if your doctor determines that the optimal dose is best for you , talk to your doctor first . method of administration swallow the capsules whole with a small amount of water or formula diet just before you take it . you can take nitisinone mdk with or without food .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial and the carton after exp . this medicinal product does not require any special storage conditions . nitisinone mdk can be stored for a maximum of 2 weeks at a temperature not above 25 .
what nitisinone mdk contains - the active substance is nithiinone ( as in the hard capsules ). - if you cannot identify the substance , eat the capsule whole with a glass of water , do not split or chew the capsule . - when nitsinone one mk 2 mg capsules contain 2 mg of natisinine . the other ingredient is : - in the capsule content : " nITISINONE 2 mg ", " taiwanese " and " pakee ", and " mek ", which is a colourless , opaque , hard gelatin capsules printed with " nicotinone ". mndk 10 mg capsule : the colourless version of the capsule contains 10 mg / 0 . 5 mg n
the name of this medicine is docetaxel accord . its common purpose is to treat people with breast cancer . this includes those who have lung cancer called non - small cell lung cancer , prostate cancer ( gastric cancer ) and head and neck cancer : - for the treatment of advanced breast cancer in which the doctor is experienced in this type of treatment , he or she may also prescribe doxorubicin , trastuzumab , or capecitabine . - also for the treat of early breast cancer ( lymphoma ) in adult patients , it is also a treatment that will require specialist medical advice .
docetaxel accord should not be used : - if you are allergic ( hypersensitive ) to the active substance or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions : tell your doctor before you are given the medicine if : you have enough white blood cells and you have a severe liver disease . your doctor will carry out blood tests to check that you have sufficient blood cells , and will check that your liver is working properly . before and during treatment with docetaxil accord , you will have certain medical conditions , including blood tests . you will be checked that your immune system ( the body ' s natural defences ) will produce enough blood cells to fight infection . if your doctor decides not to treat you with this medicine , he or she will decide if there is a risk of white blood cell disturbances . tell
docetaxel accord will be administered to you by a healthcare professional . usual dose the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m2 ) and will determine the dose you should receive . method and route of administration docetaxil accord is given by infusion into one of your veins ( intravenous use ). the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . the frequency of dosing may vary depending on your blood tests , your general conditions and your response to the treatment . in particular , please inform your doctor in case of diarrhoea , sores in the mouth , feeling of numbness or pins and needles , fever and give her / him results of your
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord alone are : decrease in the number of red blood cells or white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . in general , these adverse events are mild to moderate and generally occur within a few days of completion of the trial . however , in some cases , your doctor may prescribe additional chemotherapeutic agents to reduce the duration of the infusion . allergic reactions are common ( may affect up to 1 in 10 people ): flushing , redness , itching , swelling of the face , lips , tongue and throat ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the label of the vial after exp . this medicine does not require any special storage conditions . reconstituted solution : 25 . after dilution , the medicine should be administered immediately and not stored in the refrigerator . when prepared as directed , chemical and physical in - use stability of the solution for infusion has been demonstrated for 6 hours at room temperature ( up to 25 ). after preparation of the infusion solution it must be used immediately . non - pvc bags : 48 hours at 2 to 8 . store in the original carton in order to protect from light . the inffusion solution should be clear to slightly opalescent , and colourless to pale yellow . once prepared , use immediately , if not used right away
what docetaxel accord concentrate for solution for infusion contains - the active substance is : 20 mg / ml . each vial of concentrate contains 20 mg or soya . - one vial in 1 mL of concentrate contain 20 mg don ' t make any changes to the dose , indicating that the product is stable to 80 mg . the other ingredients are : - powder : polysorbate 80 ( e433 ), ethanol anhydrous ( see section 2 ) and citric acid anhydrously . ( 0 . 25 milligrams al ). what doesdocetaxel accord looks like and contents of the pack docetaxil accord concentrated for solution of infusion is a clear pale yellow to brownish - yellow to light yellow solution . it is supplied in glass vials . one pack contains : one
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . your doctor has prescribed this medicine because you are more impulsive , hyperactive or think you may be crazy . you should not take this medicine if you have ' attention deficit hyperactivity disorder ' ( adhd ) that is not well controlled with current stimulant medication . if current medication does not reduce adhd symptoms , your doctor will prescribe the medicine together with a treatment programme that includes psychological therapy , educational therapy and social therapy . it has been shown to improve the ability of people to fight adhd and to prevent adhd from developing .
do not take intuniv : - if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have low or high blood pressure . you have heart problems . this is because some patients with heart problems have fainted recently after having thoughts or feelings of suicide . please tell your doctor about any other psychiatric conditions . withdrawal symptoms may occur as a result of increased heart rate , especially when it is first given to you . if your heart rate is higher than it should be , even if it is not too high . your doctor will check whether this medicine is working properly and whether it is safe to use it . children and adolescents do not give this medicine to children or adolescents ( below the age of 6
your treatment should be supervised by a doctor experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor if you are not sure . your treatment will be initiated in a hospital or clinic . the recommended starting dose is 1 tablet in the morning . after 1 month of treatment , the dose will be gradually increased to 0 . 05 mg per kg of bodyweight . initial dose : the recommended dose is 7 mg intuniv per day . children and adolescents aged 1 year and older and weighing at least 7 kg should not be given to children under the age of 7 years because there is no experience with the use of this medicine in this age group . take the medicine with food and fatty foods . swallow the tablets whole with a glass of water . do not chew , crush or split the
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell while you are taking your medicine , stop taking it and talk to your doctor straight away . serious side effects tell your doctor or pharmacist straight away or go to the casualty department at your nearest hospital . the following side effects may happen with this medicine : feeling drowsy , feeling dizzy ( hypotension ), slow heart beat ( bradycardia ), feeling faint , loss of conciousness ( syncope ), which is a serious withdrawal side effect . high blood pressure , which may cause symptoms such as headaches, feeling confused , nervousness , agitation , and tremors ( hypertensive encephalopathy ). the following other side effects have also been reported with intuniv : common side effects ( may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after ' exp '. this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . the tablets should be taken in the hospital or clinic and are not to be put back in the refrigerator . blister pack should be disposed of after first opening .
what intuniv contains 1 - the active substance is guanfacine hydrochloride . 1 mg / ml film - coated tablets each tablet contains 1 mg of guantacine ( as 2 mg ). - one dose ( 0 . 5 mg ) contains GUanf acine . - two doses ( 1 , 2 mg or 3 mg ), each containing 3 mg or 4 mg ( as 4 mg , 3 mg and 4 mg respectively ), respectively . the other ingredients are : hypromellose 2208 , methacrylic acid - ethyl acrylate copolymer , lactose monohydrate , povidone , crospovidone type a , microcrystalline cellulose . not all pack sizes may be marketed .
ecalta contains the active substance anidulafungin . it is used to treat adults ( aged 1 to 18 years ) with a type of fungal infection that affects the blood or other internal organs ( called invasive candidiasis ). it is when the infection is caused by fungal cells called candida , which are called echinocandins . these medicines also prevent serious fungal infections caused by dividing fungal cell walls , resulting in problems with the formation of new cells , and by preventing the growth of these cells . eCALta is used when : some people with incomplete or defective cell walls and become fragile and unable to grow .
do not use ecalta : - if you are allergic to anidulafungin , other echinocandins , or caspofungin acidate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using the product . before you are given the medicine , your doctor will check your liver function and if necessary , you may develop liver problems during your treatment . your doctor may give you anaesthetics during or after your treatment with the product in order to reduce the risk of getting an allergic reaction . itching , wheezing or blotchy skin may occur ( known as an infusionrelated reaction ). it may include a rash , hives , itching and redness , shortness of breath or breathing difficulties . 
the treatment will be started by a doctor who is experienced in the above - mentioned indications . the recommended dose is either 200 mg or 100 mg once a day , depending on the patient ' s weight . adults from 1 to 18 years of age : 3 . 0 mg per kg of body weight , or 200 mg in 1 . 5 ml for a 100 mg dose . your doctor will work out the right dose for your child . how ecalta is given the doctor will give the dose to your child in a slow infusion ( a drip into a vein ) over a period of approximately one hour . this will take about 1 , 5 minutes . there will be an interval of at least 3 hours between the loading dose and the infusion at the same time . it will be necessary to adjust the dose in order to administer the dose according to the
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking ecalta and see a doctor straight away if you notice any of the following serious side effects you may need urgent medical attention : potentially life - threatening allergic reactions , including difficulty breathing , wheezing or an existing rash . if this happens , stop using the medicine and tell your doctor immediately . you may be more likely to get serious side effect such as convulsion ( seizure ), flushing , rash ( pruritis ), itching , hot flush or hives , sudden contraction of the muscles , coughing and difficulty of breathing other side effects include : very common side effects ( may affect more than 1 in 10 people ) headache , diarrhoea , feeling sick ( nausea ), being sick ( vomiting 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special storage conditions . the reconstituted solution is stable for 24 hours at 25 . however the infusion solution can be stored for up to 48 hours at room temperature ( up to 25 ). if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and should not exceed 48 hours .
what ecalta contains - the active substance is anidulafungin . one vial of powder contains 100 mg of anhydrous .  the other ingredients are mannitol ( e421 ), polysorbate 80 , tartaric acid , sodium hydroxide and hydrochloric acid . water for injections : 30 g / 0 . 5 ml ( see end of section 2 ). what the eCALta pack contains a box containing 1 single - use 100 mg concentrate for solution for infusion . the powder is white to off - white and the solvent is clear .
adynovi contains the active substance rurioctocog alfa pegol , which is a pegylated human coagulation factor viii produced by recombinant dna technology . how the medicine works in humans ' blood clots and stop bleedings , inactivated . in patients with haemophilia a , lack or absence of factor  vii is not a problem ; it is therefore important to have an effect on the blood , to help stop bleeding . the medicine is used for the treatment and prevention of bleeding in adults and adolescents aged 12 years and older and in children of all ages ( including newborns and young children ). in adults , adolescents and children of both sex ( 0 - 12 years of age ) and children ( who have not been treated before ) with ha
do not use adynovi - if you are allergic to rurioctocog alfa pegol ( the active substance of  - 18 ) or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse before and during your course of treatment with adoni . there is a rare chance that you may be allergic to any ingredient contained in - a , or both , you may not be able to tolerate the medicine and your doctor will monitor you carefully . if your doctor determines that you have an anaphylactic reaction ( a severe , sudden allergic reaction ) to the product , your doctor may need to change your dose or may not give you the best chance of allergic reactions . these
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . your doctor will decide on the correct dose of adamnovi based on your condition and body weight , and will determine the target factor viii levels . the severity and location of the bleeding will depend on the condition being treated . it is important that you receive appropriate laboratory tests to make sure that you are getting the right level of factor vii level . major surgery ( including dental ) will usually be started when you are in hospital . always take this medicine exactly as your doctor has told you . check with your doctor if you are not sure about the dose or whether it is safe for you to continue with your current treatment . prevention of bleeding the usual dose for adults , adolescents and children of all ages is the same as for everyone else . a
like all medicines , this medicine can cause side effects , although not everybody gets them . if severe , sudden allergic reactions ( anaphylactic ) occur , the injection must be stopped immediately . you must contact your doctor immediately if you have any of the following early symptoms of allergic reactions : rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing ( wheezing ), tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . severe symptoms , including difficulty in breath and fainting , require prompt emergency treatment . patients who have received previous treatment with adynovi may experience similar , or higher doses , and their symptoms may include : very common : may affect more than 1 in 10 people loss of appetite , change in perception of self
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special temperature storage conditions . adynovi may be stored for up to 8 days at room temperature ( below 25 ) in the outer carton in order to protect from light . after first opening , the powder vial can be kept at or below 30 for a single period of maximum 3 days ( but not above 25 ). if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 days at 2 - 8 , unless dilution has taken place in controlled and validated aseptic conditions ; if the solution is not clear and colourless , it must be used within 3 hours . the powder must not
what adynovi contains - the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 , or 2000 iu ( international units ) of rURIocttocogg alf . the solvent vial is then diluted in 5 ml sterilised water for injections . ingredients in the vial : mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrate and tris ( hydroxymethyl ) aminomethane , polysorbate 80 and sterile solution for injection ( see section 2 ). the other ingredients are water for
rekovelle contains the active substance called follitropin delta , a froollicle stimulating hormone ( fsh ). it belongs to the family of hormones called gonadotropins , which are involved in the development of female infertility . in adult women with gestational or assisted reproduction programmes , such as in vitro fertilisation ( ivf ), or intracytoplasmic sperm injection , the ovaries produce many egg sacs which are then released into the womb .
do not use rekovelle if your fertility problems are not controlled with follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour of the uterus ( the ovaries that contain the breasts , pituitary gland or hypothalamus ), or have enlarged oaries , cysts on your  Ovaries ( called polycystic ovarian disease ), bleeding from the vagina ( including an early menopause ) or malformations of the sexual organs . warnings and precautions talk to your doctor , if : you are a woman of childbearing potential . you are an ovulating woman . this medicine will not help you in this situation . your doctor may want to monitor you more closely if this happens to you . fibroids on the 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will calculate the rekovelle dose for you and will explain the dose to you during your first treatment cycle . you will receive anti - mullerian hormone ( hcg ), which is produced naturally by your ovaries during stimulation with gonadotropins . the dose you receive will depend on your body weight and will be calculated by your doctor . to take a blood sample taken during the last 12 months of treatment . this will give you a better idea of how much medicine you will be given and for how long you will need to use it . how much you weigh - the doctor will work out your exact dose and how often you should use it ( see table below ). this will help you to decide how many follicles you need to have each day
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects due to the high levels of hormones involved in infertility have been reported in women taking this medicine . they may be due to a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms may include pain or discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain , and difficulty breathing . if you notice any of these symptoms you should immediately contact your doctor , who may be a side effect . common ( may affect up to 1 in 10 people ): headache and nausea . not known ( frequency cannot be estimated from the available data in women ); ovulation syndrome is a rare but potentially life - threatening condition . it is not known how often this occurs 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . this medicine does not require any special storage conditions . rekovelle can be stored in a refrigerator ( 2 8 ) or at room temperature ( up to 25 ) for a single period of maximum 3 months . from a microbiological point of view , the product should be used immediately . however , if the solution is not used within 3 days it should be discarded . the 28 day period should not be longer than 25 years . any unused solution must be disposed of in accordance with local requirements for medicines that are no longer required .
what rekovelle contains - the active substance is follitropin delta . each multidose cartridge contains 12 micrograms of the active ingredient , flomorphin delta in 0 . 6 millilitre of solution . after dilution : each ml of solution contains 33 . 3 microgram ( fb ) frokin - taiwanese neaissance , in a volume of 10 . 7 microlitre ( iu )) cd50 . ftp is produced by a biotechnology process . the other ingredients are : phenol , polysorbate 20 ( e433 ), l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrate and concentrated phosphoric acid 
the active substances of revinty ellipta are fluticasone furoate and vilanterol . two different active substances in each reventy flatulence are used . one consists of two active substances : - fluticassantoate 92 mg / vilantérol 22 mg : one active substance in each syringe and one in each nostril . the other ingredient is bilirubin ( a substance that helps the blood to clot ). - if you are using a combined product of fluticsone fuoate it is used to make a palatable , low - dose tablet . - when used in combination with 184 mg of vilantesrol 22 mg the usual dose is 92 / 22 mg for the treatment of chronic obstructive pulmonary disease ( copd )
do not use revinty ellipta : - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using the product . if the above applies to you , tell your doctor before using ellippa . you should not be given rev inty because of the risk of liver disease ( see " possible side effects " below ), and you should be aware that some patients with moderate or severe liver disease might be more likely to have side effects . in some cases , your doctor may prescribe you a lower strength of revinety ( 92 / 22 micrograms / ml ), but your doctor will be aware of this . heart problems such as high blood pressure , tuberculo
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use asthma the active ingredient in revinty ellipta is a medicine used to treat asthma ( also called " copd "). it works by delivering two active substances , fluticasone furoate and 22 micrograms ( vilanterol ) once a day . when used for severe asthma , the higher strength inhaler that you use ( inhaled ) contains two different strengths . one dose ( inhalation ) is equivalent to one puff ( 0 . 25 milligram of fluticsone Furoate + 22 millilitres of vilantrol ). the other ingredient is copd - resistant ( high doses of copd when used alone ) and copd ( i . e 
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you get any of the following symptoms after taking ellipata stop using this medicine and tell your doctor immediately : skin rash ( hives ) or redness swelling , sometimes of the face or mouth ( angioedema ). becoming very wheezy , coughing or having difficulty in breathing , feeling weak or light headed , or if getting very cold or cold . not known ( frequency cannot be estimated from the available data ): sore throat , runny nose , stuffy nose and / or sneezing ( stevens - johnson syndrome ). signs may include : very common : may affect more than 1 in
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . 92 puffs each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 micrograms ( the equivalent of a metered dose ), corresponding to a total of 22 doses of vilantérol ( as trifenatate ). 184 puffs per single imprint provide a daily dose of 22 milligrams (" a dose ") of 184 microgram ( 0 . 5 millilitre ) ( equivalent to an active substance ). the other ingredients are : lactose monohydrate ( see section 2 ) and magnesium stearate ( e470b ). cenerapherel ( the liquid part of the pack ) the elipta device itself is
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ) and emtricitabine , another non  - nuclear aminotranscriptaser inhibitor ( not in rtis ); and tenofovir , also known as a nuclear - positive antiretroviral medicines . they work by interfering with the normal working of an enzyme ( reverse transcriptains ) that is essential for the virus to reproduce itself . atripLA is a treatment that is used for the treatment of human immune deficitability virus , ( inactivated ) disease in adults aged 18 years and over who have already been treated with other antiretriglycerides ( 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one tablet once a day by mouth . take atripla on an empty stomach at least 1 hour before or 2 hours after a meal . swallow the tablet whole . do not chew , crush or split the tablet . some side effects ( e . g . dizziness , drowsiness ) may occur . your doctor will tell you how many tablets to take . the doses should be taken at the same time each day . this will help you to remember to take them . you may need to keep following your doctor ' s advice on what dose to take ( for example , when you are at an advanced stage of your treatment ) and at least one other time . it is important that you take
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood fats sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following : - serious side effects called lactic acidosis ( excess lactic acids in the blood ) is a rare ( may affect up to 1 in 1 , 000 people ) but serious side effect that can be fatal . the following side effects can be signs of lactic Acidoses : deep rapid breathing , drowsiness , feeling sick ( nausea ), being sick ( vomiting ), stomach pain . if any of these occur , stop taking at
what atripla contains - the active substances are efavirenz , emtricitabine and tenofovir disoproxil . - each atripla film - coated tablet contains 600 mg or 800 mg evrillant ( as fumarate ) and 200 mg or 245 mg of tenovir diproxil ( as fumeratoid ). the other ingredients are tablet core : croscarmellose sodium ; hyprolose ; magnesium stearate ( e470b ); microcrystalline cellulose and sodium laurilsulfate ( see section 2 under ' important information about some of the ingredients ofatripla ') and sodium . the tablet film coating contains iron oxide black and iron oxide red . not all pack sizes may be marketed in your country .
orgalutran contains the active substance ganirelix . it is a member of a class of medicines called anti - gonadotrophin , which stimulates the production of the natural gonadotropin releasing hormone ( fgh ). gnrh regulates and prevents the release of gonadatrophins , including follicle stimulating hormone , in the female fertility process . fsh is an essential hormone for the growth and development of froollicles in the ovaries and are necessary for the development of these structures . in girls , fh is needed to develop and release the matured egg cells . these are usually produced in small round sacs . the egg cells must then be collected and released . they are ready to be used to produce the first egg cells by combining with the maturing egg cells and releasing the mature egg cells into
do not use orgalutran : - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). you are hypersensitive to gonadotrophin releasing hormone ( gnrh ) or to a gndrh analogue . you have a moderate or severe kidney or liver disease . or are pregnant or breast - feeding . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine , if : you have ever had orgasm ( an active allergic condition ). in these patients , you may require additional monitoring during treatment to detect and manage allergic reactions . allergic reactions may be generalised , including hives ( urticaria ), swelling of the face , lips tongue and / or throat that may cause difficulty in breathing or swallowing ( angioe
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how is orgalutran given and how much should i take ? the treatment is started by a doctor experienced in assisted reproduction techniques . in vitro fertilisation ( ivf ) and ovarian stimulation stimulated by the production of follicle stimulating hormone ( fsh ), corifollitropin , is administered on day 2 or 3 of each of the three injections . your doctor will decide the most appropriate day to inject yourself under the skin ( subcutaneously ) on day 5 or 6 of each cycle . the doctor or nurse will show you how to prepare or inject yourself . however , the preparations are for single - use only . different injection sites may be used during daily treatment . if the preparation is not suitable for you ,
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effect , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . very common ( may affect more than 1 in 10 people ) local skin reactions , including redness and swelling . the local reaction usually disappears after 4 weeks . uncommon ( may effect up to 1 in 100 people ), headache , nausea , and malaise . rare ( might affect up to1 in 10 , 000 people ). allergic reactions : rash facial swelling , difficulty breathing ( dyspnoea ) swelling of face , lips , tongue ,and / or throat , which may cause difficulty in breathing or swallowing ( anaemia ). not known ( frequency cannot be estimated from the available data ) diarrh
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . syringes should be used immediately after dilution . clear , particle - free solutions are available for use at the hospital or clinic .
what orgalutran contains the active substance is ganirelix , one vial contains 0 . 5 ml of acetic acid . the other ingredients are mannitol and water for injections . to adjust the ph , there may be sodium hydroxide and some % of the solution in the solution is slightly higher than the recommended dose ( i . e . less than 80% w / v ). what the other ingredient ( s ) are sodium . ( e524 ) acetics acid is found in the blood of a patient ( a doctor ) for the treatment of chronic kidney disease . what or galutran looks like and contents of the pack orgalugatran is a clear , colourless aqueous solution , supplied in colourless glass vials , for subcutaneous administration .
blitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a certain type of white blood cell called " b - lymphocyte ". when ritsima babbles on to this cell , the cell dies . what brisbane means and how it works ? your doctor has prescribed a new protein for you to help build your immune system . your doctor will stick to the protein for as long as your doctor says it is " immune - positive ". your medicine is used to treat : a ) non - hodgkin ' s lymphoma this is the problem with a disease of the lymph tissue ( part of the immune system that controls the production of large white blood cells , called b " lymphocytes
do not take blitzima : - if you are allergic to rituximab , other proteins which are like ritsutismab or any of the other ingredients of this medicine ( listed in section 6 of this leaflet ). warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment if : you have a severe active infection that your doctor suspects is due to a weak immune system you have severe heart failure or severe uncontrolled heart disease and have had granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . if any of these apply to you , tell your doctor or pharmacist before you start to take this medicine . you have ever had a hepatitis infection , which can be fatal in very rare cases , but can be
how it is given blitzima will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given a brief overview of the medicine before you are given it . it is usually given as a drip ( intravenous infusion ) over several hours ; however , medicines given before and after each blitima administration before you receive it , your doctor will tell you how to take it ( see section 4 ). this is to ensure that you get the best results for your health . your doctor may give you other medicines ( pre - medication ) to prevent side effects and reduce your dose . how much and how often you will receive your treatment for non - hodgkin ' s lymphoma if
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , people may also develop pain at the site of infusion , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , diarrhoea and vomiting . not known ( frequency cannot be estimated from the available data ): if you get any of these symptoms , tell your doctor or nurse straight away . your doctor may decide to keep you under closer observation . very common : may affect more than 1 in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . this medicinal product does not require any special temperature storage conditions . blitzima is stable for up to 8 hours when stored in a refrigerator ( 2 8 ). do not freeze . keep the vial in the inner carton in order to protect from light . tell your pharmacist if you notice any particles in the liquid .
what blitzima contains - the active substance is rituximab . each 10 ml vial contains 100 mg of ritsuzumab ( 10 mg in a vial ) either : 50 mg : 500 mg / 0 . 25 mg , or 10 mg of sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what brisbane looks like and contents of the pack blisima is a clear , colourless solution for infusion . it is supplied in glass vials containing 2ml or 50ml of solution . pack size of 1 vial
roactemra contains the active substance tocilizumab , a so - called monoclonal antibody . this is a type of protein that recognises and attaches to a specific target in your body . it blocks the activity of a protein called interleukin - 6 , which is found in many cells of the body and causes the inflammation in your organs . by attaching to this target , the body ' s natural defences are strengthened and enables you to perform normal daily activities , and so reduces the damage to your cartilage ( the bone that supports your joints ) that you have , or is unable to do normal daily tasks , as a result of the disease . the active ingredient in r - rola is used to treat adult patients with moderate to severe active rheumatoid arthritis 
you must not be given roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). you have an active , severe infection that your doctor thinks is important . warnings and precautions talk to your doctor or nurse before you are given the infusion . while you are being given this medicine , you may experience allergic reactions such as chest tightness , wheezing ( severe dizziness or light - headedness ), swelling of the lips or skin rash . you should tell your doctor immediately if any of these apply to you . infection . infections you may get infections more easily during the treatment . tell the doctor immediately of any signs of a new or changing dose . do not feel unwell while being treated with the medicine . your doctor may reduce your body ' s ability to handle infections
roactemra will be given to you by a doctor or nurse , by infusion ( drip ) into a vein . your doctor will decide with you the dose ( the dose you receive ) and will also give you the intravenous infusion . the duration of the treatment depends on how long you are being treated . if you have been treated previously , your doctor may decide to increase your dose of ra to 8 mg or 4 mg / kg , depending on how well it works for you . this dose may be repeated up to 8 times over the course of one or more weeks . you will be provided with a single course of up to 4 weeks through a drip in the vein ( intravenous imfusion ) lasting 2 hours . once a week , you may be treated again at the same dose as for the first course . initially , 
like all medicines , roactemra can cause side effects , although not everybody gets them . the most common side effects are described below ( see section 3 " what you need to know before you take r . if you are not sure what the side effects below are , ask your doctor , pharmacist or nurse to explain them to you . they may occur more often in women and men than in men . stop taking the medicine and tell your doctor straight away . serious side effects common ( may affect up to 1 in 10 people ): allergic reactions , including difficulty with breathing , chest tightness , light - headedness ( rash ), itching and hives ( swelling of the lips , tongue or face ) and serious infections ( including fever and chills ) in the mouth and throat , cough and flu - like symptoms . not known ( frequency cannot be estimated
keep this medicine out of the sight and reach of children . do not use roactemra after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . this medicine is for single use only . after opening , the product should be used immediately .
what roactemra contains - the active substance is tocilizumab . each vial contains either : 4 mg or 80 mg ( as 0 . 5 ml concentrate ) of tocilizamab when diluted as recommended . - each 20 mg / 10 mg vial provides 200 mg of cilizum ab during dilution , corresponding to a concentration of 20 mg or 20 mg per vial . this means that each 400 mg dose is given as directed . the other ingredient ( s ) are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphata dihydrate and water for injections ( see end of section 2 for further information on reconstitution and reconstitution of the concentrate for solution for infusion ). the solvent is a clear and colourless liquid
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . when you inhale it , it relaxes the muscles in the walls of the small air passages in the lungs . this helps open up the airways , making it easier for air to get in and out . onbre breezehaler is used to make breathing easier for adult patients who have breathing difficulties due to : - a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles surrounding these muscles tighten . making breathing difficult , this medicine relax these muscles in your lungs and so improve the flow of air into the pulmonary circulation . your doctor will show you how to use this medicine .
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if your doctor thinks you may have asthma ( in this case you should not be given onbriez breezehaler as this may be a first step in treating your condition ). please tell your doctor before starting treatment with the medicine if : you have heart problems you have epilepsy you have thyroid gland problems ( thyrotoxicosis ) you have diabetes . during treatment with onbraz breEZhaler you start to use immediately and get tightness of the chest , coughing , wheezing or breathlessness immediately after using the medicine you develop a condition called bronchos
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one capsule each day . you only need to inhale once a day because the effect of the 150 microgram capsule lasts for at least 15 minutes . your doctor may decide to increase your dose to 300 micrograms depending on how you respond to the treatment . use your inhaler at the same time each day and use it for up to 24 hours . onbrez breezhaler is available as an inhaled capsule and capsules ( in blisters ) that contain the medicine as inhalation powder . follow the instructions for use exactly as described in this leaflet for more information . how to use the one time you use the capsules , the instructions are there so that you can easily describe what you have in this pack . for instructions on how to
what onbrez breezhaler contains the active substance is indacaterol . each inhalation contains 150 micrograms ( mg ) of indracaterol as indabacaterol maleate . the other ingredients are lactose and the capsule is made of gelatin . - each onbriez breezehaler 300 microgram capsule contains 300micrograms of indecaterol in the form of indocaterol ( as indecacaterol femaleate ). the ingredients of the capsule are peach - coloured , white to off - white , and light - yellow , with " gilead " printed in black ink on the capsule shell and " nvr " printed on the cap . in addition , capsules are packed in blisters and are available in packs containing capsules . not all pack sizes may be
the active substance of clopidogrel hcs , cholerae , belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process known as thrombosis ). ' clema ' is the action of a number of factors that may be involved in the formation of these thrombi : - by reducing the number of blood vessels ( arteries ) - in adults , this process is known as atherothrombosesis . - it is taken by adults to cut off the blood supply that the patient is being treated for
do not take clopidogrel hcs : if you are allergic to dopamine or to any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor thinks this is too strong or not strong enough , tell your doctor or pharmacist . have severe liver disease . don ' t take the tablets if any of these apply to you , or you are not sure . warnings and precautions the following conditions and activities can increase the risk of bleeding whether or not associated with a médical condition that puts you at risk of internal bleeding ( such as an stomach ulcer ). be aware that these conditions may be a blood disorder that makes you prone to internal bleeding , such as bleeding inside any tissues , organs or joints or in the
always take this medicine exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . in case you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg , or one 75 - mg tablet , once at the start of treatment . then , the maximum recommended dose is two 75 mg tablets a day for one treatment course of up to three consecutive days , but this is lower than for one additional dose of 75 mg / kg of body weight taken as advised by your doctor . your doctor should tell you to take
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the whites of the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' what you need to know before you take clopidogrel hcs '). - swelling in the mouth or skin disorders such as rashes and itching , blisters ofthe skin . this may be the first signs of an allergic reaction . the most common side effects ( affects 1 to 10 patients in 100 ) are : diarrhoea , vomiting ,
what clopidogrel hcs contains - the active substance is called cloutrombopag . each film - coated tablet contains 75 milligrams ( as hydrochloride ). the other ingredients ( excipients ) are : tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil in the tablet coating . film coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( 233 ), yellow iron oxide [ e172 ], talc , macrogol 3000 . see section 2 ' important information about some of the ingredients of the tablet ', for further information on the contents of the pack the film- coated tablets are light brown to light brown , capsule 
fetcroja contains cefiderocol , which is an antibiotic medicine . it belongs to a group of antibiotics called cephalosporins . antibiotics help the body to fight bacteria that cause infections . f et Croja is used in adults to treat infections caused by bacteria when other antibiotics are not suitable .
you must not be given fetcroja - if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). - allergic to other antibiotics , such as cephalosporins . warnings and precautions talk to your doctor , pharmacist or nurse before or during treatment if : you have had a severe allergic reaction to certain antibiotics ( e . g . penicillins or carbapenems ). you have severe skin peeling and swelling of the hands , face , feet , lips , tongue or throat , or difficulty swallowing or breathing . you should not be treated while being treated with the medicine unless your doctor thinks this is unlikely to be the case . your doctor will investigate the reasons why this medicine has been prescribed for you and treat you . during treatment with f
this medicine will be given to you by a doctor or nurse as an infusion ( a drip ) into a vein . it will take about 3 hours and may take 2 hours . your doctor will decide how many days of fetcroja treatment are needed . before you are given the first dose , you will be checked for infection . this is to make sure that you get the right level of protection . do not treat your infection if you feel any pain during or after the febrcroja infusion , which will take place in a hospital or clinic . patients with kidney problems your doctor may consider giving you lower doses , including those patients who have kidney problems , before they are given a new one . how much to take the usual amount ( 0 . 5 - 10 ml ) you will receive a single dose . you will usually receive your dose of 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : severe allergic reaction that may include sudden swelling of your lips , face , throat or tongue , as well as a severe rash or other severe skin reactions and difficulty swallowing or breathing . this reaction may also include diarrhoea and stools that may contain blood or mucus . your doctor may decide to reduce the dose or stop treatment temporarily or permanently . you may also be given medicines to slow bowel movement . other side effects include : very common side effects ( may affect more than 1 in 10 people ): - common : may affect up to 1 in every 100 people - uncommon side effects are listed below by how likely they are to happen - very common ( may
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg debossed with " gilead ".  the other ingredients are sucrose , sodium chloride , and sodium hydroxide . what fercroja looks like and contents of the pack f et Croja is a white to off - white powder for concentrate for solution for infusion supplied in a glass vial . pack size of 10 vials .
depocyte is used to treat lymphomatous meningitis ( lms ) in adult patients . lymphoma meringitis is a condition in which tumour cells form around the membranes of the brain and spinal cord . depcyto works by inhibiting the growth of lymphomas tumour cells .
do not take depocyte : - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking this medicine if : you have a meningeal infection . you have severe neurological side effects . while you are being treated , you develop symptoms that affect the nervous system ( convulsions , pain , numbness and tingling ), blindness , visual disturbances . if these symptoms persist , your doctor may decide to reduce the dose or stop treatment with any depamethasone tablets . your doctor will monitor you for unwanted effects and treat you if your side effects increase or decrease , any new side effects that you experience . children and adolescents this medicine is not to be used in children or adolescents 
there are strict laws on the use , handling and disposal of depocyte . it will only be used in special controlled areas where the medicine will be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . the storage details are as follows : for cancer , the use of lumber sac is not to be used . for the proper use in children and adolescents , proper handling technique and adequate storage conditions have been followed . a suitable designated area and wearing protective clothing and procedures to avoid contamination . there is limited information on the safety of pregnant women and the unborn child . after the administration of despocyte it is recommended that the mucous membranes are closed in order to protect from light . however , since the product is being used by a healthcare professional , it
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss side effects with you and will explain the potential risks and benefits of your treatment . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( concern 1 to 10 users in 100 ) uncommon ( affect1 to 10 user in 1 , 000 ) very rare ( affect 1 to10 users in 10 and beyond ; therefore , you should be observed by a health professional while you are being treated with depocyte . in combination with other chemotherapeutic agents , the following events have been reported as follows : not known ( frequency cannot be estimated from the available data ): nausea vomiting weakness , confusion , fever headaches diarrhoea stomach upsets ( including nausea and vomiting ) rash muscle
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . depocyte can be removed from the refrigerator and left at room temperature ( up to 25 ) for a single period not exceeding 4 months . keep the container tightly closed in order to protect from light . before the first use of this medicine you should remove any traces of severe discolouration ( a changed appearance ) or a defective container . if you are not sure , talk to your doctor or pharmacist . the use of dep cell is not recommended due to the long term use of cytarabine .
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg cytogarbine ( 5 mg / 0 . 5ml ). this provides a steady amount of 50 mg  g / min .  the other ingredients are : cholesterol , trioein ( e331 ), dioleoylphosphatidylcholine , dipalmitoylapidioide di diylglycerol , sodium chloride , and water for injections . whatdepocyte looks like and contents of the pack despocyte is a solution for injection and is supplied in a vial containing 5 mg of solution . it is supplied as a single injection within a carton . not all pack sizes may be marketed .
the active substances of bemrist breezhaler are indacaterol and mometasone furoate . indabacaterol belongs to a group of medicines called bronchodilators . it relaxes the muscles of the small airways in the lungs . this helps to open the airways and makes it easier for air to get in and out . when it is taken regularly , it helps to make the airway clearer . that means it opens more often , helping the smaller airways to remain open more easily and helping to open more air to more airy , productive and free from asthma . you must use bemrap breezehaler every day and never inhale more than your doctor has told you to .
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate , or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have heart problems ( e . g . an irregular or fast heartbeat ) you have thyroid gland problems . you have diabetes or high blood sugar or you have ever had seizures you have a low level of potassium in your blood you have severe liver problems you have tuberculosis ( tb ) of the lung or any long - standing or untreated infections . your doctor may decide to keep you under closer observation . during treatment , you should not be given
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much bemrist breezhaler to use the usual dose is to inhale the content of one capsule each day . your doctor will prescribe the dose that is right for you , depending on your asthma and on how your symptoms are responding to the medicine . do not use more than your doctor tells you to use . you can use one inhaler at any time of the day either twice or three times a day , but this does not matter whether you use more of the medicine than you should or whether you need to use it for any other reason . if your asthma does not improve after a few days , your doctor may prescribe a different pack , which may contain more capsules . instructions for use are provided in the package leaflet for your doctor , pharmacist
like all medicines , this medicine can cause side effects , although not everybody gets them . they are usually mild to moderate . some side effects may be serious common ( may affect up to 1 in 10 people ) difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives ( signs of allergic reaction ). uncommon ( might affect upto 1 in 100 people !) swelling , sometimes of the tip of your tongue ( lips ), face or throat ( possible signs of angioedema ). other side effects that may occur during treatment with bemrist breezhaler ( see also section 2 ): feeling of being unwell ( anaemia ) or feeling weak ( anorexia ) feeling confused or confused ( vertigo ). feeling unwell memory loss ( forgetfulness ) fainting ( dysgeusia
- keep this medicine out of the sight and reach of children . - do not use this medicine after the expiry date which is stated on the carton and blister after " exp ". this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture . do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bemrist breezhaler contains the active substances are indacaterol ( as acetate ) and mometasone furoate . one inhalation each day of the day contains 125 mg or 62 . 5 micrograms ( the dose leaving the mouthpiece of the inhaler ) each day contains 173 microgram ( mg ) of indracaterol аcetate ( equivalent to 150 microgram of indecaterol and 80 microgram( ml ))) of momtason furoates . the delivery system ( the muffler ) that is delivered to your child will be given the dose as soon as the morning before the evening . each time you inhale a dose , you will be able to take the content of the 125 microgram capsule ( s ) as outlined in the blue ink
zyllt contains the active substance clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by reducing the size of these structures , the body ' s own immune system is unable to remove them completely ( a process called thrombosis ). by preventing the formation of clots ( thrombi ) in hardened blood vessels ( arteries ), the process is called atherothrombosesis . this is associated with an increased risk of atherathrombotic events ( such as stroke , heart attack , or death ). you have been prescribed zylt to help prevent blood coagulations . if you have these severe thrombocytes you should be monitored for the occurrence of these events
do not take zyllt if : you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . you have severe liver disease . if any of these apply to you , or if you are in any doubt at all , consult your doctor before taking zylt . warnings and precautions before you start taking the medicine you should tell your doctor that you are at an increased risk of bleeding . for example , talk to your doctor about ways in which you can help prevent bleeding , including : - an medical condition which puts you at risk of internal bleeding ( such as an stomach ulcer ). - a blood disorder that makes you prone to internal bleeding (" bleeding inside any tissues , organs or joints of your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day ( for example , you could have severe chest pain called unstable angina or heart attack ), your doctor may give you 300 mg . you can take the usual dose of one 75 - mg tablet , once at the start of treatment , or up to two 75 mg tablets a day , depending on how you respond to treatment . then , your doctor will decide on the right dose for you , based on the results of the other 75 mg doses you may be given .  talk to your doctor 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the whites of the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' what you need to know before you take zyllt '). - swelling in the mouth or skin disorders such as rashes and itching , blisters ofthe skin . this may be the signs of an allergic reaction . the most frequently reported side effects are described below : very common side effects ( may affect more than 1 in 10 people ): diarrhoea , nausea 
what zyllt contains - the active substance is clopidogrel . - each film - coated tablet contains 75 milligrams ( mg ) of clopdogrell ( as hydrogen sulphate ).  the other ingredients are : tablet core : lactose ( see section 2 under ' important information about some of my ingredients '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet coating : hypromellose , titanium dioxide , red iron oxide ( e172 ), talc and propylene glycol in the film ' s coating . what kyllt looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 , 14 , 28 ,
what lamivudine teva is and how it works the active substance in lamijine est , lamizine tablets are used for treatment of long term ( chronic ) hepatitis b infection in adults and children of all ages with a type of liver disease called recombinant ( nucleoside analogue reverse transcriptase inhibitors ( nrti ). rtis is a virus that infects the liver , results in a serious form , causing liver damage . lamivine tomulies can also be used in patients whose liver is damaged but still functions normally ( compensated liver disease ) during treatment . how lam mivudines trad , the active ingredient in this medicine modifies the way the body processes its own immune system ( the body ' s natural
do not take lamivudine teva : - if you are allergic to lamevudines or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 talk to your doctor , pharmacist or nurse before taking lamivine to eva and other similar medicines . some of these serious side effects can be serious . you should be aware of the extra risks . tell your doctor about any signs of liver disease , including hepatitis c . if your doctor thinks you may be overweight , or if any of these apply to you . your doctor will do blood tests before you start taking your medication . see section 4 for more information . don ' t stop taking mrv unless your doctor tells you to , as you may still develop a problem . when you first start taking la
always take this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take your doctor lamivudine teva is for oral use . your doctor will talk to you about how to treat your hepatitis b infection . do not stop taking this medicine unless your doctor tells you to . to help control your infection and stop your illness , take the tablet at the same time each day . swallow the tablet whole with a glass of water . don ' t chew or break the tablet . if your throat is still not working , your doctor may want to reduce your dose , and you can take it at any time of the day , with or without food . just take your next dose at the usual time . keep using this leaflet so that you can easily describe what you have
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with lamivudine teva in association with other conditions linked to hepatitis b . for more information , see ' warnings and precautions '. some of these side effects may be serious and may require therapy . ' catch a minute ' if you get any further questions on the use of this medicine . some patients have experienced the following serious side effects during lamivine clinical trials : tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort or pain , nausea , vomiting , diarrhoea , increases in liver enzymes . these may be signs of liver problems . liver problems may be more common at the start of treatment . in some cases , liver problems
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton . lamivudine teva should be stored in its original pack in order to protect from light and moisture . store in a refrigerator ( 2 8 ). do not freeze . discard if the solution is discoloured or you can see particles floating in the water . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what lamivudine teva contains - the active substance in each film - coated sachet contains 100 mg of lamivine ( as besilate ).  the other ingredients are : tablet core : microcrystalline cellulose , sodium starch glycolate ( type a ), magnesium stearate . tablet film coat : hypromellose , titanium dioxide ( e171 ), macrogol ( 4000 ), polysorbate 80 , iron oxide yellow , and iron oxide red . what lamevudines travesty looks like and contents of the pack orange , round , biconvex film scored tablet , debossed with " ldt " on one side and plain on the other side . the tablet can be divided into equal doses . one carton contains 32 tablets . lam
nespo is ( may be called an anti - anaemic ) used to treat your anaemia . your doctor will test your blood to make sure that you have enough red blood cells , which are important for the symptoms ( fatigue , weakness and shortness of breath ) that are caused by the low levels of the natural hormone erythropoietin in your blood . this helps to stimulate your kidneys and makes your bone marrow more able to produce red blood cell . darbepoetine alfa is used for the treatment of chronic renal failure in adults , adolescents and children ( 6 years of age and older ) who have had symptomatic anaboemia before . chronic renal fail is also a treatment for adult patients with kidney failure . kidney failure is a failure when your kidney does not produce enough of the naturally hormone rythropowoi
do not use nespo : - if you have high blood pressure , are taking other medicines , or you are allergic to the active substance darbepoetin alfa or r - hiepo , and / or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine if your doctor thinks this applies to you . you must not be given nеspo if : you have been told by your doctor that you have sickle cell anaemia ; you have a history of epileptic fits ( seizures ). you have ever had fits ( convulsions , fits or seizures ); you have liver disease caused by drugs . your doctor may want to keep you under closer observation or change your dose . if any of these apply
nespo will be given to you by a doctor or nurse who is experienced in the use of this type of medicine . your doctor will carry out blood tests to check that your haemoglobin level is within the normal range of 10 micrograms / dl and will regularly check if you are still growing . the usual dose for adults is a healthy adult , who can use a haemagoglobIN level between 10 and 12 microlitres every other week . how is given the pre - filled syringe is injected into a vein ( intravenous ). in chronic renal failure , a single injection is given under the skin , buttered through a canal ( intravenously ) to treat your anaemia . dose the amount of naspo you receive is based on your body weight ranging from 0 . 75 to 
like all medicines , nespo can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : 471 very common ( affects more than 10 users in 100 ): high blood pressure ( hypertension ) with fluid retention ( oedema ) uncommon ( impact affects 1 to 100 users in 10): blood clots ( thrombosis ) pain in or around the area injected rash or redness of the skin rare ( effect affects less than 1 user in 10 , 000 ). serious allergic reactions including sudden life - threatening allergic reactions ( anaphylaxis ) which may include swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedemo ) not known ( frequency cannot be estimated from the available data 
keep out of the reach and sight of children . store in the original package in order to protect from light . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . this medicinal product does not require any special storage conditions . after first opening : store in a refrigerator ( 2 - 8 ). do not freeze . if you want to remove a pouch from the refrigerator , simply put it next to the stove top and wait at least 30 minutes to allow it to reach room temperature . you may remove the pouches after this time period , or store it at room temperature for a maximum of 7 days ( but not above 25 ). once you have removed the product you should use it again , the next carton should be used within this period . medicines should not be disposed of via wastewater or household waste . ask your
what nespo contains - the active substance is darbepoetin alfa . - each pre - filled syringe contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu ( international units )).  the other ingredients are : - sodium phosphate monobasic , salt ( 0 . 5 ml ), water for injections . the resulting solution is a clear , colourless to slightly pearly liquid , and may contain trace amounts of cloudy particles . each pack contains 1 or 4 pre – filled pens . all pack sizes may be marketed .
macugen is a solution which is injected into the eye by a doctor or a nurse . it contains the active substance pegaptanib . this medicine helps to prevent abnormal formation and development of new blood vessels in the eye . macugagen is used for the treatment of patients with macular degeneration . people with this disease may also suffer from vision loss or damage to the part of the retina called the macula , which is at the back of the eye ( amd ). abnormal blood vessels grow and become larger , causing the eye to shrink . in amd ( when abnormal blood vessel vessels grow out of control ), the maculate is surrounding the retina and helps to repair these new cells .
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). you have an active or suspected infection in or around your eye . warnings and precautions talk to your doctor , pharmacist or nurse before you are given Macugen you may develop an infection or bleeding in the eye that is serious . bleeding inthe eye that does not stop after macuGEN injection tell your doctor immediately : you have the following symptoms : eye pain increased discomfort , worsening eye redness , blurred or decreased vision , increased sensitivity to light , or small particles in your vision . these may be signs that the eye is working properly before and after the injection . if the injection is completed , you have to stop the injection serious allergic reactions . the symptoms are usually mild to moderate and usually go away within 4 to 18 years of age
macugen will only be given to you by a doctor or a nurse who is experienced in the use of injections . how much is given - the doctor or nurse will decide on the dose that you need . - your doctor will decide how many injections you need and for how long . the recommended dose is one vial ( a single injection ) into your eye , every 6 to 9 weeks . after the injection , the solution will be injected into the vitreous ( transparent ) part of your eye ( the clear part of the eye that absorbs light ). - after you have been given macuGEN , you will be given antibiotic eye drops to prevent infection in your eye and help your doctor to clean your eyes . you may also be given some local anaesthetic ( numbing medicine ) to reduce or prevent any pain you might have with the injection ( see section
like all medicines , this medicine can cause side effects , although not everybody gets them . possible serious allergic reaction ( anaphylactic reaction ) or angioedema of which symptoms include : breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting / rapid pulse , stomach cramps , nausea , vomiting , diarrhoea . the frequency of these side effects is not known ( frequency cannot be estimated from the available data ). an infection in the internal portion of the eye has been reported in patients receiving macugen treatment . these symptoms may progress to more than 2 out of 10 people . if you experience any of these symptoms , seek medical advice from your doctor as soon as possible . your doctor may decide to reduce the dose to half of the dose . in some cases ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . this medicine does not require any special storage conditions . if the medicine is not used immediately , in - use storage times and conditions prior to use are the responsibility of your doctor , pharmacist or nurse .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegabib in 90 mg / ml solution for injection .  the other ingredients are : sodium chloride , monobasic sodium phosphate monohydrate ( e339 ), dibasic salt phosphating heptahydrate , sodium hydroxide and hydrochloric acid ( for ph adjustment ) and water for injections ( see section 2 . important information about some of the ingredients in the pack macarugen solution for injecting is provided in a single dose pack , which may be stored in the original carton , a pouch and / or a ready to use pre – filled yysringe ( 0. 25 mg - 0. 27 mg )
kepivance contains the active substance palifermin which is produced by recombinant dna technology in escherichia coli . it belongs to a group of proteins called epithelial cells , which are found in the mouth , digestive tract and in the tissues below the skin . when the mouth is cut , it is cut in half , so that there is no food left in the body . this helps to kill the bacteria that cause it . the medicine is used to treat oral mucositis ( soreness , dryness and inflammation of the mouth that is a common side effect of treatments to treat your blood cancer ). if you have been told by your doctor that you have a different type of blood cancer ( e . g . chemotherapy , radiotherapy or autologous hematopoietic stem cell transplantation
do not use kepivance if you are allergic to palifermin or escherichia coli derived proteins , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . children and adolescents do not give this medicine to children or adolescents less than 18 years of age . other medicines and kepeivance tell your doctor or pharmacist if this medicine is harmful to the environment . this medicine may affect the way other medicines work . also , it is important that you tell your pharmacist , doctor or nurse if using , have recently used or might use any other medicines . do not share this medicine with other medicines that are obtained without a prescription . it is also better to avoid the possibility of taking heparin with food that is high in a blood stream . 
kepivance will be given to you in a hospital or clinic under the supervision of a doctor experienced in cancer treatment . usually , a dose of 60 mg is given each day . if you need to , you can get a lower dose . your doctor will decide how many treatments you need . the recommended dose is one millilitre ( 0 . 5 ml ) of solution for injection into a vein , by infusion or drip . you can have a consultation with your doctor , nurse or pharmacist . instructions for use follow - up on dose and frequency of administration are given at the end of this leaflet ( see ' handling instructions '). you will be asked to wait at least one hour before chemotherapy and radiotherapy and for three days after chemotherapy and radiation . it is recommended that you receive chemotherapy andradiotherapy at least 24 to 48 hours after the chemotherapy
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects reported with kepivance were skin rash , itching and redness ( pruritus ) and erythaema ( an increase in the thickness in the mouth or tongue , change in colour of the mouth ou tongue ), generalised swelling , oedema ( swelling of hands , ankles or feet ), pain , fever and aching joints ( arthralgia ), altered taste , lipase and amylase levels . uncommon :  a type of white blood cell ( leucopenia ), increased blood sugar levels ( hypoglycaemia ).  anaemia . if you have any questions about how this medicine works or why this medicine has been
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliffermin as the other ingredients are : mannitol ( e421 ), sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid ( see " e507 " at the end of this leaflet ). what the bitter taste is and how it reacts to the emulsion , it is a white powder for concentrate for solution for injection . it is available in packs containing 6 vials .
the active ingredient cinacalcet , which is used to lower the levels of parathyroid hormone ( pth ), calcium and phosphorous in the blood . it is used in adults to treat problems with organs called parathyroid glands . the parAThyroids are four small glands in the neck , next to the thyroid gland , that produce parathormone (  - chol ) activity . cinacacet accordpharma is used : on its own to treat secondary hyperparathyroidism in patients with serious kidney disease who need dialysis to clear their blood of waste products to reduce the amount of calcium inthe blood ( hypercalcaemia ) in adults with parat thyroid cancer to control the level of calcium within the blood ( hypocalcae ) that is not controlled in primary hyperparathyroidists when removal of the gland is not feasible . using 
do not take cinacalcet accordpharma : - if you are allergic to citriccet or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . there are very low levels of calcium in your blood . your doctor will monitor your blood calcium levels . if this applies to you , your doctor may decide to lower your dose of cinacacet acordpharma . while you are being treated , tell your doctor about seizures ( convulsions ). these are seizures that last for several hours or may last for months or years . you have liver problems , heart failure or have been in close contact with someone with similar ages . when you are treated properly , calcium levels can lead to life threatening events and fatal outcomes . low calcium levels ( hypocalcaemia ) can be life -
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how much cinacalcet accordpharma you need and for how long . you will be prescribed a different dose each time you have the same tablet . - the dose is calculated by your doctor . the tablets must be taken whole and are not to be chewed , crushed or split . it is important that you take regular blood samples during treatment to monitor your progress and to adjust your dose if necessary . patients with secondary hyperparathyroidism the recommended starting dose for cina Calcet accord Pharma is 30 mg . adults with cinacacalcet acordpharma can give the lowest dose for children 3 months to less than 18 years of age , with a starting dose of 0 . 20 mg , to be taken before meals . children should not take
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you start to get numbness or tingling around the mouth , muscle aches or cramps and seizures . these may be signs that your calcium levels are too low ( hypocalcaemia ). signs include : swelling of the face , lips ,mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea and vomiting . all of these side effects are usually mild and usually go away within a few days . very common : may affect up to 1in 10 people dizziness . not known ( frequency cannot be estimated from the available data ) headache . your doctor will tell you how to recognise them and what you can take to ease these effects . common
what cinacalcet accordpharma contains - the active substance is infusion - free . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinacacalcet ( as hydrochloride ). - in the tablet core : cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminium lake , and iron oxide yellow , all ink : shellac , iron oxide red , round , marked with ' cbc ' on one side and plain on the other side , for the duration of the tablet . what the medicinal product looks like and contents of the pack the 30 mg tablets are light green colored , oval shaped ( approximately 9 . 65 mm 
jentadueto contains two different active substances , linagliptin and metformin . - ligapitin belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 5 inhibitors ) - this medicine works by increasing the levels of sugar in the blood , and by slowing the absorption of biguanides , which help to control blood sugar levels in adult patients with a form of diabetes called ' type 2 diabetes mellitus '. this medicine can be used alone or together with insulin . your doctor may prescribe this medicine alone or with certain other medicines to treat diabetes ( such as sulphonylureas , empagliflozin ) which are used to increase the level of insulin that your body produces . it is important to keep following the advice about
do not take jentadueto if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before taking any medicine : - if your doctor has told you that you have severely reduced kidney function - in - patients with uncontrolled diabetes , with e . g . severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis ( see section " risk of lactic acidsis " below ) or ketoacidosis , see section risk of ketoacicidosis below . ketoaicidosis is a condition in which substances called ' ketone bodies ' accumulate in the blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the amount of jentadueto that you will take varies depending on your condition and the doses you currently take of metformin and / or individual tablets of linagliptin . your doctor will prescribe the strength that is right for you , depending on how your condition is now . the recommended dose is one tablet once a day . do not change your dose unless your doctor tells you to . taking this medicine swallow your tablet ( s ) whole with water . you can take your tablet with or without food . if your doctor prescribes this medicine to treat an upset stomach , your doctor may prescribe you a daily dose containing 5 mg lagliptine ( equivalent to 2 , 000 mg per day ) and 2
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention you should stop taking jentadueto and see a doctor straight away if you notice any of the following symptoms : low blood sugar ( hypoglycaemia ): trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change , confusion ... the frequency of this side effect is unknown ( may affect up to 1 in 10 people ). the most common side effect was low blood glucose when taken in combination with jentedueTO plus sulphonylurea or with the combination jentraeto plus insulin . the frequency was common . if this happens to you , it may take longer than usual for you to sit or lie down . your doctor will explain to you the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , blister or bottle after exp . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from light and moisture and only remove immediately before use . any unused medicine should be disposed of via wastewater or household waste . ask your pharmacist how to re - open the bottle , if you notice any damage to the pack or if there are any signs of tampering .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . - each japanese 2 . 5 mg / 850 mg film - coated tablet ( tablet ) contains 2 , 5 mg delamanid , and 3 mg prasugrel , both at the same dose as in the movie - making process . each jentadustueto 2 / 5 mg or 1 , 000 mg film ( coated tablet ), each jadetunes 2 : 5 mg desiccant , containing a total of 1 . 000 mg of delaminated , respectively . the other ingredients are : arginine , copovidone , magnesium stearate , maize starch , silica , coll
edurant contains the active substance rilpivirine . it is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children of all ages who are also taking hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). it is given to hiv people who have already taken hiv medications and who are now starting them at an advanced stage of their treatment , but who are not sure how to treat them , please read the package leaflet for ' use ' in this leaflet . you must keep following your doctor ' s advice about what you need to do if you think you are infected by hiv or if someone else in your family has hiv and you are not using hiv drugs before . your doctor will discuss with you which combination of medicines is best for you 
do not take edurant - if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking e pendant . if the following medicines apply to you : carbamazepine , oxcarbazepine ( e1200 ), phenobarbital and phenytoin ( medicines to treat epilepsy and prevent seizures ) rifampicin and rifapentine ( medicines for treating some bacterial infections such as tuberculosis ); omeprazole ; esomeprazolazole and lansoprazolе , pantoprazole , and rabeprezole ( proton pump inhibitors ) protease inhibitors
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is : adults : 1 . edurant must be given to you by a doctor or nurse . adults ( 18 years of age and over ) : your doctor will decide on the correct dose of e during your treatment . there is no need to change the dose . your doctor may ask you to take rifabutin , a medicine used to treat some bacterial infections , before and after your treatment with eDuring , as a precautionary measure . it is recommended that the doctor decides to reduce the dose your doctor prescribes . in addition , the doctor may also decide to give you a lower dose , either : - one tablet , or two tablets , at the same time , in order to reduce
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience : headache , nausea , difficulty falling asleep , insomnia , dizziness . these may be signs that your routine liver tests may increase in levels of transaminase and increase in cholesterol and pancreatic amylase in your blood . abnormal dreams , rash and stomach pain . signs of depression , tiredness , vomiting and drowsiness . decreased appetite . sleep disorders , stomach discomfort , depressed mood , and difficulty sleeping . common side effects ( may affect up to 1 in 10 people ): diarrhoea , constipation , flatulence , dry mouth , loss of appetite , weight loss , low blood sugar , increased blood fats ( a type of fat ) in the blood 
what edurant contains - the active substance is rilpivirine . - each film - coated tablet contains riilpirine hydrochloride . each tablet contains 25 milligrams of rillpiviline .- the other ingredients in the film  coated tablet core are : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . in addition , the film coat contains lactoses monohydrate and hypromellose 2910 ( 6 mm in diameter ), titanium dioxide , macrogol 3000 and triacetin . not all pack sizes may be marketed in your country .
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes in adults . people with this type of diabetes either don ' t make enough insulin ( a hormone that controls blood sugar levels ), or don  t respond normally to the insulin their body makes , and they can help control your blood sugar . rochetamet works in exactly the same way as insulin and it does this by helping your body make better use of it . it helps to increase the levels of insulin produced after a meal and lowers the amount of sugar made by your body . when it is taken regularly , it can also be used in combination with a sulphonylurea ( another medicine for diabetes ).
follow all instructions given to you by your doctor , pharmacist or nurse carefully as they will explain how to treat your diabetes . do not take avandamet if any of the following apply to you : - are allergic ( hypersensitive ) to rosiglitazone , metformin , or peanut or soya ; - have had a heart attack or severe angina , that amounted to heart failure . have had heart failure in the past and have severe breathing difficulties . - suffer from liver disease or diabetic ketoacidosis ( a complication of diabetes that can cause rapid weight loss , nausea or vomiting ) and kidney disease 107 - you may be very dehydrated ( lose too much fluid ) as a result of this medicine , and your doctor may ask you to stop taking it . you should continue to follow your food and exercise plan
always take avandamet tablets exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the usual starting dose is 2 mg rosiglitazone and 1000 mg metformin , taken once a day . this dose is given on days 1 and 8 of each 3 - week cycle . your doctor will work out the right dose for you , depending on how you respond to the treatment . the maximum dose is 4 mg  Rosiglitabazone , given twice daily , in two equally divided doses , with a combined dose of 1000 mg of metforminer ( see section 2 ). you should swallow your tablets whole with water . do not chew or break the tablets as they may have harmful effects . if your stomach gets upset ( indigestion , nausea , vomiting or diarrhoe
like all medicines , avandamet can cause side effects , but not everybody gets them . allergic reactions may occur with the use of this medicine . signs include : raised and itchy rash ( hives ) swelling , sometimes of the face or mouth ( angioedema ), causing difficulty in breathing collapse . contact a doctor immediately if you have any of these symptoms . stop taking avand amet and seek medical help immediately . lactic acidosis : a build - up of lactic acids in the blood ( lactose ) has been reported very rarely in patients taking metformin . it is not known how often this occurs . this is particularly common in patients with severe kidney disease . some patients have experienced symptoms of lacecidosis such as rapid breathing , cold sweats or other changes in the way your heart beats .
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and the blister after exp . this medicine does not require any special storage conditions . if you have any unwanted tablets , do not throw them away . ask your pharmacist how to throw away tablets you no longer use . these measures will help protect the environment .
what avandamet contains - the active substances are rosiglitazone and metformin . - each tablet contains a total of two different active substances : - avand amet tablets : 1 mg rosviglit azone 500 mg / 0 . 5 milligrams of metformIN - 2 mg debossed with " r " on one side and " g " on the other side of the tablet . the total content of one tablet contains one total of three times a day ( 15 , 30 , 60 and 90 " on either of these two substances ). the other ingredients are : sodium starch glycollate , hypromellose , microcrystalline cellulose , lactose monohydrate . desiccant : maize starch , modified granules ( gluten free ),
the active substance of clopidogrel mylan , claudine , belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . principially , platelets are formed by a chemical in the body that binds to receptors in blood vessels causing them to forming their own clots . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood coagulations forming ( a process known as thrombosis ).  c d ' s action in a very small number of cases , hardened blood vessels ( arteries ) can form a condition known as atherothrombosesis . this can lead
do not take clopidogrel mylan 31 - if you are allergic to the active substance , or to any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor thinks this is too strong or not strong enough , tell your doctor or pharmacist . have severe liver disease . don ' t take the tablets at all unless your doctor has told you that any of these conditions are unacceptable . warnings and precautions talk to your doctor , pharmacist or nurse before taking clopgrell mylan if : you are at increased risk of bleeding , including : - an academic or medical condition which puts you at risk of internal bleeding ( such as an stomach ulcer ). you have a blood disorder that makes you prone to internal
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if vous have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg , or one 150 mg tablet , to make up for a forgotten tablet . then , you should continue with the 75 mg dose . once at the start of treatment , the next dose should be taken as usual ( 1 tablet of 75 mg ), but your doctor should then switch to the next 7 - day cycle . you should take the tablet with food and drink .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and the whites of the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' what you need to know before you take clopidogrel mylan '). - swelling in the mouth or skin disorders such as rashes and itching , blisters ofthe skin . this may be the first signs of an allergic reaction . the most common side effects ( affects 1 to 10 users in 10 ): diarrhoea , vomiting , nausea , cons
what clopidogrel mylan contains - the active substance is clopizil . each film - coated tablet contains 75 milligrams ( as hydrochloride ).  the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' important information about some of the ingredients of the tablet ') and hydrolysed polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide , yellow iron oxide [ e172 ], talc and macrogol 3000 . see section 4 ' possible ingredients '. not all pack sizes may be marketed .
doptelet belongs to a group of medicines known as thrombopoietin receptor agonists . dopetelet is used to treat patients with chronic liver disease associated with low platelet count , a condition known alsp , which can be treated by a medical procedure preventing bleeding , by increasing the number of platelets . platelets are blood cells that help the blood to clot and so prevent bleeding . this helps to cut off the blood supply that you have .
do not take doptelet : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment : blood clots can form in the veins or arteries , which can be fatal . this can be very dangerous because blood coagulations can be prevented by adequate prevention . tell your doctor before you start treatment and if there are still a possibility that it can harm your own unborn child . you can still pass on the dose , if your doctor thinks this applies to you . children and adolescents do not give this medicine to children or adolescents under the age of 18 years because the safety and efficacy in this age group has not yet been fully established and therefore no other medicines are recommended . pregnancy and breast - feeding 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine the dose you should take , depending on the results of your procedure . the recommended dose is 5 mg once a day . however , your doctor may prescribe a lower dose of 8 mg doptelet per day depending on your individual needs . swallow the tablet whole with a glass of water . do not crush , chew or break the tablet before swallowing . you can take dopetelet with or without food . this will give your body a chance to increase your dose over a period of time ( e . g ., 20 to 40 ) or 60 mg once per day ( whichever is more convenient for you ), you may take the tablet at a higher or lower dose ( 5 tablets ), depending on how your platelet counts
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : common : may affect up to 1 in 10 people feeling tired uncommon : might affect upto 1 in 100 people low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain swelling bone pain muscle aches fever tell your doctor or nurse if you get any of the side effects listed above . reporting of side effects you can help provide more information on the safety of the medicine . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects it is very important that you get the information you need to know before you take doptelet
what doptelet contains - the active substance is avatrombopag . - each film - coated tablet contains avatorabopag maleate equivalent to 20 mg .- the other ingredients are : - tablet core : lactose monohydrate ( see end of section 2 ), microcrystalline cellulose , crospovidone type b [ e1201 ], silica , colloidal anhydrous , magnesium stearate - film coating : poly ( vinyl alcohol ), talc , macrogol 3350 , titanium dioxide , iron oxide yellow ( e172 ). what dopet looks like and contents of the pack dopelet 20 mg tablets are pale yellow , round and rounded , marked with " av2 " on one side and " 20 " on the other side . the tablets are provided
rapiscan belongs to a group of medicines called ' coronary vasodilators '. it works by helping to relax the muscles in your heart , allowing the doctor to see more clearly and improve heart rate . rapican is used in adults for a type of heart scan known as ' myocardial perfusion imaging . the scan contains a radioactive substance called a ' radiopharmaceutical ' which helps to obtain clearer pictures of the muscles around the heart . it can also be seen using a treadmill , which is usually used to help you see how well your heart is working . before you have a scan , you will be given the medicine by a doctor who has been trained on how to use it and what to do if it does not look like and is intended for you . your doctor may also give you a small amount of radio
do not use rapiscan - if you have slow heart rate or have high degree heart block or sinus node disease and do not have a pacemaker when you have chest pain ( unstable angina ). warnings and precautions talk to your doctor before starting treatment if any of the following applies to you : - low blood pressure ( hypotension ) - heart failure - are allergic to regadenoson 6 or higher . there are no special dose recommendations for use in children below 6 years of age . if the child is less than two years old , the doctor will decide if treatment should be started again . talk to the doctor before you are given the medicine if : the child has a recent serious heart problem such as a heart attack or have abnormal heart rhythms . your doctor will check that your heart is working properly and if there is a problem with the rhythm 
rapiscan will be administered to you by a doctor or nurse who is experienced in the diagnosis and treatment of your heart and blood pressure . it will be injected into a vein over a period of approximately 400 minutes using a 5 ml solution the injection will take about 5 to 10 minutes . the dose you receive is based on your weight . you will be given an injection of sodium chloride 9 mg / kg ( corresponding to 9 %) solution for injection , followed by 5 mg of a radioactive substance ( radiopharmaceutical ) which will be released before the next injection . your doctor will calculate your heart rate , the distance you will need and will tell you if you need to be monitored for a certain amount of time . this will be done by an experienced doctor , a patient whose heart rate is currently being monitored , blood pressure and the duration of the 
like all medicines , rapiscan can cause side effects , although not everybody gets them . some of the side effects are likely to occur after the rapican injection . they usually occur within 30 minutes to a few hours after any treatment . tell your doctor straight away if you notice any of the following serious side effects as they could be a sign of sudden stopping of the heart or damage to the heart ( for example , heart block or a disorder ofthe heart ' s electrical signal ). rapid heart beat low blood pressure , fainting , mini strokes , weakness of the face or inability to speak . it is not known how often these effects occur . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you may experience a stroke or cerebrovascular accident and have an allergic reaction that may include rash , wheals
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into the penis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . you should not take viagra as a treatment for adult men with erectile dysfunction , also known as impotence . this is when a man cannot get , or keep a hard - to - hook - up - sex just enough to make a good , normal , hard , clean penis suitable for sexual activity . your doctor will tell you why this medicine has been prescribed for you .
do not take viagra if : you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines called nitrates , as the combination may lead to a dangerous fall in your blood pressure . tell your doctor if any of these medicines are used to treat angina pectoris ( or " chest pain "). if you are not certain , ask your doctor or pharmacist for advice . if the medicines are being given to you by nitric oxide donors such as amyl nitsitrite (" poppers ") may also be used as an add - on to viagra . this may increase the risk of a deadly fall in Ihre blood pressure ( see also section 4 ). warnings and precautions talk to your doctor before taking viagra : if your doctor thinks you are being treated with rioc
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 50 mg once daily taken with viagra film - coated tablets or with viagra orodispersible tablets . you should not take viagra more than once a day . swallow the tablet whole with a glass of water . viagra will only help you to get an erection if your partner or sexual partner is sexually stimulated . it may take between two and five hours for viagra to work . taking viagra with viagra may lead to an increased sexual desire . your doctor will tell you how long you will need to keep taking viagra . do not stop taking viagra without your doctor ' s advice as this could make you less able to sexual intercourse . how long will you last ? when to take viagra take viagra for as long as your sexual stimulation stimulates you to
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with the use of viagra are usually mild to moderate and of a short duration . if you experience any of the following serious side effects stop taking viagra and seek medical help immediately : an allergic reaction , seen uncommonly ( may affect up to 1 in 100 people ) symptoms include sudden wheeziness , difficulty in breathing or dizziness ; swelling of the eyelids , face , lips or throat . chest pains : get in a semi - sitting position and try to relax . do not use nitrates to treat your chest pain . prolonged and sometimes painful erections have been reported ( seen rarely ) in men . this is estimated to be more than 1 in 1 , 000 people , but you should contact a doctor immediately 
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildinafil ( as the citrate salt ).  the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . film coat : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake . what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and are marked with ' 25 ' on one side . the tablets are provided in blister packs containing 2 , 4 , 8 or 12 tablets . not all pack sizes may be marketed .
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate receptors in the brain that play an important role in learning and memory . in this way , these receptors help to control nerve impulses inthe brain and reduce the symptoms of primary parkinson ' s disease . it can be used alone or in combination with levodopa ( another medicine for parkinsons ' disease ). it can also be used to relieve the symptoms associated with moderate to severe primary restless legs syndrome in adults .
do not take sifrol : - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking sfrol . please tell your doctor about any medical conditions and symptoms you may have . some of these conditions may be serious . kidney disease may be associated with hallucinations ( seeing , hearing or feeling things that are not there ). most visualisations are visual . dyskinesia ( ( e . g . abnormal , uncontrolled movements of the limbs ). in patients with advanced parkinson ' s disease , levodopa may also play a role in dyskineia . your doctor will advise you on what to do if this happens . you will also find this information in the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . sifrol should be prescribed by a doctor experienced in the treatment of parkinson ' s disease . the recommended dose is 3 tablets per day . during the first week , your doctor will start you on a low dose . after this , the dose will be gradually increased . you will start at the lowest dose and this will usually be in the range of 0 . 088 mg per day ( corresponding to a daily dose ): 1st week : start on the lowest level . this will be for 1 week . then , you will be instructed by your doctor to increase your dose at a lower or higher dose until your symptoms are controlled ( this may be repeated every 2 weeks , or until your doctor tells you to stop ). 2nd
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common : may affect more than 1 in 10 people common ; may affect up to 1 in every 10 people uncommon : will affect upto 1 in 100 people rare : might affect upt 1 in 1 , 000 people very rare ; will affect less than1 in 10 ,000 people not known : frequency cannot be estimated from the available data patients with parkinson ' s disease . other possible side effects include : dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ); dizziness ; nausea ( sickness ); urge to behave in an unusual way - hallucinations ( seeing , hearing or feeling things that are not there ); confusion ; tiredness 
what sifrol contains - the active substance is pramipexole . - each tablet contains 0 . 088 mg , 0. 18 mg e ; or a corresponding decrease in the activity of the cells . when given as a single tablet , the tablet can be divided into equal doses . each tablet provides a benefit of reducing the acidity of the tablet and hence lowers its acidity . the tablets also contain a protein called liposomes , which may be present in the form of tablets called ' colloidal silica ', ' povidone k 25 ' and magnesium stearate . what ifrol looks like and contents of the pack siprol is a white to off - white , round , flat , bevelled edge tablet marked with ' p8 ' on
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . it belongs to a group of medicines called ' allergic conditions '. these are allergic conditions that occur in and around the eye and can be life - threatening if the allergic reaction is severe . in adults , allergic conjugitis with some materials ( allergens ) can cause allergic reactions such as itching , redness and swelling of the surface of your eye , if you notice that you feel worse .
do not use emadine : - if you are allergic to emedastine or any of the other ingredients of this medicine listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . children and adolescents do not give this medicine to children under the age of 3 years because it contains benzalkonium chloride . the recommended dose in this group of patients is 6 mg / m2 body surface area . no clinical trials have been conducted in this age group . therefore , the use of e madine should be avoided . tell your doctor or pharmacist if : you have kidney or liver problems . use in children this medicine has not been studied in children or adolescents . there is no information on the safety and efficacy data in this population . other medicines and emagine tell your pharmacist , nurse or doctor 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop in each eye 3 times a day in the morning . do not use more than your doctor tells you to use . this medicine should only be used in the eyes . 3 . wash your hands before you start . 1 2 . after you have taken the emadine bottle , take it out with a glass of water . it is best to use it at the same time each day . if it is not , rinse your hands after using the bottle . twist off the cap . remove the cap and snap collar . hold the bottle and swivel for at least a minute until it is time for your next regular dose . thumb and finger pointing down . tilt your head back . pull down your eyelid with
like all medicines , this medicine can cause side effects , although not everybody gets them . stop using the drops and tell your doctor straight away if you notice any of the effects listed below . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye , eye redness . uncommon side effects these may affect more than 1 in 100 people ). effects at the back of the eye ( corneal disorder , abnormal eye sensation , increased tear production , tired eyes and eye irritation , blurred vision , corneal staining . not known ( frequency cannot be estimated from the available data ): allergic reactions ( e . g . swelling of the face , lips , mouth , tongue or throat ) loss of taste , inflammation of the lens , damage to the clear layer in the front layer at the front of the
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and on the blister after exp . store below 25 . keep the blister in the outer carton in order to protect from light and moisture .
what emadine contains - the active substance is benzalkonium chloride . - each ml of solution contains trometamol ( 99mtc ) sodium chloride and hypromellose ( e464 ). the other ingredients are purified water , hydrochloric acid and sodium hydroxide ( to adjust acidity levels or ph levels ), and phosphate , partially hydrolysed , yellow ( 0 . 5 %) solution , in a clear , colourless liquid ( a solution ) solution . it is supplied in : - a multipack containing one 5 - bottle ( drop - container ) bottle with a screw cap .
levetiracetam is an antiepileptic medicine ( a medicine used for the treatment of seizures in epilepsy ). levetistetam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epileptic disease , to treat a certain form of epilephewism . this is a condition where the patients have repeated fits ( seizures ) over a period of one or two weeks . levetiractam has been given to you by your doctor to reduce the number of fits . for the epiLEpsy , fits first affect only one side of the brain , but could thereafter extend to larger areas on both sides of the head ( partial onset seizure with or without secondary generalisation ). in both cases levetiacetam was given alone and taken in combination with other antieppileptic medicines to treat certain partial 
do not take levetiracetam actavis - if you are allergic to levetiractam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and while taking levetiratetam actingavis some patients with kidney problems may notice any slow down in the growth or unexpected puberty development of their children . some patients treated with anti - epileptics have had thoughts of harming or killing themselves . if at any time you have these thoughts at the moment you have any symptoms of depression and / or suicidal ideation , you should tell your doctor as soon as possible . the following side effects may be associated with unusual thoughts , feeling irritable or reacting more aggressively to changes in mood or behaviour . you should be aware that le
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . take the number of tablets following your doctor ' s instructions . levetiracetam actavis should be taken twice a day , once in the morning and once again in the evening . monotherapy dose in adults and adolescents ( from 16 years of age ) : general dose : between 1 , 000 mg and 3 . 000 mg each day . when you will last for two weeks , your doctor will prescribe you a lower dose to make up for a forgotten dose . add - on therapy dose in adult patients ( 12 to 17 years ) the usual starting dose is 50 mg twice daily . this is followed by a daily dose of between 2 milligrams 3 , 500 mg and 1 . 0 mg twice weekly . your doctor may prescribe you
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately , or go to your nearest emergency department , if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction ; swelling of the face , lips , tongue and throat ( quincke ' s oedema ); flu - like symptoms and a rash on the face followed by an extended rash with a high temperature ; increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell 56 ( eosinophilia ) and enlarged lymph nodes ( drug reaction with the hepatitis b virus ). uncommon side effects ( may affect up to 1 in 100 people )
what levetiracetam actavis contains - the active substance is called levetiractam . - one tablet ( 250 mg ) contains 250 milligrams of levetiratam ( as mesilate ). - two tablets ( 500 mg / 5 ml ) contain 500 milligrammes de lamisive nebuliser simvastatin . the smallest tablet ( 0 . 5 mm  10 mm) contains 500 million international units ( iu ) delamanid . one tablet is debossed with " lilly " on one side and " tadalafil " on the other side . two tablet( s ) have been used to make a difference in the way they work . each tablet contains a total of 750 micrograms , equivalent to 
what incruse ellipta is this medicine contains the active substance umeclidinium bromide , which belongs to a group of medicines called bronchodilators . what increse is used for this medicine is used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition in which the airways and air - sacs in the lungs gradually become damaged and blocked , leading to breathing difficulties that slowly get worse . difficulties in breathing is added to by tightening of the muscles around the air , helping to open the airway and reducing the number of these muscles , and improving your breathing difficulties , as well as for lowering the effects of copd on your everyday life . if you are intolerant to the medicine , you must use it every day , not only when you
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine , if : - you have asthma ( don ' t use increse inhalation to treat asthma ) - your doctor has told you that you have heart problems , or you have an eye problem called narrow - angle glaucoma , such as an enlarged prostate , difficulty passing urine or a blockage in your bladder , as there may be a possibility you have severe liver problems . immediate breathing difficulties such as tightness of the chest , coughing , wheezing or breathlessness immediately after inhaling the active substance in your inhaler . you must stop using
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use incruse ellipta regularly it is very important that your doctor , pharmacist or nurse shows you how to use it for as long as your symptoms are not improving after using this medicine . to reduce the chance of a sudden attack of breathlessness or wheezing , you should use a quick - acting reliever inhaler ( such as salbutamol ). you should always have the option to use the inhalers supplied with the product , so that the dose that you breathe in is
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you have any of the following symptoms after taking incruse ellipta , stop using this medicine and tell your doctor immediately : itching skin rash ( hives ) or redness 29 other side effects common : these may affect more than 1 in 10 people faster heart beat painful and frequent urination ( may be signs of a urinary tract infection ). common cold infection of nose and throat cough feeling of pressure or pain in the cheeks and forehead ( signs of inflammation of the lining of the mouth and throat ). not known ( frequency cannot be estimated from the available data ): decreased appetite , weight loss , diarrhoea and vomiting , indigestion , and bloating
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the inhaler label and carton after exp . this medicine does not require any special temperature storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . after first opening or if carried as a spare , the sealed tray can be kept in the original carton in order to protect from light . write down the date you first open the blister in the space provided on the label in this leaflet and include " use in " and " use " in section 6 for more information . once you have taken the tray of incruse ellipta , store the tray with you and keep it at room temperature ( below 30 ). keep the container in the outer carton to protect it from light and do not remove it from the refrigerator . the label should be used only 
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium , corresponding to a metered dose of 65 microgramms of umeclinium ( as metered ) at the date and time of calibration . the other ingredients ( excipients ) are lactose monohydrate ( see section 2 under ' important information about some of the ingredients of the inhaler ') and magnesium stearate ( e470b ) ( for information about ingredients '). what the incluta looks like and contents of the pack the inhaled concentrate is a white powder in a black plastic body with a light green mouthpiece cover and a dose counter . it is packaged in
nucala contains the active substance mepolizumab . this is a monoclonal antibody , a type of protein that recognises and attaches to a specific target in the body . it is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils , which are white blood cells that circulate in the lungs . in asthma nucala helps to control asthma attacks and prevents asthma attacks by attaching to medicines called high dose inhalers . your asthma cannot be controlled with these medicines alone . you may also need to take medicines called oral corticosteroids . nucalа can also help control your asthma . when it is taken regularly , it will also help your body to recognise and attach to an anti - inflammatory protein called interleukin - 5 ,
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine . this medicine has been shown to increase the risk of worsening asthma . in some patients ( more than 58 %), people have asthma - related side effects due to their asthma , and it is important that you tell your doctor if any of these apply to you . your doctor will monitor you more closely while you are receiving or have been given nuCALa . if your asthma does not improve after a short period of time , your doctor may recommend a change . do not stop nucalala unless your doctor tells you to . allergic - injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions when they are 
nucala will be given to you by a doctor or nurse under the skin ( subcutaneous injection ). the recommended dose is 12 micrograms ( 100 microgram ) given once a week on day 1 of the pre - filled pen . if you have any further questions on the use or the timing of injections , ask your doctor , pharmacist , or nurse . you or your caregiver should receive training on how to use nuclear medicine . before you are given nuCALa , your doctor will check that the treatment is having the desired effect . it is very important that you do not receive more than one injection , at the same time each day . your doctor may increase or decrease the dose if your asthma symptoms and attacks do not improve or get worse after you have received your doses . when and how often you need to receive injections of nucalа , you will be monitored carefully for signs of
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur commonly ( may affect up to 1 in 10 people ) following the injection . sometimes symptoms include symptoms such as chest tightness , cough , difficulty breathing fainting dizziness feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor or nurse immediately if you have had a reaction similar to or similar reaction to the injection or to any of the ingredients in nucalа . if this happens to you , immediately contact your doctor . not known ( frequency cannot be estimated from the available data ) allergic reactions can occur with this medicine , and are very common ( affects more than 1 user in 10
keep this medicine out of the sight and reach of children . do not use nucala after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep away from the freezer compartment . before using the Nucala pre - filled pen , keep the pen in the outer carton in order to protect from light . the pen can be removed from the refrigerator and left at room temperature for a single period of 7 days ( but not above 25 ). once you have removed the carton , do not return to the refrigerator . discard any unused product after this time period .
what nucala contains - the active substance is mepolizumab . 1 ml contains 100 mg of mepolizamab as mesilate .  the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate ( e330 ), polysorbate 80 , edta disodium dihydrate and water for injections ( see section 2 ). what Nucala looks like and contents of the pack nucalа is a clear , colourless solution for injection . it is supplied in a pack containing 1 glass vial or a multipack containing 3 vials of 1 vial . not all pack sizes may be marketed .
what ninlaro is and what it is used for it is a cancer medicine that contains the active substance ixazomib , known as a ' proteasome inhibitor '. what nicholarois used to treat multiple myeloma in adult patients whose disease has spread beyond the original tumour or to the bone marrow , in adult donors who have received at least one other treatment ( s ) since their disease had worsened ( metastasised ) in the past . ixizomimeb has been shown to delay cell survival by making sure that no one of the proteins in the tumour survive . in patients who have had at least two other treatments , their disease may have spread to other organs , and they may not be able to reproduce themselves . what are the pros and cons of using nINlARo ?
do not take ninlaro : - if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment with nnaro ( see section 3 ). if any of these apply to you , tell your doctor immediately . before you start taking the medicine , make sure that you have the following conditions : bleeding , persistent nausea , vomiting , diarrhoea , nerve problems such as tingling , numbness , swelling or a persistent rash , liver or kidney problems . your doctor may decide to reduce the dose , stop treatment , or stop treatment with the next dose . you will be monitored carefully for blood tests to make sure you have enough blood cells . children and adolescents 
ninlaro should only be prescribed to you by a doctor with experience in treating multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if necessary , your doctor may prescribe a different dose . the recommended dose is one tablet once a day , for the first 3 weeks . lenalidomide is a medicine that is taken in combination with dexamethasone , an anti - inflammatory medicine . take the tablet at the same time each day and swallow it whole . how long will i take ? when to take nnlararo ? you will be given either one tablet in the morning and two tablets in the evening , or three tablets on the same day . first - week treatment : - you will start taking n
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( likely to occur in more than 1 in 10 patients ) low platelet counts ( thrombocytopenia ) nose bleeds easily bruise nausea vomiting diarrhoea numbness , tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or legs ( peripheral oedema ) skin rash ( itchy ) all over the body . rare side effects these may affect up to 1 in 1 , 000 patients . if any of the side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister or on the carton after exp . store below 30 . keep the capsule in the outer carton in order to protect from light and moisture and do not throw away any medicines via wastewater or household waste . please return the medicine to your pharmacist if you notice any damage or signs of tampering to medicine packaging . these measures will help protect the environment .
what ninlaro contains - each hard capsule contains 2 . 3 mg of ixazomib . each capsule contains 23 . 4 mg / 0 . 5 mg of the active substance , called xazomimb citrate . - the other ingredients are microcrystalline cellulose , magnesium stearate and talc . the capsule shell consists of gelatin , titanium dioxide ( e171 ), red iron oxide , printing ink containing shellac , propylene glycol , potassium hydroxide , and black iron oxide [ e172 ] ( see end of section 2 ). some of the ingredients are lactose and water for injections ( see section 3 for further information on these substances ). - some capsules contain a substance called ' ninema ') and one capsule contains
do not use palforzia : - if you are allergic to peanuts , or to arachis hypogaea . warnings and precautions talk to your doctor or pharmacist before using palforizia , - children and adolescents ( aged 4 to 17 years ) at the start of treatment . - peanut allergy : this medicine contains peanut ( desensitisation ) and should not be used in children or adolescents under the age of 18 years . this is because it is not known how this medicine works in these age groups . children and teenagers should be carefully supervised , and the safety and efficacy in these patients have not been established . it is strongly recommended that all medicines be given to you by healthcare professionals under the supervision of a healthcare professional . during the marketing of palforzaa you should tell your doctor if any of the following applies to you :
do not take palforzia - if you are allergic to peanut allergy . warnings and precautions talk to your doctor , pharmacist or nurse before and during treatment if : you have severe asthma . your doctor will regularly check if your asthma is getting worse , - you have a problem swallowing , or you have long term problems with your digestive system such as a severe mast cell disorder , including severe or life  threatening anaphylaxis , for at least 60 days . if this happens , your doctor may stop treatment temporarily or permanently . you will not be given your pal forzia until the symptoms go away . there is a risk that you may develop an allergic reaction , especially if beginning to get worse during the first few days of treatment . do not chew or crush the tablets , as they may be harmful to other people . allergic reactions
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this is because allergy or allergic reactions to palforzia can occur very rarely ( e . g . anaphylaxis ) and can occur rarely ( more than 3 times per week ). your doctor will decide when you should stop treatment with palforzaa and will recommend an initial dose escalation . these treatment phases will be repeated every two weeks . the initial dose elevation and up - dosing phases can be repeated at any time within the first week . it may take longer than one week to get to the right dose . you should not stop taking pal forzia unless you have been told to do so by your doctor . your doctor may decide to interrupt or discontinue the treatment of your condition if necessary . initial dose elevatation can be continued
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : - severe allergic reactions tell your doctor or nurse straight away if you get any of the following symptoms while being treated with pal forzia ( see section 2 ). the reaction may or may not be severe . trouble breathing - throat tightness / feeling of fulness - trouble swallowing or speaking - changes in voice - dizziness or fainting - extreme stomach cramps or pain - vomiting , diarrhoea , severe flushing or itching of the skin palforizia may cause problems with the stomach and digestive system . tell a doctor if any of these occur . not known : frequency cannot be estimated from the available data - low blood sugar . common : may affect up to 1 in 10 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special temperature storage conditions . dispose of any hard lumps of powder when reconstituted with palforzia . any unused solution should be discarded .
what palforzia contains the active substance is pretomanid . each sachet contains 0 . 5 milligrams ( mg ) of powder in each 1 , 10 or 20 ml vial . the other ingredients are microcrystalline cellulose ( e460 ), colloidal anhydrous silica , magnesium stearate paul forzia 100 mg powder for oral powder in capsules . after opening microscopic cellulose [ e553b ], colloidal anhydrous silica , talc [ 553b ]), magnesium steel papules [ 3000 ]) and beige oral powder . initial dose escalation ( see section 3 ) available for patients from 13 years of age and older and for 5 doses ( single - dose blisters ) are available for the treatment of patients weighing 
zerene belongs to a group of substances called benzodiazepine - related medicinal products , which consists of preparations with hypnotic actions and sleeping problems . they work in different ways to help you sleep . duration of treatment : if you have problems sleeping after you have finished your capsules , you should contact your doctor .
do not take zerene - if you suffer from hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before or during the use of zeene sleep apnoea syndrome , which causes short periods to occur . - in patients with severe kidney or liver problems , such as myasthenia gravis ( very weak or tired muscles ) and severe breathing , chest problems . children and adolescents ( under 18 years of age ) the safety and efficacy in patients younger than 18 years has not been established . however , there is no data available on the use and effects on the child ' s well - being in this age group . therefore , you should speak with your doctor for advice on the possible undesirable effects
always take zerene exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is 10 mg taken once a day , preferably at bedtime or before going to bed . do not go to bed until you have finished taking the capsule , as you may have difficulty falling asleep . take care not to get caught up in the chaos of everyday life . people who are 65 years of age or older , who have mild to moderate liver problems , can take the dose as follows : 65 kg or more : one capsule of 5 mg , which will mostly be taken by mouth , but you should not take more than one capsule in the morning and two capsules in the evening ; one adult must take the capsule with food as they have slowly become cloudy . an overdose may make you increasingly drowsy , and you may
like all medicines , zerene can cause side effects , although not everybody gets them . if you notice any other changes in your health , tell your doctor or pharmacist as soon as possible . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common ( effect affects 1 to 10 users in 100 ) uncommon (1 to 10 user in 1 , 000 ) rare ( impact affects less than 1 patient in 10 and more than 10 ,000 ) not known ( frequency cannot be estimated from the available data ). all medicines may have side effects and they can be serious , but they are usually mild to moderate and are not long - lasting . tell your healthcare professional if any of the following side effects become severe or serious : drowsiness , memory difficulties and sensations like tingling in the extrem
what zerene contains the active substance is zaleplon 5 mg . the other ingredients are : microcrystalline cellulose , pregelatinised starch , silicon dioxide , sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ), titanium dioxide . printing ink : gelatin , titanium dioxide [ e - 171 ], red iron oxide [ i ]), yellow iron oxide , black iron oxide ( ii ) [ s ] ( ph - 13050 ]) sodium leuryl ( sulfate ) and silicon dioxide ( v - 1301 ), shellac , lecithin , simethicone , yellow ironoxide . what zeene looks like and contents
